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Certain bicyclams are highly potent and selective HIV inhibitors, which bind to 
the CXCR4 co-receptor. The lead bicyclam compound, AMD3100 (1,1'-(1,4-
phenylenebisrnethylene)-bis- 1,4,8,11 -tetraazacyclotetradecane, referred to as xylyl-
bicyclam) has been in clinical trials as an anti-HIV drug, and is also used clinically for 
the mobilization of stem cells. Studies have shown that the Zn(II) complex of xylyl-
bicyclam is more active than the free ligand. However, all other transition metal 
complexes of xylyl-bicyclam are less active. Zn(II) is a biologically essential metal ion 
and may play a key role in the anti-HIV activity of bicyclams. Recently, a new bis-
macrocycle was discovered with even greater activity, AMD3329, which incorporates a 
pyridine ring into the macrocyclic framework. 
In order to elucidate the mechanism of action of AMD3 100, the synthesis of 
several metal-cyclam complexes, metal complexes of xylyl-bicyclam, AMD3329 and its 
component macrocycle, and their metal complexes was carried out. 
1D and 2D 'H, ' 3C and ' 5N NMR spectroscopy revealed that Pd(II)-cyclarn 
complexes exist as one configuration in aqueous solution, the trans-Ill configuration. 
Ni(II)-cyclam was found to be in the trans-Ill configuration in the solid state, and in a 
mixture of trans square-planar (diamagnetic) and octahedral (paramagnetic) 
configurations in solution. The configuration of Cu(II)-cyclam in the solid state was 
also trans-Ill. Co(III)-cyclam was shown to be in three trans configurations by 1D and 
Ii 
2D 'U, ' 3C and 15 N studies and UV-vis spectroscopy. In the solid state, the cobalt 
cyclarn was also found to be in the trans-Ill configuration. 
Xylyl-bicyclam was synthesised, and complexed with palladium, nickel, copper 
and cobalt. 1D and 2D 'H, ' 3C and ' 5 N NMR studies revealed that [Pd2(xylyl-
bicyclam)](OAc)4 exists as one major configuration in aqueous solution, the trans-Ill 
configuration. The addition of acetate to this solution did not induce any configurational 
change. NMR studies on [Ni 2(xylyl-bicyclam)](OAc)4 showed it to be a mixture of 
paramagnetic and diamagnetic species in solution. UV-vis spectroscopy showed the 
main configuration to be square-planar. Two trans configurations of [CO2(xylyl-
bicyclarn)C14]C12 were identified using 1D and 2D 'H, ' 3C and ' 5N NMR spectroscopy. 
Upon addition of acetate to this complex, configurational changes occur, eventually to 
give one trans configuration. Mass spectrometry on this product showed it to be 
[CO2(xylyl-bicyclarn)(OAc)4] (OAc)2. 
AMD 3329 (a bis-macrocycle of pyridyl isocyclam with a phenyl linker) and its 
component macrocycle were synthesised, and complexed with Cd(H), using NMR-active 
enriched "Cd. Using 1D and 2D 'H, ' 3C, ' 5 N and "Cd NMR spectroscopy, these 
novel metallomacrocycles were fully characterised, and two configurations were found 
in solution for both the 111 Cd-macrocycle and the analogous AMD 3329 complex. The 
monomer was also complexed with Zn(II), and NMR studies showed it to exist also in 
two configurations in solution. Addition of excess acetate to the Zn(II) complex did not 
induce any configurational change in the macrocyclic framework. 
The interaction between Cu(II)-cyclam, Ni(Il)-cyclam and Cu(II)-xylyl-bicyclam 
and lysozyme was studied. NMR spectroscopy revealed binding sites in lysozyme 
11 
involving tryptophan residues. Solid-state x-ray crystallographic studies on the copper 
complexes showed the presence of two distinct binding sites. Polar and non-polar 
interactions were established in the protein recognition of the metallomacrocycles, 
including H-bonding between the cyclam ring and protein carboxylate groups, and 
hydrophobic stacking interactions. These studies provide the first direct demonstration 
of the mode of interaction between metal cyclams and proteins and the relevance to 
binding to the CXCR4 protein is discussed. 
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Chapter 1 Introduction 
1.1 Metallodrugs 
Since the discovery of the anticancer drug cisplatin (cis - [Pt(NH3)2C 121) in the 
1960's, 1  the field of bioinorganic chemistry has expanded rapidly. Inorganic 
elements are known to play a vital role in many biological processes, and many 
organic compounds used in medicine are activated by metal ions including 
metalloenzymes. 2  Inorganic elements are used in many fields ranging from 
therapeutic agents, radiopharmaceuticals and enzyme inhibitors to essential elements 
mineral supplements. 2 
Diam(rn)ino Pt(II) complexes are now well established in the clinic as 
anticancer drugs. 3  Cisplatin in one of the most widely used anticancer drugs, as is 
the second generation drug carboplatin. Four injectable Pt(II) complexes have been 
approved for clinical trials, and many other cis-diam(m)ine complexes are in clinical 
trials . 2 It was initially thought that trans Pt(II) drugs were inactive, as trans-platin is 
inactive. However, recent discoveries have shown that the cytotoxic activity of 
trans .-diam(m)inedichlorOplatinUm(II) complexes can be comparable to, or even 
greater than, that of cisplatin, and as such, trans complexes are being studied in 
increasing numbers. 48  With the large variety of amine ligands available, it is 
possible to vary the rates of hydrolysis of the platinum drugs, and in some cases, the 
mode of binding of Pt to DNA has been changed, resulting in drugs that can be used 
in cisplatin resistant cells. 9 
Another group of inorganic compounds found to have anticancer activity is 
metallocenes. The first of these complexes to have its anticancer activity recognized 
1 
was titanocene dichloride (Cp 2TiC12) in 1979 . 10  Since then, the activities of 
vanadium, niobium, molybdenum, iron, germanium and tin metallocenes have also 
been reported." These complexes were initially tested as possible analogues of 
cisplatin, however, the activity of Cp 2TiC12 in platinum resistant cell lines suggests a 
different mechanism of action. 12-14 
More recently, ruthenium complexes have been shown to have anticancer 
activity. 3, Ruthenium(H) arene complexes [(1 6-arene)Ru(en)Cl][PF6] (en = 
ethylenediamine) have been shown to be cytotoxic to cancer cells including cisplatin-
resistant cancer cells. 16, 17 DNA is a potential target for this class of anticancer 
complexes, which exhibit a high selectivity for binding to N7 of guanine bases and in 
contrast to cisplatin, these ruthenium(1I) arene complexes show little interaction with 
adenine.' 8-20 
Several injectable gold drugs are used in the clinic for the treatment of 
rheumatoid arthritis . 2 ' These include Au(I) thiolate complexes which have a high 
affinity for sulfur ligands, yet bind only weakly to N and 0 ligands. As such, the 
targets for Au(I) drugs are proteins which contain cysteine thiolate groups. 
Throughout Au(1) therapy, Au levels in the blood can reach 20 LM, and gold is 
primarily bound to albumin, which implies a protein-mediated transport of gold 
during therapy. It is known that Au(1) complexes can be oxidised to Au(III) after 
administration, and it is thought that this could be responsible for some of the toxic 
side effects of Au(I) drugs. 22 
Radioactive metal ions can be used in diagnosis and therapy. 23 24 High 
intensity y-ray emitters, such as 99huhlc and 67 G are used for diagnostic imaging, and 
3 emitters, such as 89Sr and 153Sm are used for therapy. More than 20 99mTc 
2 
complexes are currently in clinical use. Technetium has an extensive redox 
chemistry, with oxidation states ranging from -1 to +7, and can be tailored to target 
different areas of the body. 99 Tc also has a half life of 6 hours, ideal for use in 
radioimaging, long enough to synthesise, purify, inject into the patient and observe, 
while short enough to minimise the radiation dose to the patient. 
Magnetic resonance imaging is now a common used powerful diagnostic tool 
used in medicine. Contrast agents, containing for example Gd(III) complexes, are 
used to detect differences between normal and abnormal tissues, observable by 
differences in the 'H NMR resonances of H 20.25  Four Gd(III) complexes are widely 
used in the clinic, and can be used to detect many problems in the body, for example 
abnormalities at the blood-brain barrier. There is also a Mn(II) complex used in the 
clinic for similar purposes. Most contrasting agents consist of ions which have a 
large number of unpaired electrons, for example Gd(ITI) has 7, and long electron 
relaxation spin times. 
Bismuth compounds have long been used as a treatment for intestinal 
disorders . 26  Bi(IIl) complexes, such as the nitrate and salicylate salts, are used to 
treat ulcers, although little is known about their structure and exact mode of action. 
BI(Ill) citrates are used as antiulcer drugs, as they have antimicrobial activity against 
Helicobacter pylon, a bacterium which prevents ulcers from healing. 
Lithium is used in the treatment of bipolar affective disorders such as manic 
depression.' It is taken in tablet form, as Li 2CO3. Li is a very small ion, which 
binds weakly to ligands, and becomes strongly hydrated in water. After 
administration, lithium is widely distributed throughout the body, with blood plasma 
concentrations reaching up to 0.8 mM. However, lithium has a narrow 
3 
therapeutic/toxic ratio, and as such, blood plasma concentrations must be monitored 
closely. 
1.2 HIV and AIDS 
1.2.1 The Discovery of HIV and AIDS 
In 1981, health care workers in the USA became aware of an increased 
frequency of Kaposi's sarcoma, a cancer of the skin and blood vessels, and of 
Pneumocystis pneumonia, a respiratory infection. 27 Both of these diseases are 
extremely rare in the general population, but occur more frequently in 
immunosuppressed individuals. This led to the recognition of an immune system 
disorder that was named acquired immunodeficiency virus (AIDS). By 1983, the 
precursor was identified, and called human immunodeficiency virus (HIV). It is 
thought that the virus arose by evolution from another virus in central Africa and 
may have been an unrecognised cause of death for many years. The virus has been 
identified in preserved blood samples from as early as 1959.27  As HIV causes T 
helper cells to become depleted, the immune system becomes extremely 
compromised as more and more T helper cells are destroyed, until a point when 
opportunistic diseases, such as Kaposi's sarcoma, can become established in the 
body without the body's normal defence mechanisms to fight off these diseases. 
1.2.2 HIV Life Cycle 
HIV enters the cell by first binding to the CD4 cellular receptor, which causes 
a conformational change in gp120, a viral envelope protein. 
28  It then binds to a 
An 
second receptor, which exposes part of the gp4 1 viral protein, which allows fusion to 
the host cell membrane and the viral protein gp4l anchors to the cell membrane. 
This allows the contents of the virus to be emptied into the cell, and then replication 
of the viral RNA can occur. The second receptor was found to be the CXC-
chemokine receptor CXCR4. Its natural ligand is stromal-cell derived factor 1 (SDF-
1). Chemokines are small secreted proteins that control the recruitment of many cell 
types to sites of infection or injury, and guide immature cells to their sites for 
maturation and activation. 
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Figure 1.1 WV replication cycle in a T helper cell, showing the eight steps 
involved in viral replication. Key targets for anti-HIV drugs shown. A T helper cell 
is a type of white blood cell. 
Once the virus has released its contents into the cell, reverse transcriptase catalyses 
the synthesis of a DNA strand complementary to the viral RNA (Figure 1.1). The 
new DNA strand then acts as a template for the synthesis of its complementary DNA 
strand and the double stranded DNA is then incorporated as a provirus into the host 
cell's genome. Proviral genes are then transcribed into messenger RNA molecules 
that are translated in the cytoplasm into HIV proteins. The RNA transcribed from 
the provirus also provides genomes for the next generation of viruses. The assembly 
of capsids around the genomes is followed by the budding of the new viruses from 
the host cell. The infected cells may then produce more viruses for some time or 
may be killed quickly by the virus itself or by the immune system. This process 
occurs in T helper cells, which defend against intracellular pathogens. The T helper 
cell binds to antigens on the surface of a pathogen, and this triggers a response in the 
body that causes the destruction of the pathogen. CD4 is a protein on the surface of 
T helper cells that greatly enhances the binding of T helper cells to the pathogen. 
27 
1.3 Current Treatments for HIV 
There are three main types of drugs currently used in the treatment of HIV 
infections. The classes are (i) nucleoside reverse transcriptase inhibitors (NRTIs), (ii) 
non-nucleoside reverse transcriptase inhibitors (NtRTIs) and (iii) protease inhibitors. 
However these only target two parts of the HIV life cycle, so new targets are being 
considered, mainly (i) viral adsorption, through binding to the viral envelope 
glycoprotein gp120, (ii) viral entry, through blocking the viral coreceptors CXCR4 
and CCR5, (iii) virus-cell fusion, through binding to the viral envelope protein gp4 1, 
(iv) viral assembly and dissembly, (v) proviral DNA integration, through integrase 
inhibitors and (iv) viral mRNA transcription, through inhibitors of the transcription 
process. Combination therapy, consisting of at least three different anti-HIV drugs 
has become the standard method of treatment for HIV-infected patients. 
1.3.1 Nucleoside Reverse Transcriptase Inhibitors 
This category consists of zidovudine, 1, didanosine, 2, and abacavir, 3, shown 
in Figure 1.2, which act by inhibiting the replication of HIV by blocking the 
synthesis of proviral DNA .21  They are first activated in the cell after 
phosphorylation steps by cell enzymes and then act as chain terminators and/or 
inhibitors at the substrate binding site of the reverse transcriptase, hence inhibiting 
viral DNA replication. Zidovudine is commonly known as AZT. 
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Figure 1.2 Zidovudine, 1, didanosine, 2, and abacavir, 3 
1.3.2 Non-Nucleoside Reverse Tran scriptase Inhibitors 
Non-nucleoside reverse transcriptase inhibitors are not DNA chain-
terminators. These interact with the reverse transcriptase enzyme at a non-substrate 
7 
binding site, which changes the conformation of the binding site, preventing virus 
replication. 27 However, resistant mutated viruses quickly arise and as such, these 
drugs are best used in combination with other anti-HIV drugs. This category 










Figure 1.3 Nevirapine, 4, efavirenz, 5, and delavirdine 6 
1.3.3 Protease Inhibitors 
Protease inhibitors specifically inhibit the virus-associated protease, and 
drugs such as saquinavir, 7, and indinavir, 8, shown in Figure 1.4, fall into this 
category. Saquinavir was the first drug of this type to be approved for the treatment 
of HIV, and it was designed by computer modelling as a molecule that would fit into 
the active site of the HIV protease enzyme. 
27 This protease cleaves the viral 
structural proteins to form the mature virion core and activate the reverse 
transcriptase needed for the next round of infection. Protease inhibitors produce non-
infectious viral particles. 
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Figure 1.4 Saquinavir, 7, and indinavir, 8 
1.3.4 Entry Inhibitors 
Entry inhibitors are potential new anti-HIV drugs. 29  An example of an entry 
inhibitor is a CXCR4 antagonist. CXCR4 antagonists work by blocking the 
replication of X4 HIV- 1 strains through selective antagonism of CXCR4. A series of 
bicyclams have been found to be the most potent CXCR4 antagonists to date. 3° The 
most active of these is xylyl-bicyclam, 9, shown in Figure 1.5, (also known as AMD 
3100, which is the octahydrochloride salt) which inhibits the replication of X4 HIV-1 
strains within the nanomolar concentration range. It is not toxic to the host cells at 
concentrations up to 500 .iM, as such its ratio of 50 % cytotoxic concentration 
(CC50) to 50 % antivirally effective concentration (EC50) can be estimated at > 
100,000. 11 
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Figure 1.5 Xylyl-bicyclam, 9 
1.4 CXCR4 Coreceptor 
1.4.1 CXCR4 Coreceptor Function and Structure 
The CXCR4 chemokine receptor is expressed on a wide variety of cells, not 
only leukocytes, but also cells outside the immune system. 27 The receptor and its 
ligand SDF are involved in the control of migration and tissue targeting. 
The CXCR4 receptor is a G-protein-coupled, seven-helix transmembrane 
protein (Figure 1.6). G-protein-coupled receptors are involved in the regulation of 
nearly all physiological conditions. 
The CXCR4 receptor does not have any free extracellular cysteines, the main 
interaction points with xylyl-bicyclam has been shown to be two aspartates. 32 
Several histidine residues are located in the TM-Ill, TM-V and TM-VII helices 
pointing toward the main ligand binding crevice. As such, metal ion coordination 
10 
could improve the binding mode of xylyl-bicyclam by interacting with one or both of 
the aspartates (Aspl71 and Asp262), or histidine residues could interact with the 
metal ions in bicyclam. 33 
CCR5 is also a chemokine receptor located on the surface of T helper cells, 
and HIV also uses this receptor to enter the cells. It has been shown that different 
phenotypes of the virus, R5 and X4, use the different receptors, CCR5 and CXCR4 
respectively. The X4 virus has been associated with a faster decline in T cell counts 
and faster progression to AIDS. 34 
LJXJ -COOH 
Figure 1.6 Helical wheel (A) and serpentine diagram (B) of the CXCR4 receptor. 
White letters in red circles represent residues that could interact with xylyl-
bicyclam.33 
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Xylyl-bicyclam does not interfere with the replication of the R5 HIV strains, 
which use the CCR5 receptor to enter host cells. The natural ligand for the CXCR4 
receptor. SDF-1, was found to inhibit HIV replication for X4 HIV strains. When 
exposed to a mixture of X4 and R5 HIV-1 strains, xylyl-bicyclam specifically 
impeded the replication of X4 strains, although it allowed the growth of the R5 
strains. These findings suggest that the selective blockade of the CXCR4 receptor by 
xylyl-bicyclam would prevent the switch from the less pathogenic R5 HIV strains to 
the more pathogenic X4 HIV strains. When this process occurs in vivo, it leads to 
the onset of AIDS. 30 
1.4.2 Side-effects 
By blocking the CXCR4 receptor, xylyl-bicyclam mobilises CD34 stem 
cells from the bone marrow. Stem cells are normally retained in the bone marrow by 
the agonistic action of SDF- 1 (Agonist - triggers a response, antagonist - blocks a 
response). By blocking this agonist interaction, xylyl-bicyclam causes stem cells to 
be released into the bloodstream. This has been observed in mice and in humans. 
Mice that are genetically modified so as not to have CXCR4 receptors die in utero, 
and are lacking in vascular development. However, this is related to development, 
and it is questioned whether or not CXCR4 and its ligand SDF- 1 are essential and 
functional in post development. 30 Moreover, as opposed to being a side effect, the 
mobilization of stem cells has been utilized as an important action of AMD 3100, 
and it is now in clinical trials, as the drug Mozobil. Stern cell mobilization therapy is 
used to restore the immune system of cancer patients who have had treatments that 
previously destroyed their immune cells. 
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1.5 Optimising the Structure of the Bicyclams 
1.5.1 Varying the size of the ring 
In order to maximise the anti-HIV activity of the newly discovered 
bicyclarns, many derivatives were synthesised and tested . 35 Firstly, the size of the 
cyclam ring was varied, from 12 membered to 16 membered, compounds 10-19 in 
Figure 1.7, with both meta and para substituted aromatic bridges. It was found that 
by increasing the size of the ring from 12 to 14 membered generally increased the 
activity in both meta and para substituted bicyclams. However, upon increasing the 
size of the ring further, activity began to decline again. 
In varying the substitution of the phenyl linker, it was found that meta 
substituted compounds had a greater activity than para compounds at a ring size of 
12 and 13, however, a ring size of 14 or above was found to result in the para 
variants having greater activity. The activities for these are summarised in Table 1.1. 
Ortho, meta and para xylyl-bicyclam have all been tested for their anti-HIV activity, 
para having the greatest, meta slightly less, and ortho being significantly less active 
than both. 
One of the cyclam rings has been replaced with an acyclical polyamine 
equivalent, compound 20, shown in Figure 1.7. This resulted in an 89-fold reduction 
in activity, suggesting that a more rigid array was necessary for optimum activity. 
Adding ethyl groups to each of the nitrogen groups (21) reduced the activity by 2 
orders of magnitude, as did changing the position of the linker from the nitrogens to 
6, 6' carbons (22). 
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Figure 1.7 Various bicyclams that have been tested for their anti-HIV activity, with 
varying macrocyclic ring size 35,36  
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Table 1.1 EC50a  and CC501  values for bicyciam derivatives of differing ring 
3 size 5 





9 0.0042 0.0059 >421 
10 0.3218 2.3600 >55 
11 0.0751 0.5364 >20 
12 0.1668 0.2341 >216 
13 0.0408 0.0618 >191 
14 1.3574 3.1279 >168 
15 0.0337 0.0422 >421 
16 1.6714 2.0072 171 
17 2.7247 11.715 >190 
18 9.1301 13.695 48 
19 16.739 71.519 193 
20 0.3730 0.7110 >444 
21 7.7947 14.564 >341 
22 0.5059 0.6745 406 
a  EC50 = The 50 % antiviral effective concentration; the molar concentration of an 
agonist which produces 50% of the maximum possible response for that agonist. 
CC50 = The 50 % cytotoxic concentration; the concentration of an agonist which 
reduces viral viability in infected cells by 50%. 
Where greater than is used, this was the highest concentration tested. 
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1.5.2 Varying the Linker 
The effect of adding substituents, of varying electron-withdrawing and 
donating strength, to the phenyl linker has also been investigated. 
35  The results 
showed that by adding dimethyl, dichloro, bromo, dimethoxy and tetrafluoro to the 
phenyl linker did not significantly alter the activity compared to xylyl-bicyclam 
alone (Table 1.2). However, the introduction of multiple halogen substituents did 
significantly increase the cytotoxicity of the compounds. It was found that the 
addition of bulky substituents to the phenyl linker, for example, another phenyl ring, 
greatly reduced the activity. It is thought that this reduction in activity was brought 
about by a restriction in the ability of the cyclam rings to rotate around the linker. 
This was proved by showing that the para-substituted phenyl linker with another 
phenyl group attached in the 2 position has a much lower activity than that of the 
meta substituted analogue, where the substituent is in a nonrestricting position 
(position 5) and the activity is not as reduced. 
In a further series of tests, the length of the linker was increased, to an 
ethylene or a propylene chain, to study how the activity changed. The results of this 
were surprising. Although both had reduced activity compared to xylyl-bicyclam, 
the compound with the propylene linker was found to have a high selectivity against 
HIV-1 over HIV-2, with its EC50 value against HIV-1 being 36-fold lower than its 
EC50 value against HIV-2. However, it is clear that the optimum activity is achieved 
by having a methylene group between the cyclam ring and the phenyl group. 
1.5.3 Heteroaroinatic Linkers 
Bicyclam analogues with pyridine and pyrazine linkers in place of the phenyl 
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Table 1.2 Structure of linkers (each one replacing the phenyl linker in xylyl-
bicyclam, 9) and EC50 and CC50 values 
-e
Linkeç 
NH 	N 	 N 	HN 













0.0107 0.0025 58 
2-bromo 








0.0079 0.0079 47  
2-phenyl 0.1062 0.0800 >198 
5-phenyl 0.2060 0.0246 >198 
14.852 69.713 >201 
0.4025 14.489 283 
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linker have been synthesised and their anti-HIV properties determined. 36 It was 
found that the position of the substituents on the heteroaromatic linker greatly 
influenced the anti-HIV activity. The 2,6- and the 3,5-pyridine-linked bicyclams 
showed good anti-HIV activity, but the 2,5- and the 2,4- versions had substantially 
reduced activity and a higher lever of cytotoxicity. Replacing the pyridine linker 
with pyrazine, which is a weaker base, gave similar results, in that the 2,6- analogue 
had better anti-HIV activity than the 2,5- analogue. It was suggested that when the 
pyridine is linked via the 2,4- or the 2,5- positions pendant interactions to occur 
between the rnacrocycle cavity and the pyridine N, which would prevent favourable 
interactions occurring with the anti-HIV target. 
Replacing the pyridine linker with an aniline linker, with aniline having a 
relatively similar pK a  as pyridine, had little effect on the overall activity of the 
compound. Adding a carboxylate to the phenyl linker greatly reduced the activity of 
bicyclam, possibly because the carboxylate on the linker may have a repulsive 
interaction with the target for bicyclam activity, the CXCR4 receptor. This is 
supported by the activity of the methyl ester derivative, which has good activity 
(EC50 values of 0.6825 and 0.5904 .tM against HIV-1 and HIV-2). This shows that it 
is not a steric effect that is causing the reduction in activity when the CO 2H group is 
added. 
1.5.4 Changing the Amine Groups 
Replacing two of the NH groups in each cyclam ring with either sulfur (23, 
Figure 1.8) or oxygen (24) resulted in a significant decrease in activity. 37 In addition 
to this, the introduction of sulfur to the macrocycle greatly increased the cytotoxicity 
of the compound. 
A macrocycle similar to cyclam, but with the CH2 chain lengths having the 
sequence 2,2,3,3 (compound 25, meta version and 26, para version, Figure 1.8) 
instead of 3,2,3,2 as in cyclam, has been prepared and analogues of it tested. 38 
Replacing one of the NH groups with either oxygen (27) or a methyl (28) resulted in 
a loss of activity, compared to the 4 amine version, showing that all 4 amine groups 
are necessary for the anti-HIV activity. This isocyclam had slightly less activity than 
the original xylyl-bicyclam. 
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Figure 1.8 Bis-macrocycles that have been tested for their anti-HIV activity 
1.5.5 Incorporation of Pyridine Rings Into the Macrocyclic Framework 
Several analogues were also prepared with a pyridine ring incorporated into the 
macrocyclic framework (Figure 1.9) . 38  The first reported compound with a pyridine 
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ring (29) was found to have an EC 50 value of 0.53 jiM against HIV-1. The 
corresponding phenyl analogue (30) was found to have an EC 50 value of 7.96 .LM, 
showing that the pyridine ring was a factor in improving the activity. The basicity of 
the pyridine ring was varied by adding different substituents in the 4-position. 
Adding an electron-withdrawing chioro group (31), and hence lowering the pK a of 
the pyridine ring, had little effect on the overall anti-HIV activity, but increased the 
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Figure 1.9 Anti-HIV bis-macrocycles, with aromatic rings incorporated within the 
macrocyclic framework 37 
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more basic, for example electron-donating methoxy (32) or phenyl (33) groups, 
resulted in a loss of anti-HIV activity. Exchanging the pyridine ring for a pyrazine 
ring (34), which is significantly less basic than pyridine, resulted in an unexpected 
loss of activity. 
The ring size of the macrocycle with a pyridine ring incorporated into it was 
also varied to optimise the anti-HIV activity. The ring size was varied from 12 (35) 
to 16 (36), with little difference being found in the activity between the different ring 
sizes, unlike in the analogous bicyclam study. Finally, an isomer of the most potent 
pyridine macrocycle was synthesised (37), and it was found to have the best EC 50 
values of any of the bicyclams synthesised, including xylyl-bicyclam. This new 
compound, AMD3329, had EC50 values of 0.8 nM against HIV-1 and 1.6 nM against 
HIV-2, with the CC50 value being 199 RM. 
Table 1.3 EC50 and CC,  0 Values against HIV for Bis-Macrocycles with 
Aromatic Rings Incorporated into the Framework 37 





29 0.5 342 Not tested 199 
30 7.9605 Not tested 133 
31 0.7509 0.7593 17.8 
32 3.0979 8.4605 216 
33 1.7547 Not tested 19.3 
34 30.942 20.741 209 
35 0.5238 0.1273 8.5 
36 0.4213 1.2068 142 
37 0.0008 0.0016 199 
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1.5.6 Metals and Bicyclam 
The activity of M21 transition metal complexes of xylyl-bicyclam has been 
investigated .35, 39  It was found that the addition of zinc gave a similar result to 
bicyclam against HIV-1, and a 2-fold increase in activity against HIV-2 (Table 1.4). 
The copper complex was found to be slightly less active, and the palladium 
derivative was inactive. It was suggested that perhaps xylyl-bicyclam forms 
complexes with zinc in the blood, and as such should be considered a prodrug, rather 
than a drug. 








Zn2 0.0077 0/0009 >250 
Ni2 0.0078 0.0157 >250 
Cu2 0.0436 0.1818 >250 
Co 3+ 0.7697 0.5200 >250 
Pd-' + 57.881 10.544 >250 
Zn2  is located in the centre of the cyclam ring, bonded to the 4 nitrogen groups 
Zn2  can be 4-, 5- or 6-coordinate, and this can leave one or two vacant coordination 
sites which could interact with histidine or cysteine residues on the protein, or with 
acidic residues such as aspartates. 
22 
The affinity of xylyl-bicyclam for to the CXCR4 chemokine receptor is 
enhanced 7, 36, and 50-fold respectively, by incorporation of Cu 
2+,  Zn2 or Ni2 into 
the cyclam rings of the compound 
.33  Studies of xylyl-bicyclam with only one metal 
ion complexed (either Cu 2 or Ni2 ) showed that the increased binding affinity of the 
metal ion substituted xylyl-bicyclam is achieved through an enhanced interaction of 
just one of the ring systems. Mutational analysis showed that the binding of the 
xylyl-bicyclam is dependent on both Aspl71 and Asp262. 33 The enhancing effect of 
the metal ion was selectively eliminated by substitution of Asp262 located at the 
extracellular end of TM-VT. It was concluded that the increased binding affinity of 
the metal ion substituted xylyl-bicyclam is obtained through enhanced interaction of 
one of the cyclam ring systems with the carboxylate group of Asp262. It was 
suggested that this occurs through a strong interaction of one of the oxygen atoms 
directly with the metal ion and the other oxygen with one of the nitrogens of the 
cyclam ring through a hydrogen bond. 
The only crystal structure of a metal -xyl yl-bicycl am is zinc(II) xylyl-
bicyclam, as the acetate complex [Zn 2(xylyl-bicyclam)(OAc)21(OAc)2. 40 It was 
shown that both cyclam rings crystallised in the same configuration, the folded cis-V 
configuration (see Figure 1.10 for configurations of metal cyclams). The zinc is in a 
distorted octahedral geometry. The acetate ligand is chelating, and on the other face 
of the ring, the acetate forms a double hydrogen bond to two of the NH protons. 
However, NMR studies showed that in solution, over a period of approximately 20 
minutes, equilibrium was reached and the configuration of the macrocycle altered. 
The end composition of the solution was 58 % cis-V, 35 % trans-I and 7 % trans-Ill. 
It was shown that the predominant species was cis-V/trans-I (44 %) with cis-V/cis-V 
23 
Figure 1.10 Configurational isomers of cyclam 
making up 29 % of the total solution. The solution structure for Zn2(xylyl-
bicyclam)(ClO)4 has also been determined. This solution took longer to reach 
equilibrium (6 hours) and was found to be 45 % trans-I, 34 % trans-Ill and 21 % cis-
V. The cis-V/trans-I was again found to be the major configuration in the solution 
(26 %). Addition of acetate (4 molar equivalents) to this solution was found to 
induce a configurational change, with the cis-V configuration becoming the most 
predominant. The cis-V/cis-V configuration increased from 0 % to 19 %, and the 
cis-V/trans-I configuration increased to 38 %. 
1.5.7 Zn 2(XyIyI-Bicyc1am) Binding to CXCR4 Coreceptor 
An homology model of the CXCR4 coreceptor, based on the 7 helical 
transmembrane structure of bovine rhodospin has been prepared '41 and this model 
24 
was used to model the binding of Zn 2-xylyl-bicyclam to the receptor. 4° The cis-
V/trans-I model was used as this is the most predominant configuration in solution. 
The cis-V cyclarn ring was coordinated to Asp262, with the Zn(II)-carboxylate bond 
length of 2.27 A, which was similar to the equivalent bond length in the [Zn2(xylyl-
bicyclam)(OAc)21(OAc)2 crystal structure. The opposite face of the cis-V cyclam 
ring forms a double hydrogen bond from the two NH groups to the oxygens of the 
G1u288, with the hydrogen bonds being 2.01 A in length. The trans-I cyclam ring is 
bound to the oxygens of Asp 171, with the bond length being 2.28 A. 
Aspl7l and Asp262 are found in the trans-membrane helices IV and VI, 
respectively, and these were identified as key binding sites for xylyl-bicyclam by 
mutagenesis studies. 32 The phenyl linker is known to be important for the high anti-
HIV activity of the bicyclams, 37  and in the homology model of the CXCR4 
coreceptor there is a high population of aromatic amino acid side chains in the 
extracellular loop which could form aromatic 2t-7t stacking interactions with the 
phenyl linker. This could stabilize intermediate binding steps along the pathway 
through the extracellular loops. 
1.6 Cyclam 
1.6.1 Cyclam Background 
Macrocyclic ligands are prominent in naturally occurring ligands in biology, 
such as the 16-membered inner ring in the porphyrin ligand of heme proteins and the 
15-membered ring in the corrin ligand of vitamin B12. The man-made ligand 
cyclam (1,4,8.11 -tetraazacyclotetradecane, 38, Figure 1.11), was first synthesized in 
25 
193742, and is a 14-membered heterocycle. Cyclam, along with its derivatives, is of 





Figure 1.11 Cyclam, 38 
Macrocyclic polyamines are highly protonated and bind transition metal ions 
strongly via coordination. 
49 As macrocyclic polyamines have a restricted geometry, 
the nitrogen lone pairs may overlap to bring about high electron density within the 
cavity. Cyclam has a high affinity for protons, the first two pK a values being 11.5 
and 10.3 (See Table 1.5). However, once these two protons are incorporated, steric 
and electrostatic repulsions come into effect (shown in Figure 1.12) and the last two 
proton affinities are weak, with pK a values for cyclam of 1.6 and 0.9.50  For the linear 
tetraamine, the third and fourth pK a values for it are 7.3 and 6.0. 
Several values for the pK a  values for cyclam have been published. Most are 
in close agreement for the first three, but the values of the last pK a differ from 0.9 to 
2.4. These are shown in Table 1.5. 
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Table 1.5 Protonation Values for Cyclam 
pKa i pKa2 pKa3 pKa4 Conditions Reference 
11.49 10.24 1.64 0.86 Unknown 50 
11.585 10.62 1.61 2.41* 0.5 M KNO3, 25 °C 51 
11.3 10.23 1.43 2.27* 0.1 MNaNO3,25 °C. 52 
11.29 10.19 1.61 1.91* 0.1MKC1,25 °C 53 
* No explanation is given for the value of pKa4 being higher than that of pKa3. 
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Figure 1.12 Protonation steps for cyclam. 
Macrocycles are also extremely favourable for metal complexation. In terms 
of the entropy factor, this can be seen as an extension of the "chelate effect" that is a 
major contribution to an increase in complex stability as the number of chelate rings 
increases. The size of the metal ion and the cavity size greatly influences the 
stability of a metal- macrocycle complex. For example Cu(II)-cyclam is more stable 
(log K = 30.5) than the equivalent 15-membered macrocycle complex (log K = 
27 
24 4)49 
Macrocyclic amines form stable complexes with nearly all transition metal 
ions. 49 The stability of the macrocyclic complexes depends on the size of the metal 
ion and the configuration of the cyclam. The values for log K for Cu(ll), Ni(II), 
Co(II), Zn(II) and Cd(II) cyclam complexes have been determined and are shown in 
Table 1.6, and this shows the stability depends on the size of the metal ion. 
Table 1.6 Stability constants for cyclam complexes and ionic radii 
M2 r (A) 
log K 
Cyclam Reference 
Cu2 0.72 27.2 54 
Ni2 0.69 22.2 50 
Zn2 0.74 15.0 or 15.5 55,56 
Co2 0.75 12.7 57 
Cd2 0.97 11.7 58 
Work has been done on the uptake of zinc by cyclam under physiological 
conditions. It is possible that bicyclam picks up zinc from the blood so this was 
investigated. It was shown that at 37 °C and pH = 7.4, cyclam can complex zinc, and 
that the initial reaction rate is 7.2 x 10 M s, with equilibrium being reached in 
approximately 2 hours, at which point 66 % of the zinc was bound to the cyclam. 59 
In the same study, competitive binding between zinc and copper was monitored, as 
copper is also present in the blood. It was found that zinc bound in preference to 
copper under these conditions, despite Cu(II) being the more thermodynamically 
WZ 
favoured metal ion. 
1.6.2 Configurational Isomers 
There are five configurational trans isomers of metal cyclarn adducts, which 
differ in the chirality of the N atoms. 
60, 61 These are usually designated as trans-I 
(RSRS,++++), trans-I! (RSRR,+-++), trans-Ill (RRSS,+--+), trans-IV (RSSR,++--) 
and trans-V (RRRR,+-+-), shown in Figure 1.10. The configurations that are 
symmetrical about the diagonal can fold to form cis isomers, e.g., the trans-V isomer 
can fold to give the cis-V structure. Semi-quantitative analysis of the relative strain 
energies of the five isomers indicates that the trans-Ill form is the most stable.61' 
62 
However, it has been noted that trans-I is more favoured for square-planar 
complexes, while octahedral complexes prefer trans-I11.63 
In contrast to oxygen-donor and sulfur-donor macrocyclic ligands, 
macrocyclic polyamines are much more basic and are also subject to deprotonation. 64 
Much work had been carried out on the kinetics of the formation of Ni(II) cyclam in 
aqueous solution. 65  It was found that the monoprotonated and diprotonated species 
exhibit formation rate constants 3 x 10 4  times slower than the equivalent open chain 
species. 
1.6.3 Metal Cyclams 
A search of the Cambridge Crystallographic Structural Database was carried 
out for configurations of nickel, cobalt, copper, zinc and palladium cyclam 
complexes. The results are shown in Table 1.7. For Ni(II) and Zn(II), the reported 
Im 
trans-Ill structures all contain 6-coordinate, octahedral metal ions, while the cis-V 
complexes all contain bridging or chelating ligands. However, there is one exception 
to this. Barefield et al. 66  reported a cis-V complex with two water molecules bound 
to a Ni (11)-cyclam. In this case, the complex was prepared via the acidification of 
cis-V [Ni(cyclam)(en)] 2t The ethylenediamine ligand can coordinate only in the cis 
positions, which forces the cyclam to fold. Their findings indicate that 
configurational interconversion of cis-V to trans-ill Ni(II)-cyclam is slow, in 
contrast to Zn(II)-cyclam. 4°  There is an interesting example of a Ni(II) complex that 
crystallises with two different cyclam configurations within the unit cell. 67 The 
complex [N1 2(cyclam)2(SH)2](Cl04)2 [Ni(cyclam)(SH)2] features two cis-V Ni(II)-
cyclam units bridged by two SW groups, and a separate Ni(Il)-cyclam in the trans-Ill 
configuration, with two SH ligands bound in the axial positions to octahedral Ni(II). 
The only trans-V complex found in the database is tNi(cyclam)i1(ZnC 14), which 
66 contains four co-ordinate Ni(H). 
Table 1.7 Number of Entries and Configurations of Metal-Cyclam Complexes 
in the CSD 
Metal trans-I, II, IV trans-Ill trans-V cis-V trans-Ill + cis-V 
Nickel 0 53 1 6 1 
Cobalt 0 17 0 5 0 
Copper 0 34 0 0 0 
Zinc 0 11 0 0 0 
Palladium 0 8 0 0 0 
30 
In the X-ray crystal structures of [Zn(cyclarn)(H20)2](OAc)2 the macrocycle 
adopts the trans-Ill configuration and the axial Zn—OH2 bonds are long (2.27 A).68 
Similarly the phthalate bridged complex [Zn(cyclam)(phthalate)1(CH30H) 2  is also 
trans-Ill. In aqueous solution these carboxylato Zn(II) cyclam complexes exist as 
mixtures of trans-I, trans-Ill and cis-V configurations. 
Liang et al. carried out NMR solution studies on Cd(cyclam)(C104)2, 
Cd(cyclam)C12 and [Cd 3 (cyc1am) 3(CO3)](Cl04)43H20 and used these to identify key 
markers for various configurations adopted by these complexes. 
69 Cadmium was 
used for this study because its isotopes (II  'Cd and 113Cd, I = 1/2) are favourable for 
NMR studies, unlike those of zinc. A variety of solution conditions were analysed 
using 1D and 2D 'I-I, 13C, 15 N and 111 C NMR spectroscopy, including Karplus-type 
analyses of 'H, 'H and 'H, 111 Cd coupling constants. Only the trans-I and trans-Ill 
configurations have six non-equivalent protons and hence give rise to six proton 
resonances, while the trans-IV, trans-V and cis-V configurations have five non-
equivalent protons and give rise to five proton resonances. The X-ray crystal 
structure of [Cd3(cyclam)3(CO3)I(C104)43H20 showed it to be in the uncommon 
folded cis-I configuration with all of the N—H bonds oriented upwards, while the 
NMR studies suggested that it adopts the trans-I configuration in solution. 
Co(III)-cyclam chloride and Mn(II)-cyclam chloride complexes have been 
co-crystallised by Chen et al. 
70 in both of these units, the cyclarn rings are in the 
trans-Ill configuration. Both metals are octahedral with two trans chloride ligands. 
All the reported Co(III)-cyclam complexes contain octahedral cobalt. There are three 
reported Co(ffl)-cyclam complexes that have chelating ligands, 
[Co(cyclam)(acetyl acetonate)] (BF4) ,' 
	
[Co(cyclam)(ethylenediamine)]C13 . 3H 2072 
31 
and [Co-(cyclam)(oxalato-O, 0 ')1(NO3).73 These complexes are in the cis-V 
configuration, which is expected as a chelating ligand would not accommodate the 
mOre common trans-Ill configuration. The reported trans-Ill Co(II) structures are all 
six coordinate, except for the complex [Co(cyclam)](Cl04), reported by Endicott et 
al., which is four-coordinate, with a perchlorate counterion. 74 There are only two 
reported cis-V cobalt complexes that contain bridging ligands, [{Co(II)(cyclam)(ji2-
HS) } 21 2(HS) and [{ Co(III)(cyclam)(112-S) } 2] .2(Cl0 4).2(C2H3N);67 both are dimers, 
with SH and S as bridging ligands. 
The Cu(II)-cyclam complexes are again mostly six coordinate, but five four-
coordinate complexes have been reported. These are [Cu(cyclam)](BH4)2, 75 
[Cu(cyclam)] (CuBr3), 76 [Cu(cyclam)1(CuCI4), 77  the catena complex IjCu(cyclam)(i2-
Cl)],,, n(CdC1 3 .2H20)78  and the tri-cyclam complex 3 [Cu(cyclam)] •2(C1 2 - 
Cu206S6),2(H30)(H20). 79 
The reported Pd(II)-cyclam complexes are all trans-Ill and are four-
coordinate. Yamashita et al. reported the unusual mixed valence complex 
[pd(II)(cyclam)llPd(IV)(cyclam)Cl2](Cl04)4.80 The four-coordinate Pd(II) and six-
coordinate Pd(IV) units are stacked alternately in the direction of the c axis, which 
forms linear chains of Cl—Pd(IV)—Cl—Pd(II), with successive cyclam units rotated 
1800 about the chain axis. Neighbouring Pd(II) and Pd(IV) units are held together by 
two hydrogen bonds, NH-0—NH. These hydrogen bonds are thought to play a vital 
role in the formation of the mixed-valence complex. They also made the six-
coordinate Pd(IV) complex, [Pd(cyclam)C12](NO3)2H20HNO3. The Pd(IV)—Cl 
bond lengths in the mixed-valence complex are slightly longer than in that of the 
Pd(IV) complex. This was attributed to electronic interactions along the chain. A 
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further six coordinate Pd(IV) complex, Pd(II)(cyc1am)] [Pd(IV)(cyclam)C12] (PF 6)4, 
has been reported by Toriurni et al.8 ' In both mixed-valence complexes, the Cl 
bridging ligands are statistically disordered and all the Pd sites comprise 1/2Pd(II) + 
1/2Pd(IV). 
1.7 Recent Developments Involving Cyclam Derivatives 
Interest in cyclam and its derivatives remains strong, and new uses for it are 
still being identified. Lipophilic derivatives of cyclam, have been shown to inhibit 
tumour cell growth. 82  It is thought the lipophilicity of the new analogues facilitates 
the transport of the macrocycles into the cell, where the macrocycle can then carry 
out its function. Cyclam was found to have no effect on the tumour cell growth, 
while the two derivatives had IC50 values of 6.2 and 8.7 pM. Xylyl-bicyclam has 
also been suggested as a possible treatment for tumours, such as breast cancer, which 
are partially dependent on signalling through the CXCR4 receptor. 83 
A series of covalently-coupled cyclam and bicyclam conjugates with AZT 
have been synthesised. AZT was the first drug to be approved by the US Food and 
Drug Administration as an anti-HIV drug and has been extensively studied. One 
variant was shown to be particularly effective, and it seems to target the CXCR4 on 
the cell surface and selectively delivers AZT into the cell, thus increasing the 
efficiency of action. 
Xylyl-bicyclam is currently in Phase 2 clinical trials as a stem cell mobiliser, 
marketed as Mozobil.84' 85  By blocking CXCR4, a specific cellular receptor, xylyl-
bicyclam triggers the rapid movement of stem cells out of the bone marrow and into 
circulating blood. Once in the circulating blood, the stem cells can be collected for 
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use in stem cell transplant. Stem cell transplant is a procedure used to restore the 
immune, system of cancer patients who have had treatments that previously destroyed 
their immune cells. 
Xylyl-bicyclam has also been shown in mice to reduce the severity of 
autoimmune collagen-induced arthritis, which is used as a model for rheumatoid 
arthritis in man. 83,86  
1.8 Aims of This Thesis 
Xylyl-bicyclam is a CXCR4 receptor antagonist and metal complexation by 
xylyl-bicyclam greatly influences its activity. The aims of this thesis were to 
investigate solid and solution state structures of metal complexes of cyclam and 
bicyclarn, and also of the new anti-HIV compound, AMD 3329 and its component 
macrocycle. 
Specific aims were as follows. 
To synthesize and characterise Pd 2+, Ni2 , Co3 and Cu2 complexes of both 
cyclam and xylyl-bicyclam, using techniques such as X-ray crystallography and 
multidimensional NMR spectroscopy. 
To synthesize and characterise 111 Cd2 complexes of AMD 3329 and one of its 
component macrocycles, using "Cd NMR studies to obtain information on the 
solution structure of these novel complexes. 
To investigate the interaction of metal-cyclam and metal-xylyl-bicyclam 
complexes with lysozyme, a model target protein, using X-ray crystallography and 
NMR spectroscopy. 
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Chapter 2 Materials and Methods 
2.1 Chemicals and Instruments 
2.1.1 Chemicals 
Cyclam (1,4,8,11 -tetraazacyclotetradecane), palladium acetate, nickel nitrate 
hexahydrate, potassium tetrachioropalladate, cobalt acetate tetrahydrate, copper 
acetate monohydrate, cobalt chloride hexahydrate, ethyl trifluoroacetate, 2,6-
pyridinemthanol, zinc acetate dihydrate, methane sulfonyl chloride, Raney nickel, 
(Aldrich Chemical Co.), a,' -dibromo-p-xylene, diethyl chlorophosphate, 
diethanolamine, histidine (Fluka), nickel acetate tetrahydrate, (BDH Ltd.), nickel 
chloride hexahydrate, hexamethyl phosphoric triamide, cetyl trimethylammonium 
bromide, p-toluene sulfonyl chloride (Acros Chemical Company) and hen egg white 
lysozyme (Sigma Chemical Co.) were used as received. Isotopically enriched 
cadmium oxide ('CdO, 95.29%) was purchased from Oak Ridge National 
Laboratory, TN. 
Anhydrous solvents were prepared using standard methods. NMR solvents, 
deuterium oxide (Aldrich, 99.9 %) and chloroform-d (Aldrich, 99.9 %), were used as 
received. 
2.1.2 JR Spectroscopy 
Infrared spectra were recorded as KBr pellets in the range 4000 - 400 cm- 
I  on 
a Perkin-Elmer Paragon 1000 Fourier-transform spectrometer. 
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2.1.3 NMR Spectroscopy 
NMR spectra were recorded on either Bruker DPX 360, DMX 500, AVA 
600, BlO 600 or AVA 800 spectrometers using TBI ['H, ' 3C, X] or TX! ['H, ' 3C, X] 
probeheads, and equipped for z-gradients. All spectra were acquired at 298 K, unless 
otherwise stated, using standard pulse sequences in 5 mm NMR tubes. The 'H shifts 
for aqueous solutions were referenced to 1, 4 - dioxane (3.75 ppm).' When DMSO-
d6 was used, peaks were referenced to 1, 4 - dioxane (3.57 ppm) and for CDC13 
solutions, peaks were referenced to CHC13 (7.27 ppm).' NMR data was processed 
using XWIN-NMR (version 3.5, Baiker U.K. Ltd.). 
2.1.4 X-ray Crystallography 
X-ray crystallographic studies were carried out on a Bruker SMART-APEX 
CCD Stadi-4 diffractometer equipped with Oxford Cryosystems low-temperature 
devices by Dr. Simon Parsons and Dr. Andrew Parkin. 
2.1.5 CHN Analysis 
CHN elemental analysis was performed by the CHN service at the University 
of Edinburgh. 
2.1.6 Electrosp ray Ionisation-Mass Spectrometry (ESI-MS) 
Positive-ion electrospray ionisation mass spectra were obtained on a Platform 
II mass spectrometer (Micromass, Manchester, UK). The samples were infused at 8 
pL/min, The source temperature was 383 K, and the drying gas flow rate was 300 
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L/h. A potential of 3.5 kV was applied to the probe tip, and cone voltages of 20 - 45 
V over 200 - 1300 Da were used. Data were processed using Masslynx (v3.5) 
Windows XP PC data systems. 
2.1.7 Ultraviolet and Visible Spectroscopy (UV-Vis) 
UV-Vis absorption spectra were acquired on a Perkin-Elmer ? 16 UV-Vis 
recording spectrophotometer using 1 cm pathlength quartz cuvettes. The temperature 
was controlled using a PTPI Peltier Temperature Programmer. Spectra were 
processed with UVWinIab. Spectra were referenced to the solvent alone. 
2.1.8 pH Measurements: 
The pH values of solutions were determined using a Coming 145 pH meter equipped 
with a micro combination electrode, calibrated with Aldrich buffer solutions at pH 4, 
7 and 10. No correction was made for deuterium isotope effects. 
2.2 NMR Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy provides information about 
the types, number and connectivity of particular atoms. 2 NMR signals were first 
recorded in 1946 and can now routinely be detected for almost any magnetic 
resonance. 3-5 	Many textbooks have been published describing the theory and 
applications of NMR.3' 	6  The nuclei used in this thesis and their magnetic 
properties are shown in Table 2.1. 















½ 4.84 26.75 99.99 1.000 
13C ½ 1.22 6.73 1.11 0.016 
½ 0.49 -2.71 0.37 0.001 
" 1 Cd 1/2 1.03 -5.70 12.80 0.0095 
2.2.1 Nuclear Spin 
For a nucleus to be NMR active, it must possess a magnetic moment. Nuclei 
possess magnetic moments when their spin quantum numbers are equal to or greater 
than ½. The spin states of such nuclei are characterised by the magnetic quantum 
numbers rn = 1, 1-1, 1-2, ... , -I. The spinning of a nucleus generates a magnetic 
moment. The magnetic moment is a vector, because it has both magnitude and 
direction. It is defined by its axis of spin. The NMR experiment utilises these 
magnetic properties of nuclei to provide structural information. The spin properties 
of the protons and neutrons in a nucleus combine to give the overall spin of the 
nucleus. Protons, neutrons and electrons all have a spin of 1=1/2. When both the 
atomic number and the atomic mass are even, the nucleus has no magnetic properties 
and the spin quantum number is 0 (1=0). Every nucleus with a spin angular 
momentum I therefore also possesses a nuclear magnetic moment V. The moment is 
proportional to the spin with a constant of proportionality, 'y, called the magnetogyric 
ratio. Every isotope has a characteristic value of 'y. 
The energy of an NMR transition depends on the magnetic-field strength and 
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the magnetogyric ratio, 'y. The frequency of a transition is given by: 
	
v = (y12t)B 0 	 (Equation 2.1) 
where v is the frequency of the resonance radiation, and B 0 is the strength of the 
magnetic field. 
Without a magnetic field, all 21 + 1 orientations of a spin-I nucleus have the 
same energy. The degeneracy is removed when a magnetic field is applied. The 
magnetic field experienced by a nucleus in a molecule differs slightly from the 
external field in such a way that the exact resonance frequency (the chemical shift) is 
characteristic of the chemical environment of the nucleus. Nuclei with spins greater 
than ½ are called quadrupolar nuclei and generally give broad NMR lines, making 
them difficult to study. 
2.2.2 Chemical Shift 
When an atom is placed in a magnetic field, its electrons circulate about the 
direction of the applied magnetic field (B 0). This circulation causes a small magnetic 
field at the nucleus which opposes the externally applied field.' 
Chemical shifts arise because the field, B, actually experienced by a nucleus 
in an atom or a molecule differs slightly from the external field B 0. In an atom, B is 
slightly smaller that B0 because the external field causes the electrons to circulate 
about the direction of the applied magnetic field. This motion generates a small 
magnetic field B' at the nucleus which opposes the externally applied field. The 
nucleus is hence shielded from the external field by its surrounding electrons, as 
calculated from Equation 2.2. B' is proportional to B0. 
B = B 0 - B' 	 (Equation 2.2) 
Similar effects occur for nuclei in molecules, referred to as nuclear shielding. 
Both the size and sign of the shielding constant are determined by the electronic 
structure of the molecule in the vicinity of the nucleus. The resonance frequency of a 
nucleus is therefore characteristic of its environment. 
The chemical shift is defined in terms of the difference in resonance 
frequencies between the nucleus of interest (v) and a reference nucleus (Vref), by ö, 
= 106 [(V - Vref)/ V ref] 	(Equation 2.3) 
The factor 106 is introduced to scale the numerical value of to a convenient size, 
quoted in parts per million. The more heavily shielded nuclei appear on the right 
hand side of the spectrum, as they have smaller v and smaller & 
Hydrogen bonding can result in large observable deshielding effects in 1 F1 
NMR.6  Intermolecular hydrogen bonds can produce small deshielding effects, but 
intramolecular hydrogen bonds can have a significant effect on the chemical shift of 
a nucleus, resulting in the resonance shifting upfield. 
2.2.3 Spin-Spin Coupling 
Nuclear spin-spin coupling arises from nuclei interacting with each other, and 
causes NMR lines to split into a small number of components with characteristic 
relative intensities and spacings. 
Non-equivalent nuclei which are close to one another exert an influence on 
each other's effective magnetic field. If the distance between non-equivalent nuclei is 
less than or equal to three bond lengths, this effect is observable. This effect is called 
spin-spin coupling or J coupling. 
In general, it is the s-character of the bonds between the coupling nuclei that 
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controls the magnitude J.7  The coupling between nuclei is transmitted via the 
bonding electrons rather than directly through space. Only s-electrons have a finite 
density at the nucleus so the amount of s-character in the valence hybrids used to 
form the chemical bond influences the strength of the coupling. The percentage s-
character can be influenced by many factors. Increasing coordination number leads 
to a decrease in the coupling constant, the s-character of the bond to any given ligand 
decreases as the number of ligands increases. The coupling constant also increases 
with increasing electronegativity of the substituents, in line with a presumed increase 
in the s-character of the bond. 
Interbond angles can also affect the coupling constant. 7 For two bond 
couplings, trans couplings would normally be larger than cis couplings. The larger 
the interbond angle, the larger the coupling constant. For three bond couplings, the 
dihedral angle, 0, between planes containing a coupling nuclei and the bonds 
between them becomes important. The dihedral angle dependence of three bond 
couplings is calculated from the Karplus equation (Equation 2.4), which predicts that 
3J will be greatest when 0 is close to 0° or 180° . 
= Ccos4 + Bcos + A 	(Equation 2.4) 
where A = 4.22, B = -0.5 and C = 4.5, for 1 H- 1 H couplings. 
2.2.4 15N NMR Spectroscopy 
It is possible to detect proton resonances from NH protons with 14N present in 
natural abundance (99.6 %), but they are often broadened, as ' 4N is a quadrupolar 
nucleus (I = 1), hence quadrupolar relaxation occurs. It is also necessary to work in 
H20 (as opposed to D 20) since NH protons usually exchange with deuterium rapidly. 
However, 15 N (1 = ½) can be detected despite its low natural abundance (0.37 %) and 
low NMR sensitivity. Its receptivity compared to 'H is only 3.85 x 106.8  The 
sensitivity of detection can be improved by the use of polarisation transfer from 
'H-detected polarisation transfer methods are applicable to any system which 
contains a ' 5N atom with a measurable spin-spin coupling to 'H. 
The intensity increase available by polarisation transfer from protons to an X 
nucleus is given by the ratio of magnetogyric ratios, YH/YX. For ' 5N, the gain in 
signal intensity achievable by polarization transfer is 9.8 (H/x). 8 
2.2.5 Quadrupolar Relaxtion 
Relaxation refers to the processes which allow nuclear spins to lose energy 
and drop from the excited state to the ground state without emitting an NMR signaL 7 
Quadrupolar relaxation occurs when a quadrupolar nucleus is present, and depends 
on the size of the nuclear quadrupole and the electric field gradient at the nucleus. 
Quadrupolar relaxation has the effect of broadening signals, sometimes to the extent 
of making them NMR invisible. Signals can be broadened to thousands of hertz 
wide. 
2.2.6 JD NMR Spectroscopy 
A basic 1D NMR experiment consists of exciting the nuclei with a single 
pulse then receiving the free induction decay (FID), which is then Fourier 
transformed to produce the spectrum. The basic pulse sequence is shown in Figure 
2.1. The single-pulse sequence to record a standard proton spectrum consists of three 
steps. The first step is the relaxation period (dl) which allows a pre-equilibrium state 
to be reached. The second step is to apply a radiofrequency pulse (p1) to create 
transverse magnetization. The final step is the acquisition, during the t2 period. Data 
are collected following the RF pulse. The pulse angle can be varied to optimise the 
signal. The two pulse sequence parameters shown in Figure 2.1, dl and p1, 
correspond to the length of the recycle delay and the length of the RF pulse, and acq 
is the acquisition time. After the acquisition is complete, a delay time is necessary to 
allow the nuclei to relax before the RF pulse is applied again. 
di _ 
Pi 
Figure 2.1 1D NMR pulse sequence 
2.2.7 2D NMR Spectroscopy 
2D NMR refers to an additional frequency axis, which can either be 
homonuclear or heteronuclear. Using this second dimension can allow for more 
detailed studies of structural connectivity, spatial proximity, or kinetic interchange. 
A 2D experiment has two detection periods, one directly detected, and one indirectly 
detected. Multiple pulse experiments can be used to transfer polarization selectively 
in a coupled spin system between the sensitive, S. and insensitive, I, spins in such a 
way that signals from the insensitive nuclei can be observed. 
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2.2.8 COrrelation SpectroscopY (COSY) 
.COSY is a two-dimensional homonuclear ( 1 H, 'H)-correlated NMR which is 
used to identify pairs of nuclei which are f-coupled to one another.9' 
tO  Through-
bond connectivities between protons separated by two or three bonds can be 
established by COSY experiments. COSY experiments can be used to identify 
protons that have a mutual scalar coupling. A cross-peak in a COSY spectrum 
indicates that the protons giving the connected resonances on the diagonal are 
geminally or vicinally coupled. Trans couplings are generally larger than cis 
couplings. The pulse sequence used in this work was a magnitude COSY. A typical 
pulse sequence for a COSY experiment is shown in Figure 2.2. The 2D spectrum 
acquired in the magnitude COSY experiment has line-shapes in both Fl and F2 that 
have both absorption and dispersion contributions, which means that it is not possible 
to phase the spectrum so the peaks are purely absorptive, and the spectrum must be 
displayed in magnitude mode. Typical resolution is 3 Hz/pt. 
ic/2 
dl 	 pH ac . 
Figure 2.2 Pulse sequence for a two-dimensional COSY NMR experiment. 
The resolution can be improved by using the double-quantum filtered COSY 
sequence (DQF-COSY)," shown in Figure 2.3. In this experiment, an extra 90 ° 
pulse is added after the second 90 °  COSY pulse. A DQF-COSY spectrum correlates 
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chemical shifts of the same nucleus in both dimensions. Both cross-peaks and 
diagonal multiplets have the same anti-phase absorption character. In DQF-COSY 
spectra, the diagonal signal size is reduced, allowing analysis of signals close to the 
diagonal. 
7tI2 	7c/2 	7t/2 
di ri 1 	d2 	t2 
Figure 2.3 Pulse sequence for a two-dimensional DQF-COSY NMR experiment. 
2.2.9 Nuclear Overhauser Effect SpectroscopY (NOESY) 
Through-space connectivities between protons that are close in space can be 
established by NOESY experiments. 12, 13 NOESY yields correlation signals, which 
are caused by dipolar cross-relaxation between nuclei ('H, 'H) in close spatially. A 
key feature of the NOESY experiment is the mixing time, t. The pulse sequence for 
a NOESY experiment is shown in Figure 2.4. The cross-peaks are generated by 
magnetisation transfer that takes place during the mixing time, so the length of this 
delay must be chosen according to the rate of the transfer process. The intensities of 
the cross-peaks are inversely proportional to the sixth power of the distance between 
two nuclei, i and j, oc  1/r 6 . 14 
2.2.10 TOtal Correlation Speciroscop V (TOCSY) 
In TOCSY experiments, cross-peaks are generated between all members of a 
coupled spin network. Hence this can be useful in identifying how many different 
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ic/2 	icI2 	it/2 
acq. 
di 	I I 	t i 
Figure 2.4 Pulse sequence for a two-dimensional NOESY experiment, 'trn is the 
mixing time. 
products or isomers are present in a sample. 6, 15 TOCSY experiments can be used to 
obtain the subspectrurn characteristic of part of a molecule that has no scalar 
couplings to other spins in the molecules. TOCSY uses a different mechanism of 
coherence transfer from COSY for 2D correlation spectroscopy. In TOCSY, 
oscillatory exchange is established, which proceeds through the entire coupling 
network, so that there can be a net magnetisation transfer from one spin to another 
even without direct coupling. The pulse sequence for a TOCSY experiment is shown 
in Figure 2.5. 
The coherence transfer period of the TOCSY sequence occurs during a 
multiple-phase spin-lock period. 6  The multiple-phase spin-lock sequence most 
commonly used is MLEV-17 which contains a set of 17 90/1800 pulses whose 
duration represents the mixing time t. The length of the spin-lock period 
determines how far the spin-coupling network will be probed. The TOCSY spectrum 
can be phased so that all cross peaks and the diagonal peaks have positive intensity. 
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rcI2 	Spin lock 
CI C 
d 1 	t i 	
TM 
Figure 2.5 Pulse sequence for a two-dimensional TOCSY experiment. 
2.2.11 Heteronuclear Single-Quantum Correlation (HSQC) 
HSQC experiments allow identification of the chemical shifts of protons and 
X-nuclei that are directly coupled. This allows easy correlation of the assignments 
already made for one nuclear species to their corresponding X-nuclei. Another 
feature is that it allows proton resonances to be spread out according to the shifts of 
the heteronuclei to which they are coupled, which allows assignment of protons 
which may be overlapping in ID or 2D proton NMR spectroscopy. An HSQC pulse 
sequence is shown in Figure 2.6. 
HSQC spectroscopy uses indirect (or inverse) detection techniques. 	An 
important feature of this experiment is that the proton magnetisation which is 
detected during t2 originated as proton magnetisation at the start of the sequence. 
The main advantage of this technique is the enhanced sensitivity with respect to 
direct detection, a theoretical maximum of (IyuI/IyxI) 512  (306 for ' 5N). 8 
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7rJ2 	'it 	ir12 	it 	7U2 	it 
acq.. 
1 H i JAI JAI _ II 	ILiL 
it 	ir12 	 it12 	it 
X 	I I I I ti [1 Li GARP(dec.) 
Figure 2.6 Basic ['H, X] HSQC pulse sequence. The delays A and 'r are 1/&1  and ½J 
respectively, where J is the one-bond HX coupling constant. 
2.3 IR Spectroscopy 
Infrared spectra result from vibrations that occur naturally and predictably 
within molecules. The spectra produced can be used to provide a variety of 
information about a molecule's structure, particularly its symmetry and identity of its 
functional groups. 6  The infrared spectra of compounds are unique and can be used as 
fingerprints to identify molecules. Vibrations of many functional groups always give 
rise to features within well defined regions of the spectra, regardless of the overall 
structure of the molecule. Hence, characteristic shifts for groups such as carbonyls 
and nitriles can be identified easily. 
There are two types of fundamental vibrations in molecules, stretching, in 
which the distance between two atoms increases or decreases, but the atoms remain 
on the same bond axis, and bending, in which the position of the atoms changes 
relative to the original bond axis. 6 The various stretching and bending vibrations of a 
bond occur at quantized frequencies. When infrared light of the same frequency is 
55 
incident on the molecule, energy is absorbed and the amplitude of that vibration is 
increased. A molecule can be said to be a system of balls of varying masses, and 
springs of varying strengths, corresponding to the chemical bonds of a molecule. 
This model can be used to account for the fundamental vibrations occurring between 
the nonvibrating state and vibrationally excited state in a simple diatomic molecule 
A-B. The vibrational frequency is given in cm' by Equation 2.5. 
v = 1/2 it c(k/i) 2 	(Equation 2.5) 
Where k = the force constant of the bond 
= the reduced mass of the molecule defined by l =mAmB/(mA + MB) 
Bending vibrations generally require less energy and occur at a longer 
wavelength than stretching vibrations. Stretching vibrations are found to occur in the 
order of bond strengths. The triple bond (absorption at 2300 - 2000 cm -1 ) is stronger 
than the double bond (absorption at 1900 - 1500 cm 1 ), which is stronger than the 
single bond (absorption at 1300 - 800 cm- 1 ). When the single bond involves 
hydrogen, stretching vibrations occur at high frequencies (absorption at 3700 - 2630 
cm'). Metal-ligand vibrations tend to appear in the low frequency region (500 - 200 
cm- I ). 
2.4 Electrospray lonisation Mass Spectrometry (ESI-MS) 
A mass spectrometer determines the molecular weight of compounds by 
ionising, separating and measuring molecular ions according to their mass-to-charge 
ratio (m/z). 6  A mass spectrometer consists of three major parts. These are a source 
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of gaseous ions, an evacuated dispersing region in which the ions of different mass-
to-charge ratios are forced to travel different paths, and a detector that locates the 
paths followed by the different ions. A beam of electrons, produced from a heated 
filament collide with gaseous atoms of the sample, produces ions, some of which are 
fragments of the original molecules. The ions are then accelerated by an electric 
field, and these enter an evacuated flight tube in which they are subjected to a 
magnetic field. The different sized molecules are accelerated at different rates, and 
are detected. This records the position and intensity of each ion beam, and this is 
used to calculate the mlz of the ion. 
Electrospray Ionization (ESI) generates ions directly from solution (usually 
an aqueous or aqueous/organic solvent system) by creating a fine spray of highly 
charged droplets in the presence of a strong electric field. As the droplet decreases in 
size, the electric charge density on its surface increases. The mutual repulsion 
between like charges on this surface becomes so great that it exceeds the forces of 
surface tension, and ions begin to leave the droplet. The ions are then 
electrostatically directed into the mass analyzer. Vaporization of these charged 
droplets results in the production of singly or multiply charged gaseous ions. Neutral 
fragments are lost using this technique. Because mass spectrometers measure the 
mlz ratio, the resultant ESI mass spectrum contains multiple peaks corresponding to 
the different charged states. 
ESI is a highly sensitive technique, and since the ions are formed directly 
from solution, it has the advantage that it can be used in conjunction with liquid 
chromatography, commonly referred to as LCMS. 
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2.5 CIIN Analysis 
In CHN analysis, the carbon, hydrogen, and nitrogen content in organic and 
inorganic compounds can be determined. 16  Combustion of the weighed sample 
occurs in pure oxygen under static conditions. Helium is used to carry the 
combustion products through the analytical system. Helium is used for this purpose 
because it is chemically inert relative to tube packing chemicals, and it has a very 
high co-efficient of thermal conductivity. The products of combustion are passed 
over suitable reagents in a combustion tube to assure complete oxidation and 
removal of undesirable by-products such as sulfur, phosphorous, and halogen gases. 
The next step is carried out in a reduction tube. In the reduction tube, oxides of 
nitrogen are converted to molecular nitrogen and residual oxygen is removed. This 
mixture is released into the thermal conductivity detector. Between the first of three 
pairs of thermal conductivity cells an absorption trap removes water from the sample 
gas. The differential signal read before and after the trap reflects the water 
concentration and, therefore, the amount of hydrogen in the original sample. A 
similar measurement is made of the signal output of a second pair of thermal 
conductivity cells, between which a trap removes carbon dioxide, thus determining 
the carbon content. The remaining gas now consists only of helium and nitrogen. 
This gas passes through a thermal conductivity cell and the output signal is compared 
to a reference cell through which pure helium flows. This gives the nitrogen 
concentration. 
Drawbacks with this technique include the requirement for the sample to be 
very pure. If there are any solvents or moisture trapped in the sample, this will affect 
the accuracy of the results. This usually happens with samples that are oils. Also, if 
the sample is not homogeneous, duplicate runs will not agree to within 0.3%. If a 
sample is extremely volatile, it may lose mass due to evaporation after it has been 
weighed out. This can also cause the results to be inaccurate. Furthermore, some 
compounds are inherently difficult to combust completely. Incomplete combustion 
can also cause inaccurate results. 
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Cyclam can complex a variety of cations, including transition metals, often 
with high thermodynamic and kinetic stability with respect to metal ion dissociation. 
As cyclam is flexible enough to coordinate a wide variety of metal ions, it is of little 
use as a selective metal chelating agent. There has been extensive work on tetra N-
substituted cyclams, with more work been done in recent years on mono-, di- and tn -
N-substituted cyclams! 
There are five configurational trans isomers of metal-cyclam adducts, which 
differ in the chirality of the N atoms (Figure 1 . 12) .2 . 3  Semi-quantitative analysis of 
the relative strain energies of the five trans isomers indicates that the trans-Ill form 
is the most stable. 3 ' 4  However, it has been shown that square-planar complexes 
prefer to adopt the trans-1 configuration, as opposed to octahedral complexes, which 
prefer trans-Ill.5  Key configurations are shown in Figure 3.1. 
Trans-I (R,S,R,S) 	Trans-Ill (S,S,RR) 	 Cis-V (R,R,R,R) 
Figure 3.1 Major configurational isomers of metal-cyclam 
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Complexation of metals to xylyl-bicyclam affects its anti-HIV activity in the 
following series: 
Zn(II) > xylyl-bicyclam> Ni(II) > Cu(II) >> Co(III) >>> Pd(II) 
As there are free metals in the blood, there is a possibility that xylyl-bicyclam picks 
UI) metals, especially zinc, from the blood, and that this is the active form of the drug. 
There has been a lot of work done on the configurations of Zn-cyclam and Zn(II)2-
xylyl-bicyclams, but not much work on the other metal complexes. 6,7 
In the X-ray crystal structures of [Zn(cyclam)(H20)2](OAc)2 the macrocycle 
adopts the trans-Ill configuration and the axial Zn—OH 2 bonds are long (2.27 A). 6 
Similarly the phthalate bridged complex [Zn(cyclam)(phtha1ate)](CH30H)2 is also 
trans-Ill. In aqueous solution these carboxylato Zn(II) cyclam complexes exist as 
mixtures of trans-I, trans-Ill and cis-V configurations. 6 
The X-ray crystal structure of a Zn(II) complex of AMD3 100, [Zn2(xylyl-
bicyc1am)2](OAc)22CH30H showed that both the cyclam rings were in the cis-V 
configuration with chelation by acetate on one cyclam face, and double H-bonding 
on the other .7  Detailed NMR studies of this complex showed it to be cis-V/trans-I in 
aqueous solution, in contrast to the perchiorate complex which was largely trans-I 
and trans-Ill. Addition of acetate to the perchlorate complex induced a rapid, major 
structural change, significantly increasing the amount of cis-V/cis-V and cis-Vltrans-
I species. Liang et al. 8 carried out NMR solution studies on Cd(cyclam)(C10 4) 2 , 
Cd(cyclam)C12 and tCd(cyclarn)3(CO3)1(C104)43H20 and used these to identify key 
markers for various configurations adopted by these complexes. Cadmium was used 
for this study because its isotopes (11  'Cd and ' 3Cd, I = ½) are favourable for NMR 
studies, unlike those of zinc. A variety of solution conditions were analysed using 1D 
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and 2D 'H, ' 3C, ' 5N and "Cd NMR spectroscopy, including Karplus-type analyses 
of 1 H, 'H and 'H, "Cd coupling constants. Only the trans-I and trans-Ill 
configurations have six non-equivalent protons and hence give rise to six proton 
resonances, while the trans-TV, trans-V and cis-V configurations have five non-
equivalent protons and give rise to five proton resonances. The X-ray crystal 
structure of [Cd 3(cyclam) 3(CO3)](C104)43H20 showed it to be in the uncommon 
folded cis-I configuration with all of the N—H bonds oriented upwards, while the 
NMR studies suggested that it adopts the trans-I configuration in solution. 
In order to understand this order of anti-HIV activity via interaction with the 
coreceptor CXCR4, the properties of Co(llI), Pd(II), Ni(II) and Cu(IT) cyclam 
complexes are investigated. The most common configuration of metallocyclam 
complexes in the solid state is trans-Ill, but little is known about the solution 
structure of these complexes. 
3.2 Experimental 
Metal-cyclam complexes were synthesised using the general scheme shown 
in Scheme 3.1. 
H(' ,H 
NH HN 1 eq M(OAc)2 (N/
M N 	. 2(OAc) 
- C NHHN:J MeOH 	N 	N 
LIII~) 	
H' 
Scheme 3.1 General preparative route to metal cyclam acetate complexes. 
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3.2.1 Synthesis of Palladium(II) Cyclain Complexes 
[Pd(cyclam)]C12 (1). A solution of K2PdCI4 (489.6 mg, 1.5 rnrnol) in water (75 mL) 
was added dropwise to a solution of cyclam (300.5 mg, 1.5 mmol) in water (75 mL) 
under N2 over a period of 2.5 h. The clear yellow/brown solution was left to stir 
overnight and then the solvent removed under high vacuum to give a pale yellow 
powder. The powder was dried in vacuo (685.5 mg), and then dissolved in methanol 
(1 mL) to give a yellow solution leaving a white precipitate (KC1). The mixture was 
centrifuged and the yellow solution was pipetted off, leaving behind the KC1. The 
solvent was removed under reduced pressure and the powder was dried in vacuo. 
This produced a yellow powder of [Pd(cyclam)1C12, (251.8 mg, 0.66 mmol, 45 % 
yield). 1D and 2D NMR spectra (COSY, TOCSY, NOESY and ['H, ' 3C] HSQC) 
were recorded on this product on a 500 MHz spectrometer in 90 % 1120 / 10 % D 20. 
ES-MS : mlz = 340.9 [M-C1f, 304.9 ([M-2Cl-H] +). 
Anal. Calcd for C, 01-124N4PdC12: C, 31.80, N, 14.84, H, 6.41 %, found C, 31.48, N, 
14.55, H, 6.74 %. 
Selected IR (KBr, cm -  ): 3410 in (NH), 3152 s (NH), 2932 m (CH), 2869 s (CH). 
[Pd(cyclam)](0A022H20 (2). Pd(OA02 (236.3 mg, 1.05 mmol) was reacted with 
cyclam (200.3 mg, 1 mmol) in water (100 mL) under N2 with stirring for 8 h and 
addition of CH3CO2H to maintain a pH of Ca. 4.4. The cloudy black solution was 
filtered and gave a yellow powder after the solvent was removed under high vacuum. 
Yellow crystals suitable for X-ray diffraction were obtained by slow diffusion of 
diethyl ether into a MeOH solution of this powder. (408.1 mg, 0.66 mmol, 85 % 
yield). 1D and 2D NMR spectra (COSY, TOCSY, NOESY and ['H, ' 3C] HSQC) 
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were recorded on this product on a 500 MHz spectrometer in 90 % H20 / 10 % D 20. 
ES-MS mlz = 365.0 [M-OAc-2(H20)I, 305.0 [M-OAc-2(H2O)-H]t 
Anal. Calcd for C 14H34N4PdO6: C, 36.48, N, 7.44, H, 12.16 %, found C, 36.93, N, 
7.24, H, 12.60 %. 
Selected JR (KBr, cm'): 3411 m (NH), 2947 m (CH), 2867 s (CH), 1621 m (OH),. 
1455 m (CO), 1429 m (CO). 
[Pd(cyclam)](C104)2 (3). Warning - Perchlorate salts of complexes with organic 
ligands are potentially explosive and should be treated with great care. 
[Pd(cyclam)](OAc)2 (51.2 mg, 0.12 mmol) was dissolved in HC104 (2 molar equiv, 
120 tL, 1 M) to give a clear, pale yellow solution. The solution was left in a 
refrigerator at 277 K to allow slow evaporation to occur. Yellow crystals formed 
after 4 days (pH=1 .00). The acid was filtered off and the crystals were dried under 
high vacuum. (60.6 mg, 0.09 mmol, 77 % yield). 
ID and 2D NMR spectra (COSY, TOCSY, NOESY and [ 1 H, ' 3C] HSQC) were 
recorded on this product on a 600 MHz spectrometer in 90 % H 20 / 10 % D 20. 
ES-MS mlz = 406.9 [M-ClO4f, 304.9 [M-2(C10 4)-H]. 
Anal. Calcd for C 10H24N4PdO8C12: C, 23.75, N, 11.05, H, 4.78 %, found C, 23.91, N, 
10.99, H, 4.51 %. 
Selected JR (KBr, cm -1 ): 3271 s (NH), 3214 m (NH), 2935 m (CH), 2876 s (CH). 
3.2.2 Synthesis of Nickel (II) Cyclam Complexes 
[Ni(cyclam)](0Ac)2H20 (4). 	Cyclam (400.85 mg, 2 mmol) was dissolved in 
methanol (50 mL) and Ni(OA024H2O (363.46 mg, 2 rnmol) was added. 	The 
reaction was stirred overnight under N 2 . The resulting purple solution was filtered 
and concentrated to dryness to give a purple powder. This was recrystallized by slow 
evaporation from methanol into diethyl ether to give [Ni(cyclam)](OA02.1-120 (422 
mg, 1.12 mmol, 56 % yield). 1D and 2D NMR spectra (COSY, TOCSY, NOESY 
and ['H, 13C] HSQC) were recorded on this product on a 600 MHz spectrometer in 
100 %D20 and 90% I120/ 10%D20. 
ES-MS m/z = 376.9 [M+H-H201, 316.8 [M-OAc-H201, 256.7 [M-2(OAc)- H20- 
HI 
Anal. Calcd for C 14H32N4NiO5: C, 42.56, N, 14.18, H, 8.16 %, found C, 40.15, N, 
14.19, H, 7.84%. 
Selected JR (KBr, cm'): 3528 b (OH), 3457 m (NH), 3246 s (NH), 2939 m (CH), 
2875 s (CH), 1636 m (OH), 1571 s (CO), 1406 s (CO). 
[Ni(cyclam)]02 (5). Cyclam (50.7 mg, 0.25 mmol) was dissolved in methanol (20 
mL) and NiC126H20 (59.74 mg, 0.25 mmol) was added. The reaction was stirred 
overnight under N 2 . The resulting orange/brown solution was filtered and 
concentrated to dryness to give a green powder. Upon drying under high vacuum, 
the powder turned purple. (63.3 mg, 0.19 mmol, 77 % yield) 
1D and 2D NMR spectra (COSY, TOCSY, NOESY and ['H, "Cl HSQC) were 
recorded on this product on a 600 MHz spectrometer in 90 % H 20 / 10 % D20. 
ES-MS: m/z = 332.7 [M+H], 292.6 [M-C11, 256.6 [M-2Cl-H]. 
Anal. Calcd for C, 0H24N4NiC12: C, 36.40, N, 16.98, H, 7.33 %, found C, 36.55, N, 
17.12, H, 7.30%. 
Selected IR (KBr, cm'): 3262 m (NH), 3211 s (NH), 2926 m (CH), 2857 s (CH). 
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[Ni(cyclam)1(NO3)2 (6). Cyclam (104.65 mg, 0.52 mmol) was dissolved in 
methanol (20 mL) and Ni(NO3)26H20 (150.21 mg, 0.52 mmol) was added. The 
reaction was stirred overnight under N2. The resulting orange solution was filtered 
and concentrated to dryness to give a purple powder, which was dried under high 
vacuum. (140.4 mg, 0.43 mmol, 83 % yield). 
1D and 2D NMR spectra (COSY, TOCSY, NOESY and ['H, 13 C HSQC) were 
recorded on this product on a 600 MHz spectrometer in 90 % H 20 / 10 % D20. 
ES-MS : mlz = 319.7 [M-NO 3}, 256.7 [M-2(NO3)-H]. 
Anal. Calcd for C 10H24N6NiO6: C, 31.36, N, 21.94, H, 6.32 %, found C, 31.25, N, 
22.21, H, 6.28 %. 
Selected IR (KBr, cm'): 3261 s (NH), 3212 s (NH), 2927 in (CH), 2871s (CH), 
1381 b (NO). 
3.2.3 Synthesis of a Cobalt(III) Cyclam Complex 
[Co(cyclam)(0A021(BPh4) (7). Cyclam (404.9 mg, 2 mmol) was dissolved in 
methanol (20 mL) with stirring. To this, a solution of Co(OA02.4H20 (498.1 mg, 2 
mmol) in methanol (30 mL) was added dropwise with stirring over 10 minutes. Air 
was bubbled through the orange/brown solution for 30 minutes. Acetic acid (1 M, 2 
molar equiv, 20 mL) was added and air was bubbled through for a further 30 
minutes. The brown solution was filtered and concentrated to dryness to give an 
orange/pink oil (654.2 mg). This oil (100 mg, 0.2 mmol) was then dissolved in 
methanol (5 mL) and NH 4BPh4  (134.82 mg, 0.4 mmol) was added with stirring. The 
cloudy orange solution was stirred overnight at room temperature. The resulting 
cloudy pink solution was filtered and concentrated to dryness to give pink crystals of 
W.  
[Co(cyclarn)(OA02](BPh4) (124 mg, 65 % yield). 
1D and 2D NMR spectra (COSY, TOCSY, NOESY, ['H, ' 3C] HSQC and ['H, ' 5N] 
HSQC) were recorded on this product on a 600 MHz spectrometer in DMSO-d 6 . 
ES-MS mlz = 377,0 [M-(BPh 4)1, 318.1 [M-(OAc)-(BPh4) -H], 258.1 [M-2(OAc)- 
(BPh4) -HI1. 
Selected IR (KBr, cm'): 3432 m (NH), 3215 s (NH), 2932 m (CH), 2871 s (CH), 
1570 m (CO), 1376 rn (CO). 
3.2.4 Synthesis of a Copper('II) ('yclarn Complex 
Synthesis of [Cu(cyclam)(H 20)2](0A02 2Me0H (8). Cyclam (400.85 mg, 2 
mmol) was dissolved in methanol (50 mL) and Cu(OA02H20 (363.46 mg, 2 mmol) 
was added. The reaction was heated to reflux for two hours. The resulting purple 
solution was filtered and concentrated to dryness to give a purple powder. This was 
recrystallized by slow evaporation from methanol into diethyl ether to give 
[Cu(cyclarn)(H20)2](OAc)22MeOH. 
1D and 2D NMR spectra (['H, ' 3C] HSQC) were recorded on this product on a 360 
MHz spectrometer in 90 % H 20 / 10 % D 20. 
ES-MS rnlz = 322.2 [M-OAc-2(H 20)}, 262.0, [M-2(OAc)-2(1-1 20)-H]t 
Anal. Calcd for C 14H34N4Cu06: C, 40.23, N, 13.40, H, 8.20 %, found C, 40.24, N, 
13.36, H, 8.14 %. 
Selected IR (KBr, cm'): 3229 rn (NH), 3164 m (NH), 2938 m (CH), 2878 s (CH), 
1644 rn (OH), 1565 m (CO), 1428 m (CO). 
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3.2.5 NMR Studies of [Ni(cyckun)](OA02, 4 
Firstly, 1D and 2D (['H, 13C] HSQC, COSY, TOCSY and NOESY) spectra 
were recorded of complex 4 in 100 % D20, (5 mM, 600 ILL). Dioxane was added as 
a reference (2 IlL). The solvent was removed and the powder was re-dissolved in 90 
% HO / 10 % D20 (600 ..tL) and left to equilibrate for 24 hours. Then, the 1D and 
2D spectra were re-recorded. Two molar equivalents of NaOAc (an aliquot of a 1 M 
solution) were added and again left to equilibrate for 24 hours and the 1D and 2D 
spectra were recorded. The procedure was repeated again with 10 molar equivalents 
of NaOAc. 
3.2.6 UV-Vis Spectroscopy 
UV-vis spectroscopy was carried out on complexes 4-8 at 2.5 mM in water, 
except for complex 7, which was recorded in DMSO. All spectra were recorded at 
25 °C in 1 cm cells. 
3.3 Results 
3.3.1 NMR Studies of Pd(I1) Cyclam Complexes 
2D NMR methods were used to identify the configurations present in solution 
for the three palladium cyclam complexes. The chemical shifts of all three 
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Figure 3.2 2D ['H,' 3C] HS QC and 1D NMR spectra of [Pd(cyclam)]C12 in 90 % H20 
/ 10% D20. The protons that are on the same carbon atoms can clearly be seen. 
[Pd(Cyclam)]C12 (1). 2D ['H, ' 3C1 HSQC (Figure 3.2) and ['H, 'H] COSY, NOESY 
and TOCSY (Figure 3.3) NMR spectra were recorded. There is a singlet at 5.15 ppm 
which can be assigned to the NH protons, as it is absent in the 2D ['H, 13C] HSQC 
NMR spectrum. The 2D COSY NMR spectrum shows this signal has cross-peaks to 
four other signals. These are at 2.92, 2.82, 2.73 and 2.55 ppm. These signals must 
be either the -CH-,-CH,-CH.?- or the protons. The signals at 2.82 and 2.73 
ppm show cross-peaks to the signals at 1.53 and 2.02 ppm. This implies that the 
signals at 2.82 and 2.73 ppm correspond to the -CH ,)-CH ,,-CH?- protons and the 
signals at 1.53 and 2.02 ppm correspond to the -CH2-2-CH2- protons (' 3C shift = 
71 
30.2 ppm). Hence the signals at 2.92 and 2.55 ppm arise from the -cH2-cH -
protons (' 3C shift = 55.0 ppm). This assignment is confirmed by 2D ['H, 13C1 HSQC 
NMR spectrum as the signals at 2.82 and 2.73 ppm in the 'H dimension have the 
same 13 C chemical shift (52.2 ppm). There is a small amount of free cyclam present, 
giving rise to signals at 1.8 and 3.0 ppm. 
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Figure 3.3 2D ['H, 'H] TOCSY NMR spectrum of [Pd(cyclam)]C12 in 90 % H 20 / 
10 % D20, in which the NH peak at 5.15 ppm shows TOCSY cross peaks to all the 
proton signals in the complex. 
The 2D ['H, 'Hi TOCSY NMR spectrum (Figure 3.3) demonstrates that there 
is only one isomer present, along with a small amount of cyclam. The 2D ['H, 'H] 
NOESY NMR spectrum can be used to assign which protons are axial and which are 
equatorial in the six-membered chelate rings. The signal at 1.53 ppm shows a cross-
peak to the peak at 5.15 ppm, whereas the signal at 2.02 ppm does not. This means 
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that the signal at 1.53 ppm is from an axial proton, and the signal at 2.02 ppm is from 
an equatorial proton. For the - H 2-CH2-c.1j12- protons, the signal at 2.82 ppm has a 
crosspeak to the -NH proton signal, and therefore must be the axial proton signal. 
For the -fl- protons, both have cross-peaks to the -NH protons. Because this 
forms a five-membered ring, it is not possible to assign the protons as axial or 
equatorial. 
[Pd(Cyclam)](OAc)2 (2). There is only one NH proton signal present, at 5.27 ppm, 
indicating that there is only one isomer present. There is a peak from the acetate 
group at 1.84 ppm. The peaks at 1.51 ppm and 2.00 ppm are attributed to the CH2-
CI-12-C1-12. The CH2-CH2-j2 protons gave peaks at 2.57 and 2.96 ppm. The CH2-
CH2 protons gave signals at 2.69 and 2.85 ppm. 
[Pd(Cyclam)](CJ04)2 (3). This has a peak at 1.52 ppm and another peak at 2.31 
ppm, which is assigned to the CH2-2-CH2 protons. There are two peaks from the 
CH2-CH2-cth protons, at 2.61 and 3.01 ppm. The protons give two 
peaks. at 2.68 and 2.91 ppm. The single NH peak at 5.21 ppm shows that there is 
only one isomer present. 
Table 3.1 1H NMR Chemical shifts of Pd(H)-cyclam complexes, recorded in 90 
% HO / 10 % D20 at 25 °C at 5 mM. 
Complex 
H /ppm 
NCH2 CH2N NCH2CH2N NCH2CH2N NH 
1 2.92, 2.55 1.53, 2.02 2.73, 2.82 5.15 
2 2.69, 2.85 1.51, 2.00 2.57, 2.96 5.27 
3 2.68, 2.91 1.52, 2.31 2.61, 3.01 5.21 
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3.3.2 NMR Studies of Ni (H) Gyclam Complexes 
The 1D spectra of all three Ni(ll) cyclam complexes (4-6) showed a mixture 
of sharp and broad peaks (Figure 3.4). The broad shifted peaks can be attributed to 
one or more paramagnetic forms of the complex. As paramagnetic species are 
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Figure 3.4 Proton NMR spectra of [Ni(cyclam)](OAc)2, complex 4. (a) Over the 
range -40 ppm to +50 ppm. (b) From 55 ppm to 155 ppm. This shows there is a 
mixture of peaks from diamagnetic (between 0 - 4 ppm) and paramagnetic species. 
The scale of the vertical axis in (b) is increased by 2. 
known to have shifted peaks in NMR spectra, the spectra were recorded over a large 
sweep width from -150 ppm to 300 ppm. Peaks were observed in the spectrum 
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between -50 ppm and +150 ppm. Peaks for diamagnetic forms of the complexes 
were observed between 1 ppm and 4 ppm. The shifts observed for the paramagnetic 
species are summarised in Table 3.2, and the diamagnetic shifts shown in Table 3.3. 
Table 3.2 'H NMR Chemical shifts for paramagnetic Nickel(II) cyclam 
complexes recorded in 90 % H20, 10 % D20 at 25 °C at 5 mM. 
Peak 
Complex 
4* 5 6 
a 113.82 54.69 55.19 
b 63.02 19.01 18.64 
c 21.54 8.74 8.66 
d 9.62 -0.35 -0.32 
e -0.58 -3.18 -3.22 
f -3.08 -52.56 
*The peaks for complex 4 are labelled in Figure 3.4. 
[Ni(cyclam)](OAc)2, 4. The 1D and 2D spectra of the acetate complex, 4, recorded 
in 100 % D20 show peaks for 6 non-equivalent protons and 3 corresponding non-
equivalent carbon signals. Therefore in the diamagnetic complex the cyclam ring 
must be in a symmetrical configuration. 
From the 2D ['H, 'H] TOCSY NMR spectrum it can be seen that there are 
cross-peaks between non-equivalent protons on the same carbon and also cross peaks 
between protons on neighbouring carbons. Cross-peaks between protons separated 
by a NH group are not seen in this spectrum. 
The 1D and 2D NMR spectra were also recorded in a mixture of 90% H20 / 
10% D20 in order to assign the NH shift. A new peak at 3.60 ppm was observed in 
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the 1D spectrum and the 2D ['H,'H] TOCSY NMR spectrum and not in the 2D 
['H,' 3CJ HSQC NMR spectrum, therefore this signal was assigned as a signal from 
the NH proton. Only one signal was seen for an NH proton therefore all the NH 
groups in the diamagnetic configuration must be equivalent, and only one 
diamagnetic configuration is present. 
In order to confirm the position of the acetate peak in the 'H NMR spectrum, 
2 and 10 molar equivalents of Na(OAc) were added to the solution. This would have 
the effect of moving the equilibrium of the system and increasing the intensity of 
acetate signal observed in the 'H NMR spectrum. The signal at 1.9 ppm increased in 
intensity (Figure 3.5) and was therefore assigned as the acetate signal. As the signal 
is quite broad, both before and after the addition of excess acetate, it is likely that the 
bound acetate is in fast exchange with the non-bound acetate, as if this was not the 
case, two signals would be expected, one broad one for bound acetate and one 
sharper one for unbound acetate. The signal for the bound acetate is broadened as it 
is directly bonded to the paramagnetic octahedral Ni 2 centre. 
Using the 1D and 2D spectra, the peaks for the diamagnetic configuration 
have been assigned (Table 3.3). It was found that there were 6 peaks for protons in 
complex 4. These corresponded to 3 carbons in the HSQC spectra (Table 3.3). Two 
isomers have the correct symmetry to give rise to six non-equivalent protons: trans-I 
and trans-Ill. Only one NH signal was observed, which also supports either a trans-I 
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Figure.3.5 [Ni(cyclam)](OAc)2, complex 4, in 90 % H 20 / 10 % D20 (a) before and 
(b) after the addition of 10 equivalents of NaOAc. The assignments for the peaks are 
shown. There are peaks present for complex 4 and free cyclam present. The peak at 
1.9 ppm increases significantly, showing it is from the acetate. 
[Ni(cyclam)]C12, 5. No free cyclam was observed in solutions of the complex. 
There was only one NH peak present in the 1D 'H NMR spectrum, at 3.67 ppm, 
implying only one diamagnetic isomer was present. There is a peak at 1.34 ppm and 
another peak at 1.98 ppm, which are assigned as from the CH 2-Qj2-CH2 protons, 
with a corresponding 13C shift of 28.7 ppm. There are two peaks from the Qth-CH2 -
Qth protons, at 2.71 and 3.21 ppm, connected to the same 13C signal at 50.7 ppm. 
The Qj2 Qjj2 protons give two peaks, at 2.52 and 2.68 ppm, with a 13C shift of 53.1 
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ppm. The data are summarised in Table 3.3. 
[Ni(cyclam)](NO3)2, 6. Again, there is only one NH peak observed, at 3.67 ppm. 
The CH2-CH2-CH2 protons were observed at 1.33 ppm and 1.98 ppm. The dll-
C112-cth protons were found to be at 2.71 ppm and 3.19 ppm, with the cHz-dua 
protons being found at 2.52 ppm and 2.68 ppm. The ' 3C shifts for this complex are 
shown in Table 3.3. 
Table 3.3 'H and 13C Chemical shifts of diamagnetic .Ni(cyclam) 2 complexes 
recorded in 90 % H20, 10 % D20 at 25 °C at 5 mM. 
Ill and 13C assignment / ppm 
Complex NQflQjaN NCH2dIIaCH2N NQCH2QN NH 
711 2.69 2.53 1.32 1.98 2.76 3.20 3.60 
13 C 
53.0 28.7 50.7 
s 711 2.52 2.67 1.34 
• 
1.98 2.71 3.20 3.67 
13c 
53.1 28.7 • 50.7 
6 711 2.52 2.67 1.33 1.98 2.71 3.19 3.67 
53.2 28.8 50.8 13c 1 
3.3.3 NMR Studies of Co(III) Cyclam Complex, 7 
The 1D 'H spectrum of this complex is very complicated (Figure 3.6). No 
free cyclam was observed in solutions of the complex. There were four peaks 
observed in the 2D ['H, 15N] NMR HQSC spectrum (Figure 3.7). Two of these 
peaks show a TOCSY peak to each other, while the other two show no interaction 
ate 
... 
9 	8 	7 	6 	5 	4 	3 	2 
6( 1 H) 










10.0 9.5 9.0 8.5 8.0 7.5 
S('H) 
Figure 3.72D ['H, 15N] HSQC NMR spectrum of [Co(cyclam)(OAc)2](BPh4) in 
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Figure 3.8 2D ['H, 'H] TOCSY NMR spectrum of [Co(cyclam)(OAc)2](BPh.4) in 
DMSO-4 at 25 °C. Two NH signals show a TOCSY cross peak to each other, 
showing that they are from the one species, whereas pone of the other NH signals 
interact with each other. 
with each other, implying that there are three configurations present, as shown in 
Figure 3.8. Three acetate signals are observed, all in the region of bound acetate, 
further confirming the presence of three configurations (Figure 3.9). This suggests 
that all three are trans configurations, as if there was a cis configuration with a 
chelated acetate, there would also be a signal present for free acetate. The major 
configuration has an NH peak at 7.94 ppm ('H dimensicw) As this is the major 
configuration, and the crystal structure shows that the complex is in the trans-Ill 
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Figure 3.9 2D ['H, 1 3C] HSQC NMR spectrum of [Co(cyclam)(OAc)2](BPh4) in 
DMSO at 25 °C. 
configuration. Three sets of CH 2 peaks for this species (seen by 2D ['H, 1 H] TOCSY 
and ['H, 13C] HSQC NMR spectra) support this. Full characterisation for this species 
(species A) is given in Table 3.4. There is a second species with an NH peak at 8.99 
ppm, species B. This can also be found to have three sets of CH2 peaks, again 
suggesting a trans configuration. This one is likely to be trans-I, as the trans-I is the 
most favoured configuration after trans-Ill. The third species, C, has two NH signals 
which show a TOCSY cross-peak to each other. Six sets of CH2 peaks were 
observed in the 2D NMR spectra for this complex. The data for all three species are 
summarised in Table 3.4. 
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Table 3.4 'H, '3C and '5N Chemical shifts of [Co(cyclam)(OAc)2] (7) recorded 
in DMSO at 25 °C at 5 mM. 
ö/ppm 
Species NQ1±N NCH2QflCH2N Ncui2CH2cthN. NH 
A 111F 2.32 2.82 1.99 2.06 2.32 2.49 7.94 
55.1 29.7 50.2 
15 N -21.62 
B JIIF 2.96 2.52 2.05 2.37 2.66 * 8.99 
55.0 30.0 50.2 
15 N • -21.67 
ThF 2.44 2.90 3.21 3.27 2.52 2.59 9.35 
13C 55.7 35.8 45.4 
15 N 23.78 
C 
1ii 2.43 2.89 2.05 * 2.47 2.27 7.06 
13 C 53.1 30.1 50.6 
15 N r16.5 
* Peaks not observed due to overlap. 
3.3.4 NMR Studies of Cu(II) Cyclam Complex, 8 
1D 1 H NMR and 2D ['H, 13C] HSQC NMR spectra were recorded in 90 % 
H20 / 10 % D20 at 25 °C, at 5 mM, on this complex (Figure 3.10). Only one sharp 
peak was observed, at 1.8 ppm in the 'H dimension, and 23.52 ppm in the 13C 
dimension. Two broad peaks, at 16 ppm and -12 ppm, were observed in the 'H 
dimension, but had no connectivity in the 13C dimension. 
7 	6 	5 	4 	3 	25(1 H) 
.. 
40 	30 	20 	10 	0 	—10 —20 —30 ö (1H) 
Figure 3.10 1D 'H NMR spectrum of [Cu(cyclam)(H20)2](OAc)2, recorded in 90 % 
H20 / 10 % D20, at 25 °C, (a) over the range 1 - 8 ppm, there is a signal for acetate 
in this region, (b) over the range -40 - 40 ppm, showing two broad peaks at 16 ppm 
and -12 ppm. 
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3.3.5 X-Ray Crystallography 
Four crystal structures of metal cyclam acetate complexes were obtained in 
this work. These were [Pd(cyclam)](OAc)2.21-120 (Figure 3.11), 
[Ni(cyclam)](OAc)2.H20 (Figure 3.13), [Co(cyclam)(OAc)2](BPh4) (Figure 3.15) 
and [Cu(cyclam)(1120)2](OAc)2-2MeOl-1 (Figure 3.17). The cyclam ring was found 
to be in the trans-Ill configuration in all cases. A comparison of key bond lengths 
and angles is shown in Table 3.5. There are two independent Pd 2 units in 
[Pd(cyclam)](OAc)2.2H20 and two independent Co 3 units in 
[Co(cyclam)(OA021(BPh4); indicated by a "A" in the table. Crystallographic data 
for these complexes are shown in Table 3.6. 
Table 3.5 Comparison of bond lengths (A) and angles (°) for metal cyclam 
acetate complexes 
Complex [Pd(cyclam)] [Ni(cyclam) [Co(cyclam) [Cu(cyclam) 
(OA02.2H20, (OAc)21.H20, 4 (OAc)21(BPh4), (I-120)21(OAc)2• 
2 7 2MeOH, 8 
N-M 	bond 2.038(4) 2.0678(14) 1.932(5) 2.018(2) 
lengths 2.043(3) 2.0746(15) 1.959(5) 2.012(2) 
2.036(4)A 1.988(6)A 
2.037(3)A 1.979(6)A 
N(1)-M-N(1) 180.0(3) 180.0(7) 180.0(7) 180.0(3) 
bond angles 180.0(1)A 180.0(7)A 
N(1)-M-N(2) 95.05(15) 94.49(6) 93.5(2) 94.04(10) 
bond angles 95.28(15)A 94.2(2)A 
N(2)-M-N(1) 84.95(15) 85.51(6) 86.5(2) 85.96(10) 
bond angles 84.72(15)A 85.8(2)A 
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Formula C141134N406Pd C141132N4NiO5 C38115213CoN404 C16H42CuN405 
Formula 
weight 
460.85 395.15 698.60 482.08 
Crystal 
system 
Triclinic Monoclinic Monoclinic Orthorhombic 
Space group P-i C 2/c P 21/n Pbca 
at A 8.582900) 13.131 1(5) 11.0919(8) 15.9421(7) 
b/A 9.7811(12) 12.5959(5) 23.1481(17) 7.0819(3) 
C/A 11.6962(14) 11.6830(5) 14.566(1) 20.9833(10) 
at ° 83.521 90 90 90 
/3/0 86.559 99.906(3) 109.655(2) 90 
7/0 89.682 90 90 90 
Cell vol. / A3 973.9(2) 1903.54(13) 3521.9(4) 2369.02 
Z 2 4 4 4 
Density(Calc) 
mg/m3 
1.572 1.379 1.317 1.352 
Abs. coeff. 
mm 1 
0.989 1.049 0.533 0.967 
Unique 
reflections 
3947 2584 6155 2329 
Observed 
reflections 
7978 10647 18105 14118. 
RI 	(ohs/all 
refi) 
0.0428 0.0360 0.0663 0.0341 
wR2 	(ohs/all 
refi) 
0.1014 0.0909 0.1771 0.1059 
[*1 
IPd(cyclam)1(OAc)22H20, 2. The cyclam ring is in the trans-Ill configuration, with 
the Pd 2+  ion being square-planar (Figure 3.11). The unit cell of 
[Pd(cyclam)](OAc)22H20 contains 2 molecules, consisting of half molecules of 
[Pd(cyclam)] in an asymmetric unit along with 2 acetate ions and 2 water molecules. 
Each [Pd(cyc1am)] 2  ion appears to form an infinite hydrogen bonded sheet structure 
with the acetate and water molecules (Figure 3.12). There is no axial interaction 
between the acetate and the Pd(II), the shortest Pd-O distance being 4.0 A. The 
acetate does interact with the NH protons, forming hydrogen bonds, ranging in 
length from 2.0 A to 2.2 A. There is further hydrogen bonding between the acetate 
and the water molecules, with distances between 1.9 A - 2.1 A. 
Figure 3.11 [Pd(II)-cyc1am] 2  from [Pd(cyclam)](OAc)2.2H20. The cyclam ring is 
in the trans-Ill configuration, and the Pd(II) is square planar. 
RR 
Figure 3.12 Crystal packing of [Pd(cyclam)](OAc)2.21120, showing the hydrogen 
bonding network (in cyan) between the acetate groups and the water molecules. 
INi(cyc1am)(OA0211120, 4. The nickel is octahedral, with monodentate acetate in 
each of the axial positions (Figure 3.13). The bond length of the Ni-O bond is 2.106 
A. The cyclam ring is in the trans-Ill configuration. The molecules are held 
together in layers by a network of hydrogen bonds (Figure 3.14). The 0 of the 
acetate ligand is found to form an internal hydrogen bond to the NH of the cyclam 
ring, bond length 2.1 A, stabilising the trans-Ill configuration. The structure also 
contains a water molecule that hydrogen bonds to the acetate ligands on adjacent 
molecules (2,0 A) holding the layers of the crystal together. 
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Figure 3.13 [Ni(cyclam)(OAc)2] from [Ni(cyclam)(OAc)21 -H20. This structure is 
similar to that of the Co(III) complex, with the acetates forming H-bonds to the NH 
groups. 
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Figure 3.16 Crystal packing of [Co(cyclam)(OAC)2](BP114). There is no interaction 
between axial acetate groups and neighbouring cyclam rings. There is a hydrogen 
bond (shown in cyan) between the acetate group and an NH group on both sides of 
the ring. 
[Cu(cyclam)(H20)21(0AC)22Me0H 8. Again, the cyclam ring is found to be in 
the trans-Ill configuration (Figure 3.17). The acetate is not coordinated, and there 
are two water molecules coordinated to Cu 24  instead. The molecule forms H-bonds 
to give a ID strand (Figure 3.18). The Cu 24  ion has a Jahn—Teller-distorted 
octahedral configuration with four short equatorial Cu-N(cyclam) bonds of 2.012 A 
and 2.018 A and two long axial Cu-0112 bonds of 2.546 A. 
One of the carboxylate 
O atoms from the acetate is H-bonded to a cyclam NH. The hydrogen bonds from 
the N-H ... 0 of the acetate are approximately 2.1 A in length. This 0 atom also 
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forms hydrogen bonds to the HO from a methanol molecule, with a length of 1.9 A. 
The other carboxylate 0 atom is H bonded to bound water molecule, at a length of 
1.9 A and 2.0 A. 
Figure 3.17 [Cu(cyclam)(H20)21 2  from {Cu(cyclam)(H20)21(OAC)22MeOH. The 
cyclam ring is trans-Ill. 
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Figure 3.18 Crystal packing of [Cu(cyclam)(H 20)2](OAC)22MeOH, showing the 
hydrogen bonding (in cyan) from the unbound acetate groups and methanol units to 
the axial water molecules. 
3.3.6 UV- Vis Spectroscopy 
The extinction coefficients of the complexes were calculated and are listed in 
the Table 3.7 below. The extinction coefficients were calculated using: 
A = ccl, 	 Equation 3.1 
where A = absorbance, 
c = concentration / M, 
1 = cell path length / cm, and 
F, = extinction coefficient / M' cm'. 
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lengths range from 1.933 A to 1.988 A. There appears to be no interaction between 
axial ligands and a neighbouring cyclam ring, the tetraphenyl borate blocks any such 
interaction (Figure 3.16). 
Figure 3.15 [Co(cyclam)(OAC)21 from [Co(cyclam)(OAC)21(BPh4). The cobalt ion 
is octahedral, and the cyclam ring is trans-Ill. The 0 atoms from the acetate groups 
form H-bonds to the NH groups. 
Figure 3.14 Crystal packing of [Ni(cyclam)(OAc)2].H20, showing the H-bonding 
(in cyan) between the acetate groups, water molecules and NH groups, stabilising the 
configuration. 
[Co(cyc1am)(OA021(BPh4), 7. The Co(III) is octahedral, with an acetate molecule 
in each of the axial positions (Figure 3.1 5). The cyclam ring is in the trans-Ill 
configuration. The configuration is stabilised by a hydrogen bond from the NH to 
the carboxylate group of the bound acetate. The unit cell has two cobalt atoms in it. 
In one of the Co-cyclam units, the NH.......0 bond lengths are quite similar (2.2 A), 
whereas in the other Co-cyclam unit, there is a large difference between them (2.2 A 
and 2.6 A). In the second unit, the acetate seems to sit a lot closer to the NH, causing 
this difference. The Co-0 bond lengths are 1.917 A and 1.906 A. The Co-N bond 
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Table 3.7 Extinction Coefficients for Metal-Cyciam Complexes, recorded in 
water at 2.5 mM, 25 °C, except 8, recorded in DMSO. 
Complex 2'max A E / M 1 cm-1 
Ni(cyclam)(OAc)2, 4 448 0.0893 35.7 
Ni(cyclam)C12, 5 451 0.0601 24.0 
Ni(cyclam)(NO3)2, 6 448 0.0770 30.8 
[Co(cyclam)(OAc)21(BPh4), 7 362 0.1768 70.7 
552 0.0864 34.5 
443 0.0720 28.8 
[Cu(cyclam)(H20)2](OAc)2, 8 505 0.1830 73.2 
The cobalt complex was only complex to have more than one absorption 
maximum in the range 300 - 800 nm. All the values of E are of the order expected 
for d-d transitions. 
3.4 Discussion 
3.4.1 Comparison of Metal-Cyclam Complexes in the Solid State 
In the complexes 2, 4, 7 and 8, the cyclam rings are all in the common trans-
III configuration. The metals all sit in the centre of the 4 nitrogen atoms, with the 
angles N-M-N all being within 84 ° - 96 
There are 9 Pd-cyclam structures in the CSD. These are all in the trans-Ill 
configuration. The Pd-N bond lengths range from 2.037 A7 to 2.066 A.9' 10  In this 
work, the Pd-N bond lengths in complex 2 range from 2.036 A to 2.043 A. There are 
two reported octahedral Pd-cyclam complexes, both of these involve Pd(IV). All the 
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reported Pd(II)-cyclam complexes are square planar. Crystal data for complex 2 are 
shown in Table 3.6, with key bond lengths and angles shown in Table 3.5. 
There are 36 Cu(II) cyclam complexes in the CSD. All of these are in the 
trans-Ill configuration. Of these, five involve copper binding directly to oxygen. 
The bonds lengths range from 2.35 1 All to 2.567 A.' 2 All five of these contain 6- 
coordinate Cu(II). The Cu-N distances range from 1.922 A' 3 to 2.031 A" Two of 
these Cu(II) cyclam complexes form polymers, with chains linked through O-Cu-O 
bonds. In the case of complex 8, the Cu-0 bond length is 2.546 A, and the Cu-N 
bond lengths are 2.012 A and 2.018 A. The copper is bound to water molecules, and 
there are hydrogen bonds from the NH protons to the acetate molecules. Again, the 
cyclam ring is in the trans-Ill configuration. The copper is in a Jahn—Teller-distorted 
octahedral configuration, with two long bonds to the oxygen from two water 
molecules in the axial positions. The acetate oxygen atoms are H bonded to cyclam 
NH groups on adjacent rings and to coordinated water. The cyclam ring adopts the 
common trans-Ill configuration. 
This Cu-cyclam acetate complex (8) is very similar to that of Zn-cyclam 
acetate, which also has two water molecules in the axial positions, and acetate as the 
counter ion. 6  In this zinc complex, there are two types of hydrogen bonds, OH .0 
and N-HO •O. Both the carboxylate oxygen atoms of the acetate act as acceptors. All 
four H atoms of the amine groups and all four of the H atoms from the coordinated 
water molecules act as hydrogen bond donors. The hydrogen bonds range in length 
from 1.84A to 2.24A. 
There are 22 Co-cyclam structures found in the CSD. Five of these are in the 
cis-V configuration, while the remainder are all in the trans-Ill configuration. Of 
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these 22 complexes, 9 involve direct bonding between Co and 0. The Co-O bond 
lengths range from 1.840 A' 4 to 2.319 A' 5 , with the Co-N bond lengths ranging 
between 1.919 A and 2.102 A.' 4 The longest and shortest Co-N bonds are both 
found in a cis-V configuration. In the trans-Ill complex 7, the Co-O bond lengths 
are 1.906 A and 1.917 A, while the Co-N bond lengths range between 1.933 A and 
1.988 A. Comparing the 4 crystal structures in this work, the M-O and M-N bond 
lengths are the shortest in this Co 3 complex, 7. This is likely to be the result of this 
being Co3 , whereas the other metals are all M 2 . 
There are 61 Ni-cyclam structures in the CSD. One of these is the unusual 
trans-V configuration, 16  six are cis-V, one is a mixture of two structures, a cis-V and 
a trans-111, 17  and the remainder are trans-Ill. 28 of these involve the direct bonding 
of nickel to oxygen, with six of these involving water. The Ni-O bond lengths in 
these complexes range from 2.070 A 18 to 2.457 A,' 9 with the Ni-N bond lengths 
varying from 1.963 A' 9 to 2.109 A.' 8 In the case of 4, the Ni-O bond lengths are 
2.106 A and the Ni-N are 2.068 A and 2.075 A. 
3.4.2 NMR Studies 
In these NMR studies, the central methylene protons in the six membered 
rings were easily identified by their chemical shift, as these are often the highest 
shifted peaks in the spectra. Cyclam can adopt 5 trans configurations depending on 
the spatial alignment of the NH protons. The configurations thatcan fold along the 
diagonal can interconvert to give cis configurations. It has been stated that only 
trans-I and trans-Ill can produce six —CH2- protons signals, two of them being from 
the central methylene of the six membered rings. 6 In the trans-I and trans-Ill 
configurations, the six-membered rings adopt the stable chair configuration, which 
results in the two central methylene protons being inequivalent and hence these give 
rise to two 1 H NMR resonances. 
Configurational analysis also shows that trans-IV and trans-V configurations 
have only 5 non-equivalent —Cl2- protons, one of them being from the central 
methylene of the six membered rings.' Both six-membered rings in the trans-IV and 
trans-V adopt twist-boat conformation and the middle two —CH ,)— protons are 
equivalent and hence give rise to one 'H NMR signal. However, as these two 
configurations contain highly strained six-membered rings, these configurations are 
unlikely to form. The trans-V configuration can easily fold along the diagonal to 
give the cis-V configuration, in which the six-membered rings are in the more stable 
chair configuration. 
[Pd(cyc1am)] 2 ' Complexes, 1-3 
2D ['H, 'H] TOCSY NMR spectra showed that each of these only had one 
configuration present in solution. There were no changes in the NMR spectra with 
time, showing the structures to be kinetically stable. As no change occurs, it was 
concluded that the solution structure was the same as the solid state structure, which 
is trans-Ill. The three [Pd(cyclam)] 
2+ complexes, 1-3, were found to all be in the 
same configuration in solution. This shows that the counter ion has little effect on 
the overall structure of the [Pd(cyclam)] 2 , and the configuration cannot easily be 
changed by varying the counterion. It is notable that Pd(II)-cyclarn complexes are 
inactive as anti-HIV agents, which can be attributed to the inability of Pd(II) to bind 
to axial ligands and possibly due to its inability to adopt configurations other than 
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trans-ill. 
[Cu(CycIam)] 2 , 8 
The 'H NMR spectrum of this complex showed only one unbroadened peak 
at 1.8 ppm, (' 3C shift = 23.52 ppm) corresponding to unbound acetate, which agrees 
with the solid state structure. In the solid state, water is bound in the axial positions, 
and the acetate is a non bonded counterion. If the acetate was directly bound to the 
copper, this peak would have been significantly broadened. There are very small 
peaks present from cyclam, implying that some dissociation occurs. The spectrum 
was recorded from -400 ppm to + 400 ppm, and only two broad peaks were 
observed. These were at 16 ppm and -12 ppm. The assignment of these peaks is 
unknown. The broadening of these peaks is caused by paramagnetic Cu 2 , which has 
the configuration 3d 9, hence always has one unpaired electron. 
[Co(Cyc1am)]3 , 7 
Three configurations were identified for this complex. Two of these showed 
two resonances for the central methylene —CH.)— groups, hence it was concluded that 
these were either trans-I or trans-M.6 As the complex is trans-Ill in the solid state, it 
was concluded that the major configuration in solution is also trans-Ill, and the other 
configuration would be trans-I. The third configuration was shown to have 2 NH 
signals. This could be a result of strong hydrogen bonding between one NH and the 
acetate group, resulting in a high shift of this NH group (9.35 ppm) and a low shift of 
the other NH group (7.06 ppm). This also makes the cyclam ring inequivalent, hence 
six 13C signals are observed for this species in total. However the exact 
configuration of this configuration could not be determined. 
Ni(Cyclam)]2 Complexes, 4-6 
Work has been reported on substituted nickel-cyclams, such as cyclam with 8 
methyl groups substituted on various Cl2 groups on the ring, 
20  when substitution at 
the CH2 groups gave all trans-I structures in solution. Much work has also been 
carried out on Ni(II) complexes of tetramethyl-cyclam (tmc), where methyl groups 
are attached to each of the NH groups. It has been shown that [Ni(tmc)(Cl0 4)2 ] is 
high spin and octahedral, with trans-I and trans-Ill species being isolated. 2123 
Isornerisation between trans-ITT and trans-I configurations has been shown to occur 
in Ni(tmc)2 in non-aqueous solvents such as DMSO. 24 However, a trans-IT isomer 
has been observed by 'H NMR in nitromethane. 25 This was shown to isomerise to 
the trans-I isomer. Since Ni(II) is relatively labile, N-substitution of the cyclam 
makes isomerisation slower and aids isolation of unusual species, such as this trans- 
II isomer. 2  The less common cis-V structures have been isolated from Ni(II) 
complexes of cyclam substituted with two pyridyl methyl groups at the N positions. 26 
It has been shown that in CDC1 3 , Ni(cyclam)C12 exists entirely as the 
paramagnetic trans-Ill configuration, at 34 oc27  In the same work, cyclams 
substituted at various CH2 groups with methyl groups were found to exist in either 
trans-I or trans-Ill, depending on the position of the substitution. Trans-I, trans-Ill 
and cis-V isomers of Ni(cyc1am) 2 have all been observed in solution. 2 
2830  The 
trans-Ill isomer was shown to be in rapid diamagnetic-paramagnetic equilibrium by 
17 O NMR studies, in both Ni(cyc1am)2 and Ni(cyclen)2t30' 
H  Detailed 'H NMR 
studies have shown that the diamagnetic, square planar trans-I configuration can 
99 
isomerise to the paramagnetic, octahedral trans-Ill configuration under basic 
conditions.2 However, at pH = 3, the trans-I isomer was found to be extremely 
stable, and the half life at pH = 2 was estimated at 20 years at room temperature. 
This isomerisation between the trans-I and trans-Ill isomers can be catalysed by the 
oxidation of Ni(II) to Ni(III) at low pH values, to give a half life of 400 ms, which 
produced a trans-Ill isomer. 28 The isomerisation between cis and trans Ni(cyclam) 2 
complexes has been studied, and has been found to be rapid at pH = 10, and very 
slow at pH = 3. 29 Molecular mechanics investigations and density functional theory 
have both been used to show that trans-1 and trans-Ill are the most stable Ni-cyclam 
configurations, with there being little difference in energy between the two 
configurations. 2' 32, 33 
The I D spectra of all three Ni(II) cyclam complexes (4-6) show a large 
number of peaks. In solution it is possible for a mixture of complexes of cyclam 
molecules to exist. Both paramagnetic and diamagnetic species may exist in 
equilibrium with unbound cyclam, nickel and unbound ligands. The broad shifted 
peaks can be attributed to one or more paramagnetic forms of the complex. As 
paramagnetic species are known to have shifted peaks in NMR spectra, the spectra 
were recorded over a large sweep width -150 ppm to 300 ppm. Peaks were observed 
in the spectrum between -50 ppm and +150 ppm. Peaks for diamagnetic forms of the 
complexes were observed between 1 ppm and 4 ppm. 
The diamagnetic peaks were assigned using 1D and 2D spectra. Peaks are 
seen in the spectra for unbound cyclam suggesting that an equilibrium exists between 
the nickel complex and unbound cyclam, although previous studies have shown that 
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metal cyclam complexes have high thermodynamic and kinetic stability with respect 
to metal dissociation. 
The 1D and 2D spectra show peaks for 6 non-equivalent protons and 3 
corresponding non-equivalent carbon signals. Therefore in the diamagnetic complex 
the cyclam ring must be in a symmetrical configuration with equivalent positions that 
are related by symmetry. 
The spectra for complex 4, Ni(cyclam)(OAc)2, were initially recorded in 100 
% D20. When the spectra were recorded in 90 % H 20 / 10 % D20, a new peak at 3.6 
ppm was observed in the 1D NMR spectrum and the 2D ['H,'H] TOCSY NMR 
spectrum but not in the 2D ['H,' 3C] HSQC NMR spectrum, therefore this signal was 
assigned as a signal from an NH proton. Only one signal was seen for an NH proton, 
and therefore all the NH groups in the diamagnetic configuration must be equivalent. 
The new peak shows cross-peaks to all the protons in the diamagnetic region in the 
2D ['H,'H] TOCSY NMR spectrum showing that there is only one diamagnetic 
configuration present. In a previously reported 'H NMR characterisation of 
diamagnetic [Ni(cyclam)](C104)2, the NH proton gave a signal at 3.62 ppm, similar 
to the value found here. 28 
In order to confirm the position of the acetate peak in the 'H NMR spectrum, 
10 molar equivalents of Na(OAc) were added to the solution. The signal at 1.9 ppm 
increased in intensity and was assigned to acetate. Only one broad signal for acetate 
was observed, hence it is likely that bound acetate is in fast exchange with free 
acetate. 
Due to the presence of only one NH signal, and based on the previously 
published results on the nickel cyclam perchlorate complex, 2, 34 it was deduced that 
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the conformation of the diamagnetic component was square-planar trans-I, as is the 
previously published perchiorate complex. All three [Ni(cyclam)] 2 complexes were 
found to be in the same configuration, showing that the counterion has little effect on 
the overall structure of {Ni(cyc1am)} 2 in solution. 
3.4.3 UV-Vis Spectroscopy 
For the cobalt complex, 7, the UV-vis spectrum clearly indicates that it is in a 
trans configuration. For Co(III) complexes, the UV-vis absorptions consists of 
transitions from the 'A ig ground state to other singlet states. 
35  In octahedral Co(III) 
complexes, two absorption bands are observed, corresponding to transitions to the 
upper states 'T ig and 1 T2g . However, in trans complexes, the 1 T 1g state splits 
markedly, resulting in the appearance of a third absorption band, as seen here. This 
shows there is no interconversion from trans to cis configurations on going from the 
solid state to the solution state. 
For the nickel complexes 4-6, the UV-vis spectra show that the majority of 
them adopt a planar configuration. Tetrahedral Ni(II) complexes have a strong 
absorption band of the order c = 10 2  M cm i , at approximately 670 nm, absent in 
these complexes. 35 Furthermore, octahedral Ni(II) complexes show three absorption 
bands, corresponding to the three spin-allowed transitions 3  A2 3 3T2g , 3  A2 
3Ti g(F) and 3  A2 4 3T ig(P).35 The complexes studied here all just had one 
absorption band, at 448 nm or 451 nrn, of the order E = 24-35 M' cm* For Ni(II) 
complexes, planar geometry is generally preferred, since in the d 8 configuration, the 
planar ligand set causes one of the d orbitals, d22, to be uniquely high in energy and 
the 8 electrons can occupy the other four d orbitals without interacting with the 
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strongly antibonding d2.2 orbital. 	However, in tetrahedral geometries, the 
occupation of anti-bonding orbitals is unavoidable. For tetra aza ligands, it has been 
reported that nickel complexes are blue when paramagnetic and octahedral and 
yellow when diamagnetic and square planar. 
36  Linear tetra aza Ni(II) complexes are 
generally blue, and as such favour octahedral configuration, 37  whereas Ni(II)-cyclam 
complexes favour the square planar configuration. 38 There are reported Ni(cyc1am) 2 
complexes with absorption bands in the region of 445 nm, and were all found to be 
diamagnetic, square-planar configurations. 28,39 Furthermore, octahedral 
Ni(cyclam)2  complexes have been shown to have three absorption bands and to be 
in trans configurations. 
40, 41 The UV-vis spectroscopy carried out here show that 
there is a square-planar [Ni(cyclam)] 2  configuration present in solution. 
The UV-vis spectrum of the copper complex, 8, shows only one absorption 
band. Its intensity is that of a d-d transition. 
3.5 Conclusions 
NMR spectroscopy, UV-vis spectroscopy and X-ray crystallography were 
used to identify the configurations of Pd(II)-, Ni(II)-, Co(III)- and Cu(II)-cyclam 
complexes. Palladium was found to form only square-planar trans-Ill complexes 
with cyclam, and the counterion has little effect on the overall structure. Acetate 
does not bind to Pd(II)-cyclam directly, nor does it induce configurational changes, a 
lack of direct coordination of Pd(II)-cyclam to carboxylates may be a major factor in 
its lack of anti-HIV activity. A further factor could be its apparent lack of ability to 
change configuration, unlike the active Zn(II) complex, which can change from 
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trans-Ill to cis-V. 
In the solid state, Ni(II)-cyclam is found to adopt the trans-Ill configuration, 
with axial counterions, whereas in solution, Ni(II) cyclam can also be found in the 
diamagnetic, square-planar trans-I configuration. A paramagnetic configuration is 
also present in solution, as revealed by the NMR, likely to be the octahedral trans-Ill 
isomer, but this could not be fully characterised. 
Cu(lI)-cyclam was found to be trans-Ill in the solid state, with water bound 
in the axial positions, and acetate as a counterion. The solution NMR supported this, 
with the acetate peak being the only non-broadened peak in the spectrum, showing 
that there is no configurational change between the solid and the solution state. 
Co(III)-cyclam adopts a trans-Ill configuration in the solid state, with acetate 
in the axial positions. Three configurations were observed in solution, trans-Ill, 
trans-I and a further unidentified trans configuration. All the acetate was bound 
directly to the cobalt in solution, as no peaks were observed for free acetate. 
The antiviral activity of cyclam and its derivatives is greatly influenced by 
metal complexation. The biological target for these complexes is the membrane co-
receptor protein CXCR4. Therefore it is important to gain an understanding of the 
factors which influence the interaction between the protein and the metal 
macrocycle. It is clear that the nature of the metallocyclams and their 
stereochemistry (trans or cis), as well as the substituents on the ring nitrogen atoms 
and on the periphery can also exert a major effect. Importantly the configuration 
found in the solid state is not necessarily the only configuration found in solution, 
and the availability of low-energy pathways for interconversion between 
configurations may be important in receptor recognition and antiviral activity. In 
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particular for Zn(II)-cyclams (active) interconvers ions between configurations are 
often facile, whereas for Pd(II)-cyclams (inactive) and Co(III)-cyclams (very low 
activity) they are not. 
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Chapter 4 Synthesis and Reactions of Xylyl-Bicyclam and 
its Metal Complexes 
4.1 Introduction 
4.1.1 Discovery of AMD 3100 
In 1985, Rozenbaum et at. reported evidence of the anti HIV activity of a 
polyoxometalate.' Polyoxometalates are globular polyanionic structures, with 
peripherally located oxygen atoms that give them their anionic charge. This lead to 
the testing of many other polyoxometalates were tested, to see if the activity could be 
matched or improved .2 However, they were never really persued as long term 
potential treatments for HIV, as it was thought that they would be deposited in 
organs, such as the liver, over time. It was suggested that instead of incorporating a 
metal into the globular shell, that metal complexes of organic compounds could be 
tested. This lead to the investigation of cyclarn, with its 4 nitrogen atoms that can 
readily coordinate metal ions. 3 However, before testing on metallocyclams began, 
testing was carried out on the ligand alone to ensure the activity would come from 
the addition of the metal. It was found that the majority of the commercially 
available samples of cyclam had little anti-HIV activity, as expected. However, there 
was one sample which showed distinct activity, it was found to have an EC50 value 
of 10 .ig per ml, compared to the other samples, in which the EC50 values were all 
greater than 100 ig per ml. As this sample was the only one to have such activity, 
the purity of it was questioned. High pressure liquid chromatography (HPLC) 
analysis was carried out on it, and it was found that there was an impurity present, of 
about 1 - 2 %. When the impurity was purified and isolated, it was found to have an 
EC50 of 0.1-0.2 jig per ml. This was eventually characterised as the bicyclarn 
JM1657, consisting of two cyclam rings, joined by a carbon-carbon bridge (structure 
shown in Table 4.1). 
However, a major drawback was encountered when it proved impossible to 
resynthesise this compound. This was tackled by synthesising derivatives of this 
molecule, where the cyclam rings were joined by aliphatic bridges through the 
nitrogen groups. This lead to the discovery of JM2763, with an aliphatic bridge 
consisting of three CH2 groups, which was found to have an activity similar to that of 
JM 1657. However, it was thought that the activity of this compound could be 
further improved, so many derivatives were tested. The most significant 
improvement was found when an aromatic bridge was introduced to replace the 
aliphatic bridge. This lead to JM2987 and JM3 100 (renamed AMD3 100 at a later 
date, referred to as xylyl-bicyclam in this work, shown in Figure 4.1). 
5  Both were 
active at a concentration of — 0.005 jig per ml, and were not toxic to host cells at> 
500 jig per ml. As AMD3 100 had the slightly better activity, this one was persued 
further and eventually taken to clinical trials. 
HS1' 1,H 
Hf 	 N N 
N N () 
N N 
H' LJ'H 
Figure 4.1 Xylyl-bicyclam, 9 
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Table 4.1 Anti-HIV activity of Bicyclams3 
Compound Structure EC50/.iM CC504t 
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AMD3 100 is also in clinical trials for stem cell transplantation used in the 
treatment of patients who have cancers involving the blood and the immune system. 3 
AMD3 100 blocks the entry of T-lymphotropic HIV-1 and HIV-2 strains by 
specifically binding to the CXCR4 co-receptor. 6 
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4.1.2 Metal Complexation 
The effect of metal complexation on the activity of xylyl-bicyclam has been 
investigated .7  It has been shown that zinc increased the activity compared to xylyl-
bicyclam, while other metals decrease the activity, with the palladium complex 
having no activity at all. The overall order of activity is: 
Zn(II)2 > xylyl-bicyclam > Ni(II) > Cu(II)2 >> Co(III)2 >>> Pd(II)2 
It has been suggested that xylyl-bicyclam could pick up zinc from the blood, and that 
this could be the active form of the drug in the body. 7 It is therefore important to 
consider the solution structure of these metallobicyclams, to gain understanding as to 
why the zinc complex is active, but other metals reduce the activity. The 
concentration of zinc in blood plasma is ca 20 iM.8 The most common ligands for 
zinc in the Protein Data Bank are histidine and cysteine. 9 As such, it is possible that 
xylyl-bicyclam could extract zinc from carrier proteins. 
4.1.3 Zinc Histidine 
Much work has been carried out investigating the properties of zinc histidine. 
It has been shown that at pH = 7, [Zn(Hist)] and [Zn(Hist)2] are the principal forms 
in solution. '° Two crystal structures of zinc histidine have been reported.' 
I. 12 The 
first one has is a pentahydrate complex, with two histidines coordinated to one zinc, 
with the zinc coordinated in a distorted tetrahedral manner, consisting of an amino 
nitrogen and an imidazole nitrogen from each histidine group." The second 
structure has a similar structure, except it crystallised as the dihydrate form. 
However, it has been argued by Couves et al,' 1 that the zinc in both of these 
complexes are in fact in distorted octahedral coordination. This is due to the fact that 
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both of these complexes have two carboxylate groups in close proximity to the zinc 
(2.8 - 2.9 A)." 
4.2 Synthesis 
4.2.1 Synthesis of Xylyl-Bicyclarn, 9, Route 1 
The first attempted synthesis of xylyl-bicyclam uses a phosphoryl-protected 
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Scheme 4.1 Synthetic route 1 to xylyl-bicyclarn. 
Cyclam (501 mg, 2.5 rnrnol) was suspended in dry toluene (100 rnL) and 
hexamethyiphosphoric triamide (454 jiL, 2.5 mrnol) was added. The mixture was 
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stirred for 4 hours at room temperature and then heated overnight under reflux. The 
resulting clear solution was cooled to 0 °C, which resulted in some white precipitate 
forming. Carbon tetrachloride (375 jiL, 3.9 mmol) was added which resulted in 
further precipitation. This mixture was stirred at room temperature overnight. The 
mixture was then concentrated to dryness and 10% sodium hydroxide (25 mL) was 
added. This was then left to stir overnight. The reaction mixture was extracted with 
chloroform (5 x 100 mL) and the combined organic layers were dried over MgSO4. 
This was then filtered and dried under high vacuum to give protected cyclam as a 
white powder (575 mg, 2.35 mmol, 94 % yield). 
Protected cyclam (570 mg, 2.33 mmol) was suspended in dry DMF (70 mL) 
and a,oC-dibromo-p-xylene (0.5 molar equiv, 308 mg, 1.17 mmol) and sodium 
carbonate (580 mg, 1.83 mmol) were added. This was stirred at 120 °C for 24 hours. 
The solvent was removed under high vacuum and the white residue was reacted with 
10 % hydrochloric acid (40 mL). The resulting yellow solution was heated under 
reflux for 2.5 days. The pH was adjusted to pH ~!13 using sodium hydroxide pellets. 
This aqueous phase was then extracted with chloroform (3 x 100 mL). The 
combined organic layers were then dried over NaSO 4. The solution was filtered and 
the solvent was removed under high vacuum to give a pale yellow powder (520 mg, 
44 % yield). 
4.2.2 Synthesis of Xylyl-Bicyclam, 9, Route 2 
The second synthetic route used for xylyl-bicyclam starts from cyclam, and 
uses trifluoroacetate protecting groups, shown in Scheme 4.2. 14 
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Scheme 4.2 Synthetic route 2 to xylyl-bicyclam 
Part (a) Protection of Three NH Groups on Cyclam 
Cyclam (2.02 g, 10.08 mmol) was dissolved in methanol (8 mL) under N2 
with stirring and triethylamine (1.4 mL, 1 molar equiv) was added to give a pale 
yellow solution. Ethyl trifluoroacetate (4 molar equiv, 40.32 mrnol, 4.82 mL) was 
added dropwise over 10 minutes whilst the cyclarn solution was cooled in at ice bath. 
Once the addition was complete, the ice bath was removed and the reaction was left 
to stir at room temperature for four hours. The solvent was then removed under high 
vacuum. The residue, dissolved in ethyl acetate, was then passed through a silica 
plug (8 g) and the resulting solution was then concentrated to dryness under high 
vacuum to give a white foam (2.01 g, 4.12 mmol, 41 % yield). 
'H NMR (250 MHz, CDC13) : 3.91-3.47 (m, 12H), 3.17-2.65 (rn, 4H), 2.30-1.73 (m, 
4H), 1.20-0.8 (bs, 1H). 
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ES-MS : mlz = 489.2 [M+H]. 
Part (b) Dimerisation 
Tr-protected cyclam (2.01 g, 4.12 mmol) was dissolved in anhydrous 
CH3CN (100 mL) under an N2 atmosphere and potassium carbonate (3 molar equiv, 
12.36 mmol, 1.72 g) was added. To this, a,a'-dibrorno-p-xylene (2.06 mmol, 545 
mg, 0.5 molar equiv) was added and the reaction was heated to reflux for 22 hours. 
The resulting cloudy mixture was dried under high vacuum to give a white solid. 
This was partitioned between water (30 mL) and dichioromethane (100 mL) and the 
aqueous layer was extracted with dichloromethane (3 x 50 rnL). The combined 
organic layers were dried over MgSO4, which was filtered off and the solvent 
removed to give a pale yellow powder. The product was then purified by column 
chromatography on silica gel using ethyl acetate : hexane (9:1 ratio). The solvent 
was removed under high vacuum to give a white solid (2.75 g, 2.55 mmol, 62 % 
yield). 
'H NMR (250 MHz, CDC1 3) : 7.23-7.10 (m, 4H), 3.83-3.25 (m, 24H), 2.85-1.54 (m, 
20H). 
ES-MS : mlz = 1079.8 [M+H]. 
Part (c) Deprotection 
The hexa-protected bicyclam (2.75 g, 2.55 mmol) was dissolved in methanol 
(15 mL) and 10 % NaOH (15 mL). Immediately a white precipitate formed. The 
solution was stirred for 6 hours at room temperature to give a clear colourless 
solution. The aqueous layer was then extracted with chloroform (3 x 50 mL), and the 
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organic layer was dried with sodium sulphate. This was removed by filtration, and 
the solvent was removed under high vacuum to give a white powder (1.10 g, 2.19 
mmol, 86 % yield). 
'H NMR (250 MHz, CDC13) : 7.50-7.32 (m, 4H), 3.83 (s, 4H), 3.32-2.70 (m, 32H), 
2.18-2.08 (m, 41-1), 1.92-1.78 (m, 4H). 
ES-MS : m/z = 504.2 [M-i-H]. 
4.2.3 Synthesis of Metal-Xylyl-Bicyclam Complexes 
The metal-xylyl-bicyclam complexes 10-13 were synthesised using the 
general route shown in Scheme 4.3. 
H1" I,H 
2 eq M(OAc)2 	
4(OAc) 
MeOH, i 
H' L) H 
Scheme 4.3 General route to metal-xylyl-bicyclams 
Ni2(XylyI-bicyclam)(OA04, 10 
Ni(OA02 .4H20 (11.1 mg, 0.04 mmol) was dissolved in methanol (5 mL) and 
added to a solution of xylyl-bicyclam (0.5 molar equiv, 11.2 mg, 0.02 mmol) in 
methanol (10 mL). The mixture was stirred for while refluxing for 2 hours. The 
solvent was then removed by under reduced pressure. and the resulting purple solid 
was dried under vacuum. The product was dissolved in methanol and set up for slow 
diffusion into diethyl ether, which produced a purple powder (10.3 mg, 0.012 mrnol, 
60 % yield). 1D and 2D NMR spectra ([ ] H, ' 5N] HSQC) were recorded on this 
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product on a 800 MHz spectrometer in 90 % H20 / 10 % D20. 
ES-MS: mlz = 368.2 [M-20Ac] 2 , 368.2 [M-30Ac-H] 2 , 308.2 [M-40Ac-2H] 2 . 
Selected IR (KBr, cm- '): 3423 s (NH), 2927 m (CH), 2869 s (CH), 1565 m (CO), 
1412 m (CO). 
Cu2(XyIyl-bicyclam)(OA04, 11 
Cu(OAc)2.H20 (36.3 mg, 0.18 mmol) was dissolved in methanol (2 mL) and 
added to a solution of xylyl-bicyclam (0,5 molar equiv, 46.1 mg, 0.09 mmol) in 
methanol (10 mL). The mixture was stirred for while refluxing for 2 hours. The 
solvent was then removed under reduced pressure and the resulting purple solid was 
dried under vacuum. The product was dissolved in methanol and set up for slow 
diffusion into diethyl ether, which produced a blue/purple powder (65.2 mg, 0.075 
mmol, 83 % yield). 1D and 2D NMR spectra ([ 1 H, "Cl HSQC) were recorded on 
this product on a 800 MHz spectrometer in 90 % H20 / 10 % D20. 
ES-MS : mlz = 373.3 [M-20Ac] 2 , 343.2 [M-30Ac-H] 2 , 314.2 [M-40Ac-2H] 2 . 
Selected JR (KBr, cm 1 ): 3440 s (NH), 2917 m (CH), 1417 m (CO). 
[Pd2(Xylyl-bicyciam)}(0A04, 12 
Xylyl-bicyclam (10.1 mg, 0.02 mmol) was dissolved in methanol (1 mL) and 
Pd(OA02 (2 molar equiv, 9.0 mg, 0.04 mmol) was added and the solution 
immediately turned brown. The reaction was heated under reflux for two hours, then 
filtered and concentrated to dryness. The product was dissolved in methanol and set 
up for slow diffusion into diethyl ether, which produced a yellow powder (8.9 mg, 
0.0099 mmol, 50 % yield). 1D and 2D NMR spectra (COSY, TOCSY, NOESY, II'H, 
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' 5N] HSQC and ['H, "Cl HSQC) were recorded on this product on a 800 MHz 
spectrometer in 90 % H 20 / 10 % D20. 
ES-MS : mlz = 357.2 [M-3H] 2 
Selected JR (KBr, cm'): 3446 s (NH), 2360 m (CH), 2341 s (CH), 1560 m (CO), 
1412 m (CO). 
[CO2(Xylyl-bicyclam)C14]C12, 13 
Xylyl-biyclam (9.5 mg, 0.019 rnmol) was dissolved in methanol (1 mL) with 
stirring to give a clear, colourless solution. CoC1 2 .6H20 (2 molar equiv, 9.0 mg, 
0.038 mmol) was dissolved in methanol (1 mL) with stirring. This resulted in a 
clear, purple/blue solution. The cobalt solution was added dropwise to the xylyl-
bicyclam solution with stirring. This gave a clear, yellow/brown solution. Air was 
bubbled through the solution for 10 minutes and 1 M HCl (1 mL) was added until the 
solution became dark green. Air was bubbled through the solution for a further 10 
minutes. The dark green solution was filtered. This resulted in a clear green solution 
with a small amount of precipitate (a green powder). The green solution was 
concentrated to dryness to give a green powder. The powder was dissolved in the 
minimum amount of hot water, which produced a black solution. Once cooled, green 
needle crystals formed. These were filtered and washed with diethyl ether (9.2 mg, 
0.011 mmol, 58 % yield). 1D and 2D NMR spectra (COSY, TOCSY, NOESY, [ 1 H, 
5N] HSQC and ['H, 13C] HSQC) were recorded on this product on a 800 MHz 
spectrometer in 90 % H20 / 10 % D 20. 
ES-MS : m/z = 381.2 [M-2Cl] 2 , 363.2 [M-3Cl-H] 2 , 346.2 [M-4Cl-2H] 2 . 
Selected JR (KBr, cm - 1 ): 3418 s (NH), 2925 m (CH), 2360 s (CH), 1623 m (OH), 
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1459 in (CO). 
4.2.4 UV-Vis Spectroscopy 
UV-vis spectra were recorded for complexes 10, 11 and 13 in H20 at 25 °C, 
between 300-800 nm. 
4.2.5 Zinc Uptake of Xylyl-Bicyclan at 37 °C 
Xylyl-bicyclam (3.1 mg) was dissolved in D 20 (500 .tL, 10 mM) and dioxane 
(2 jiL) was added. The pH was adjusted using DN03 (1 M) until pH=7.28. A 'H 
NMR spectrum at 37 °C was recorded. The reaction was maintained at 37 °C and 
Zn2(OAc)2.2H20 (2 molar equiv, 2.6 mg, 20 mM) was added. The pH was adjusted 
to pH=7.28 and another NMR spectrum was recorded 5 minutes 12 seconds after the 
addition. Spectra were recorded every 10 minutes for 3 hours and then every 30 
minutes for 21 hours. A 2D ['H, ' 3 C] HSQC NMR spectrum was then recorded on 
this product on a 800 MHz spectrometer in 90 % H20 / 10 % D20. 
4.2.6 Reaction of Zn(histidine)2 with Xylyl-Bicyclana at 37C 
Histidine (31.02 mg, 0.1 mmol) was dissolved in D20 (10 mL). Zinc chloride 
(0.5 molar equiv, 6.81 mg, 0.05 mmol) was added and the mixture was stirred at 
room temperature for one hour. The solution was concentrated until white 
precipitate formed, which was then filtered off and washed with diethyl ether. This 
was then made up to 10 ml- with D20. The resulting clear solution (pH=6.02) was 
adjusted to pH=7.17 using NaOD. 
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'H NMR - 7.81 (1H, s), 7.07 (1H, s), 3.99 (1H, t, J = 4 Hz), 3.17 (s, 2H). 
ES-MS : mlz = 375.7 [Zn + 2hist + 3H], 329.6 [Zn + 2hist - COOH], 218.4 [Zn + 
hist - Hf, 157.3 [Zn + hist - Cooi-ijjt 
A 'H NMR spectrum of Zn(hist)2 (600 p.L, 5 mM) in D 20 at pH = 7.17 and 
37 °C was recorded with dioxane (2 1iL) added as a reference. Xylyl-bicyclam (0.5 
molar equiv, 300 .tL, 5 mM, pH=7.2) in D 20 was added and a spectrum was 
recorded at 37 °C, 2 minutes 56 seconds after addition. 1D 'H NMR spectra were 
then recorded every 10 minutes for 2 hours, then every 30 minutes for the following 
22 hours. 2D NMR spectra (['H, 'H] COSY, TOCSY, NOESY and ['H, ' 3C] HSQC) 
were recorded at the end of this period. 
To identify the products of this reaction, HPLC-MS was carried out on the 
product. A polymer reverse phase column was used and water and acetonitrile 
solvents were used with 0.1% TFA added as an ion pairing agent. 
HPLC conditions : 30 p.L portions, flow rate = 0.6 mL I mm, gradient: 0 - 5 
minutes, 90 % water / 10 % acetonitrile; 5 - 15 minutes, 50 % water / 50 % 
acetonitrile; 15 - 20 minutes, 50 % water / 50 % acetonitrile; 20 - 21 minutes, 90 % 
water / 10 % acetonitrile; 21-27 minutes, 90 % water / 10 % acetonitrile. The total 
separation time was 27 minutes. The absorbance was measured at 254 nm. 
4.2.7 Addition of Acetate to Pd 2(xylyl-bicyciam)](0A04 
A solution of Pd2(xylyl-bicyclarn)ROAc)4, (4 mg, 0.0044 mmol) in 90 % 
H20 / 10 % D70 (600 IlL, 7.5 mM) with dioxane (2 .iL) added as a reference was 
prepared. This was used to record 1D 'H NMR and 2D ['H, 'H] TOCSY, COSY and 
NOESY and ['H. "Cl and ['H, ' 5N] HSQC were recorded. Sodium acetate (1 M, 
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17.6 .iL, 4 molar equiv) was added and 1D 'H NMR spectra were recorded every 30 
minutes for 24 hours and then the 2D NMR spectra were re-recorded. 
4.2.8 Addition of Acetate to CO 2(xylyl-bicyclarn)C141C12 
A solution of CO2(xylyl-bicyclam)C141C12, (3 mg, 0.0036 mmol) in 90 % H20 
/ 10 % D20 with dioxane (2 p.L) added as a reference was prepared. This was used 
to record 1D 'H NMR and 2D ['H, 'H] TOCSY, COSY and NOESY and ['H, 13C] 
and ['H, ' 5 N] HSQC spectra. Sodium acetate (1 M, 21.6 L, 6 molar equiv) was 
added. A 1D 'H proton spectrum was recorded 5 minutes after the first addition and 
every 10 minutes for 2 hours and every 30 minutes for 45 hours. 2D ['H, 'I-I] 
TOCSY, COSY and NOESY and ['H, ' 3C] and ['H, ' 5N] HSQC spectra were then 
recorded on the product. UV-vis spectroscopy, (300-800 rim, 25 °C, in 90 % H20 / 
10 % D20) and ES MS were also carried out on the product. 
ES-MS : mlz = 457.7 [CO2(xyly1-bicyc1am)(OAc)5] 2 , 428.7 [Co2(xylyl-
bicyclam)(OAc)4] 2  368.1 [CO2(xy1yl-bicyclam)(OAc)2] 2 
4.3 Results 
4.3.1 Synthesis of Xylyl-bicyclam, 9 
The 1 H NMR spectrum produced from route 1 shows that there is a mixture 
of cyclam and xylyl-bicyclarn present. There are two main areas during the synthesis 
which could have caused it to give poor results. The first is the DMF, which was 
difficult to obtain in a completely anhydrous form, giving residual water in the 
reaction, hence causing a poor yield. The second is the highly air sensitive 
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phosphine protecting group, which can easily decompose. Xylyl-bicyclam (9) was 
successfully synthesised using route 2, and characterised using ES-MS and 'H NMR, 
The xylyl-bicyclam produces a characteristic multiplet at 7.50-7.32 ppm, which 
arises from the aromatic linker protons. The aliphatic linker protons give the broad 
singlet at 3.83 ppm. The 2 sets of CH29II2CH2  protons give signals at 1.92-1.78 
ppm and 2.18-2.08 ppm. There is a large multiplet between 2.70 ppm and 3.32 ppm 
which arise from2CH22 protons. 
4.3.2 INi2(Xylyl- Bicyclam)J(OAc)4, 10 
The 1D 1 H NMR spectrum (Figure 4.2) for the nickel(II)-xylyl-bicyclam 
acetate complex 10 is extremely complicated. It is likely that there is a large number 
of species present in solution. There is a mixture of peaks for paramagnetic and 
diamagnetic species. Spectra were recorded over a spectral width of -400 ppm to 
+400 ppm. Peaks were observed between -20 ppm and 250 ppm. The region 55 
ppm to -45 ppm is shown in Figure 4.3. The broadened peaks are shown in Figure 
4.4, and the data are summarised in Table 4.2. A ['H, 15N] HSQC spectrum was 
recorded, but no NH signals were observed. The two cyclam rings in the xylyl-
bicyclam molecule may be in different configurations and be either paramagnetic or 
diamagnetic giving molecules with both paramagnetic and diamagnetic components. 
Paramagnetic-paramagnetic, paramagnetic-diamagnetic and diamagnetic-
diamagnetic components may all be present in solution and affect the NMR spectrum 
obtained. Further experimentation would be required in order to assign the peaks 
seen in the spectrum. 
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Figure 4.2 1D 'H NMR spectrum of Ni 2(bicyclam)(OAc)4, 10, recorded in 90 % 
H20/10%D20,at25 °C. 
50 	40 	30 	20 	10 	0 	-10 	-20 	-30 
(1H) 
Figure 4.3 1D 'H NMR spectrum of Ni 2(bicyclam)(OAc)4, 10, recorded in 90 % 
H20 / 10 % D20, at 25 °C, over a sweep width of 55 ppm to - 45 ppm, showing the 
broad peaks observed in this region. Peak labels correspond to those in Table 4.2. 
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Figure 4.4 1D 'H NMR spectrum of Ni 2(bicyclam)(OAc)4, 10, recorded in 90 % H20 
110 % D20, at 25 °C, (a) over a spectral width of 60 ppm to 150 ppm, (b) over a 
spectral width of 150 ppm to 230 ppm and (c) over a spectral width of 230 ppm to 
265 ppm showing the broad peaks observed in this region. Peak labels correspond to 




Table 4.2 Para magnetically-shifted peaks for Ni 2(xylyl-bicyclam)(OAc) 4 , 
complex 10. (See Figure 4.3 and Figure 4.4) 
Peak 'H/ppm Peak 'H/ppm 
1 -18.2 8 69.7 
2 -15.5 9 80.3 
3 -7.5 10 117.7 
4 11.7 11 169.0 
5 13.3 12 191.8 
6 21.4 13 211.8 
7 42.1 14 245.5 
4.3.3 fCu(Xy!yl- Bkyclam)J(OAc) 4, 11 
A one dimensional 'H NMR spectrum was recorded for this complex in 90 % 
H20 / 10 % D20, and a 2D ['H, ' 3 C] HQSC. Six peaks were observed in the 1D 'H 
NMR spectra (recorded over a spectral width of -400 ppm to +400 ppm). There was 
one unbroadened peak at 1.94 ppm, (23.6 ppm in ' 3C dimension), likely to be from 
free acetate. The other five peaks were found to be broadened significantly by the 
two paramagnetic Cu 2+  centres (Figure 4.5). The data are summarised in Table 4.3. 
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Figure 4.5 1D 'H NMR spectrum of [Cu 2(XyIyl- Bicyclarn)](OAc) 4, 11, recorded in 
90 %H20 / 10 % D20, at 25 °C (a) from -I to 11 ppm, (b) from -70 to 80 ppm. Five 
broad peaks are seen in (b), labelled 1-5. 
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Table 4.3 Para magnetically-shifted peaks for Cu 2(xylyl-bicyclam)(OAc)4, 







4.3.4 [P(12(xy1y1-bicyc1am)](0A c) 4, 12 
The 'H NMR spectrum of [Pd 2(xylyl-bicyclam)](OAc)4, 12, in 90 % H20 / 
10 % D20 is shown in Figure 4.6. The resonances in the spectrum can be spilt into 4 
groups: resonances from the aromatic protons, resonances from the protons in the 
bridging linker CH2 groups, resonances from NH protons and resonances from the 
protons in the cyclam rings. In order to aid full characterisation of the 'H NMR 
spectrum, ['H, 'H] TOCSY, COSY and NOESY and ['H, 'DC] and ['H, ' 5N] HSQC 
spectra were acquired. There is one acetate signal, at 1.91 ppm, showing that all the 
acetate is in the one configuration. The acetate peak does not show TOCSY peaks to 
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Figure 4.6 1D 'I-I NMR spectrum of complex 12, [Pd 2(xylyl-bicyclam)](OAc) 4 , in 
90 % H20 / 10 % D2 0 at 25 °C, with the different regions labelled. 
NH Proton Resonances 
There are only 3 NH signals present in the ['H, ' 5N]-HSQC (Figure 4.7). 
This shows that there is only one configuration present, hence both cyclam rings 
must be in the same configuration. 
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Figure 4.7 2D ['H, ' 5N] HSQC NMR spectrum of complex 12, recorded in 90 % 





Bridging Methylene Proton Resonances 
Only one pair of resonances for the bridging methylene protons is observed in 
the 2D ['H, ' 3C] HSQC NMR spectrum, shown in Figure 4.8. One of the linker 
protons (4.15 ppm) shows a NOESY peak to one of the NH proton signals (5.67 
ppm) showing that they are on the same face of the cyclam ring. There is no 
interaction between the linker protons and either of the other two NH resonances, 
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Figure 4.8 Linker region of the 2D ['H, ' 3C] HSQC NMR spectrum of complex 12, 
[Pd2(xylyl-bicyclam)](OAc)4, recorded in 90 % H20 / 10 % D 20, showing only two 
linker protons, hence only one configuration of the macrocycle must be present. 
Aromatic Resonances 
There is only one signal in the aromatic region of the ['H, C] HSQC 
spectrum, this means that both rings have to be in the same configuration, as if they 
were in different ones, the aromatic protons would be in different environments and 
sf,] 
the signals would become inequivalent. There is a peak in the ['I-I, 'H] NOESY 
spectrum between the aromatic signal and one of the linker protons, 14b. The 
aromatic resonance shows NOESY cross peaks to one of the central methylene 
protons of one of the 3-carbon bridges, 9a, and also to protons la and 13b, 
supporting that these are the groups closest to the linker. For the numbering scheme, 
see Figure 4.7, 
Proton Resonances from the Cyclam Rings 
Only one set of NH peaks and one set of linking CH 2 groups shows that there 
is only one type of cyclam ring present in solution for [Pd 2 (xylyl-bicyclam)](OAc)4. 
This is supported by the fact that there are 10 pairs of signals in the aliphatic region 
of the 2D ['H, "Cl HSQC NMR spectrum, shown in Figure 4.9. Two of the NH 
peaks (protons 5 and 7) show NOESY cross peaks to the same central methylene 
resonance (proton 2a), showing that they are both on the same side of the ring as 
proton 2a. Proton 2a must therefore be an axial proton. The other NH, proton 10, 
shows a NOESY cross peak to the linker proton 14a, showing that proton 10 and the 
linker are on the same face of the ring. These two interactions are strongly indicative 
of a trans-Ill configuration. Proton 10 also shows a NOESY cross-peak to proton 9a, 
which is the axial central methylene proton in the other 3-carbon bridge. The fully 
assigned 2D ['H, ' 3 C] HSQC NMR spectrum is shown in Figure 4.9, along with the 
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Figure 4.9 2D ['H, ' 3C] HSQC NMR spectrum of complex 12, [Pd2(xylyl-
bicyclam)](OAc)4, recorded in 90 % H 20 / 10 % D 20. Ten sets of CH2 protons are 
from the macrocycle, and one set from the linker protons. Only one acetate signal is 
observed. The numbering scheme is included. Protons on the same carbon atom are 
referred to as a and b. 
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Table 4.4' H, ' 3C and ' 5N Chemical shifts of Pd 2(xylyl-bicyclam)J(0Ac)4, 12, 
recorded in 90 % H20 / 10 % D20 at 25 T. For numbering scheme, see Figure 
4.9. 
Assignment 1 H / 13C / 15N / Assignment 'H / ' 3C I ' 5N / 
ppm ppm ppm ppm ppm ppm 
la 2.96 8b 2.74 
62.3 
lb 2.74 9a 3.14 
56.2 
2a 2.99 9b 2.62 
53.7 
2b 2.73 10 5.67 2.6 
3 5.51 2.1 ha 3.03 
54.3 
4a 2.79 lib 2.84 
53.4 
4b 2.38 12a 2.33 
28.5 
Sa 2.12 12b 2.17 
30.9 
5b 1.54 13a 2.92 
60.6 
6a 2.91 13b 2.84 
53.6 
6b 2.69 14a 4.65 
58.5 
7 5.37 0.7 14b 4.14 
8a 3.05 56.9 15 7.65 135.0 
4.3.5 fCo(Xy1y!- Bicyclam) C1 41C12, 13 
The 'H NMR spectrum of [CO2(xylyl-bicyclam)C14]C12, 13, in 90 % H 20 / 10 
% D20 is shown in Figure 4.10. Dioxane was added as a reference. In order to aid 
full characterisation of the 'H NMR spectrum, 2D ['H, 'H] TOCSY, COSY and 
NOESY and ['H, ' 3 C] and [ 1 H, ' 5N] HSQC NMR spectra were acquired. 
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Figure 4.10 1D 'I-j  NMR spectrum of [CO2(xylyl-bicyclam)C14]C12, 13, recorded in 
90 % H20 / 10 % D20 at 25 °C. Key regions are highlighted. 
NH Proton Resonances 
There are 6 NI-I signals present in the 2D ['H, ' 5N] HSQC spectrum (Figure 
4.11). This shows that there are two configurations present. From this HSQC 
spectrum alone, it is impossible to tell if they are from one xylyl-bicyclam molecule 
with the rings in different configurations or if there are two xylyl-bicyclam 
molecules present. The 2D ['H, 'H] TOCSY spectrum can be used here to show that 
the peaks at 6.97 ppm, 6.66 ppm and 6.29 ppm show TOCSY peaks to each other, 
indicating that they are from the same cyclam ring, (system A) and the peaks at 7.28 
ppm and 6.75 ppm and 6.69 ppm show TOCSY peaks to one another, so they must 
also be from the same cyclam ring (system B) (Figure 4.12). The integrations of the 
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peaks in the 2D ['H, 15  N] HSQC NMR spectrum show that the peaks from system A 
all integrate to similar values, as do those of system B. From the integrals, it can be 
calculated that the ratio of system A : system B is approximately 60:40. The shifts 
are summarised in Table 4.5. 
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Figure 4.11 2D ['H, 15N] HSQC NMR spectrum of [CO2(xylyl-bicyclam)C14]C12, 
13, recorded in 90 % H20, 10 % D 20 at 25 T. Six signals are observed, three are 
from system A, shown in solid lines, and three are from system B, shown in dotted 
lines, showing that there are two configurations of cyclam present. The 'H and ' 5N 
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Figure 4.12 2D [ 1 H, 'H] TOCSY NMR spectrum of [CO2(xylyl-bicyclam)C1 4]Cl2 , 
13, recorded in 90 % H 20 / 10 % D20 at 25 °C, showing the TOCSY interactions 
between the NH protons. There are 6 NH signals, three of which show connectivity 
to each other, (solid black lines) therefore must be one system (system A). The other 
three also show TOSCY cross-peaks to each other, (dotted lines, system B), although 
two overlap in the proton axis and can only be seen as one signal here. 
Table 4.5' H and ' 5N Shifts for the NH protons from [CO 2(xylyl-
bicyclam)C1 4]C12 in 90 % H20 / 10 % D20 at 25 °C. (See Figure 4.11). 
System Proton*  'H / ppm ' 5N / ppm 
A Nfl 6.97 2.6 
NH2 6.66 3.5 
NH3 6.29 -1.5 
B NHa 7.28 5.7 
NHb 6.75 4.3 
NHc 6.69 3.9 
* No specific assignment 
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Bridging Methylene Proton Resonances 
There are two pairs of resonances for the bridging methylene protons is 
observed in the 2D ['H, ' 3C] HSQC NMR spectrum, further supporting the presence 
of two cyclam configurations (Figure 4.13). There is one set at 55.6 ppm ( 13 C 
dimension) and one set at 58.8 ppm. These integrate in the ratio 40:60, showing that 
the set at 55.6 ppm corresponds to system B, and the set at 58.8 ppm corresponds to 
system A. The data are summarised in Table 4.6. 
6 (13C) 
54 • 	 a b 
M. 
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Figure 4.13 2D ['H, 13C] HSQC spectrum of [CO 2(xylyl-bicyclam)C14]C12, 13, 
recorded in 90 % H20 / 10 % D 20 at 25 °C, showing two sets of linker protons. The 
'H and ' 3C NMR shifts are given in Table 4.6. 
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Table 4.6' H and 13C Shifts for the linker protons from [CO2(xylyl-
bicyclam)C141C12 in 90 % 1120 / 10 % D20 at 25'C. (See Figure 4.13). 
System Proton*  'H / ppm .. / ppm 
A CH1 4.24 
58.8 
CH2 3.94 
B CHa 3.89 
55.6 
CHb 3.81 
* No specific assignment 
Proton Resonances from the Cyclam Rings 
Two sets of NH peaks and two sets of linking CH2 groups shows that there 
are two types of cyclam ring present in solution for [CO 2(xylyl-bicyclam)C1 4]C12 . 
Four sets of protons are observed with corresponding 13  C NMR shifts between 25 
ppm and 32 ppm (' 3 C dimension, Figure 4.14), these are from the central methylene 
protons in the 3-carbon bridge. Four sets of signals in this region again suggest that 
there are two configurations of cyclam present. However, the remainder of the peaks 
in the 2D ['H, ' 3 C] HSQC NMR spectrum, from the CR 2 groups around the cyclam 
rings could not be fully characterised, due to overlapping signals in both the proton 
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Figure 4.14 2D ['H, 
13  C] HSQC spectrum of [CO2(xylyl-bicyclam)C141C12, 13, 
recorded in 90 % H20 / 10 % D20 at 25 °C, showing four sets of CH 2 CH2 
protons. 
Aromatic Resonances 
The xylyl aromatic resonances are sensitive to both of the attached cyclam 
units, being singlets when the two units are the same but AB quartets when they are 
different. In this case, there are two singlets, and one AB quartet present, (Figure 
4.15) which suggests there are three xylyl-bicyclam isomers present, two with both 
the cyclam rings in same configuration, and one with the cyclam rings in two 
configurations. 
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Figure 4.15 2D ['H, ' 3 C] HSQC NMR spectrum of [CO2(xylyl-bicyclam)C14]C12, 13, 
recorded in 90 % H20 / 10 % D20, at 25 °C. Two singlets are present, marked by 
solid boxes, which shows that there are two species present in which the both the 
cyclam rings are in the same configuration. One AB quartet is observed, marked by 
a dotted box, which means that there is one species present which has the cyclam 
rings in different configurations. 
4.3.6 UV-Vis Spectroscopy 
UV-vis spectroscopy was carried out on complexes 10, 11, 13 and 13 + 6 
molar equivalents of NaOAc. One absorption band was found for the Ni(II) and the 
Cu(II) complexes, while three bands were observed for the Co(III) complexes. The 
extinction coefficients were calculated using Equation 3. 1, and the results are shown 
in Table 4.7. 
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Table 4.7 Extinction Coefficients for Metal-Bicyclam complexes, recorded in 
H20, at 25 °C. 
Complex Conc. / mM ax' nm A C / M' 
Ni2(xylyl-bicyclam)(OAc)4, 10 0.934 456 0.0796 85.2 
Cu2(xylyl-bicyclam)(OAc)4, 11 2.23 513 0.1927 86.4 
Co2(xylyl-bicyclarn)06, 13 1.4 641 0.03400 24.3 
466 0.04962 35.4 
383 0.1143 81.6 
13 + 6 molar equiv NaOAc * 5.0 571 0.2332 44.6 
475 0.1826 36.5 
373 0.3967 79.3 
* Recorded in 90 % 1-120 / 10 % D20. Assumed final product was CO2(xylyl-
bicyclam)(OAc)6 for concentration calculation, based on the ES-MS data. 
4.3.7 Zinc Uptake of Xylyl-Bicyclani at 37 °C 
The first 'H NMR spectrum after the addition of Zn 2 from zinc acetate (2 
molar equiv) recorded showed an immediate change from that of the initial xylyl-
bicyclam (Figure 4.16). There was no observable change in the 'H NMR spectrum 
recorded over a 24-hour period. The structure of Zn 2(xylyl-bicyclam)(OAc)4 has 
been well studied by NMR spectroscopy, and shifts of particular protons can be used 
to identify the configuration of the cyclam rings. 15 In this case, the methylene linker 
protons were used to identify the configurations. There are three identifiable sets of 
methylene linker proton peaks observable in the ['H, ' 3 C] HSQC spectrum (Figure 
4.17). These were attributed to a trans-Ill configuration, a trans-I configuration and 
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a cis-V configuration. There is also a peak present from unreacted xylyl-bicyclam. 
Looking at the integrals of the peaks in this region, 12 % of the complex is trans-Ill, 
15 % is cis-V and 28 % is trans-I. Integration showed that 45 % of xylyl-bicyclam 
remained uncomplexed. 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 ö (1H) 
Figure 4.16 Stacked plot of (a) xylyl-bicyclam in 90 % H 20, 10 % D20, pH = 7.2, 
temp = 37 °C, (b) after the addition of ZnOAc2 (2 molar equiv), spectrum recorded 5 
minutes 12 seconds after addition. The changes occur before the first spectrum could 
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Figure 4.17 The methylene linker region of the ['H, 13C]-HSQC spectrum of xylyl-
bicyclarn after the addition of Zn(OAc)2. There is some unreacted xylyl-bicyclam 
left (in circle), but new signals from the linker protons are clearly observed. This 
region can be used to identify the configurations of the cyclarn rings, with three 
configurations identified. Trans-Ill (dots) —12 %, trans-i (dashes) - 28 % and cis-V 
- 15 %. 
4.3.8 Reaction of Xylyl-Bicyclam With Zinc Histidine 
Upon the mixing of xylyl-bicyclarn with Zn(hist) 2, there was an immediate 
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change in the spectrum. New peaks appeared in the aromatic region and the linker 
region of the bicyclam spectrum (Figure 4.18). However, these peaks remained 
stable over a 24 hour period, showing that the products that were immediately 
formed were stable. 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 8 (1H) 
Figure 4.18 1D 'H NMR spectra showing (a) Zn(hist)2, (b) xylyl-bicyclam and (c) 
24 hours after the addition of Zn(hist)2 to xylyl-bicyclam. All spectra were recorded 
in9O%H20/1O%D20at37 °C. 
The linker region of the spectrum can be used to assign configurations of the 
cyclam rings. 15 The trans-I and trans-Ill isomers were found to be present, along 
with some unreacted xylyl-bicyclam, shown in Figure 4.19. The HPLC-MS results 
showed the formation of TFA adducts of zinc-bicyclam. There is no evidence for 
histidine being present based on the LC-MS data. This could be as a result of the 
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change in pH caused by the addition of TFA as an ion pairing agent, causing 
displacement of the histidine with TFA. This is also likely to influence the 
configuration of the macrocycles, as it has been shown that pH can change the ratio 
of isomers in Zn(cyc1am) 2 . 8 There were peaks at 3.04 min and 4.85 min which were 
unidentified. There was a peak at 12.08 mm, which was found to be 
{Zn(cyc1am)(TFA)], one at 12.32 min which corresponded to [xylyI-bicycIam], one 
at 13.28 min which was found to be [Zn(xylyl-bicyclam)(TFA)], and one at 14.24 
min which was found to be [Zn2(xyIyl-bicyc1am)(TFA) 3]. Formic acid was tried as 
an ion pairing agent, but good separation could not be achieved. Also, the HPLC-
MS was recorded with no ion pairing agent, but this also resulted in poor separation. 
trans-Ill 
•S••S •.•e .. •• • 
trans-I 
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Figure 4.19 2D ['H, ' 3 C] HSQC NMR spectrum of the product of the reaction of 
Zn(Hist) 2 + xylyl-bicyclam. Two configurations of cyclam can be identified from 
the position of the linker protons shown here, a trans-Ill configuration and a trans-I 
configuration were found. 
145 
4.3.9 Addition of Acetate to Pd2(xy!yi -bicyc 1am)ROA c 4, 12 
The overall spectrum of 12 did not change when 4 molar equivalents of 
acetate were added (Figure 4.20). The only change in the spectrum was the increase 
in intensity of the acetate peak, the rest of the spectrum did not change. This shows 
that the configuration of the cyclam rings did not change upon addition of acetate. 
I'. 
(1 
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Figure 4.20 Staggered plot of (a) [Pd2(xylyl-bicyclam)](OAc) 4 in 90 % H20 I 10 % 
D20, dioxane ref, (b) with the addition of NaOAc (4 molar equiv). The only change 
observed in the spectrum is the increase in intensity of the acetate peak. 
4.3.10 Addition ofAcetate to c02('xy!yl-bicyclam) C1 4JC12, 13 
Addition of 6 molar equivalents of sodium acetate to this complex (13) 
resulted in an immediate shift in the spectrum. The 6 initial NH proton resonances 
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began to lose intensity, and several new peaks appeared. The reaction took 46 hours 
to reach completion. During this time several intermediate species were formed and 
disappeared, but these could not be identified due to the complicated nature of the 
NMR spectra. Once the reaction had reached completion, a ID 'H NMR spectrum 
(Figure 4.21) along with 2D ['H, 'H] COSY, TOCSY and NOESY NMR spectra 
were recorded, and 2D ['H, ' 5N] and ['H, ' 3 C] HSQC spectra. ES-MS was then 
carried out on the product, and it showed the formation of [CO2(xylyl-
bicyclam)(OAc)4] 2 . No chloride species were observed in the ES-MS, suggesting 
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Figure 4.21 1D 'H NMR spectrum of CO2(xylyl-bicyclam)Cl41C12 + 6 molar 
equivalents of NaOAc, 46 hours after the addition was made. Key regions in the 
spectrum are highlighted. 
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NH Proton Resonances 
There are 6 NH signals present in the initial chloride complex, but once the 
reaction had reached equilibrium, there were only 3 observable NH peaks in the ['H, 
13N] HSQC (Figure 4.22). The NH resonances are all shifted downfield compared to 
the chloride version. One resonance has shifted to 10.2 ppm; this shift could arise 
because is it directly involved with hydrogen bonding, possibly from an acetate 






10 	9 	8 
6(1H) 
Figure 4.22 2D ['H, ' 5N] HSQC NMR spectrum of CO2(xylyl-bicyclam)C141Cl2 + 6 
molar equivalents of NaOAc, recorded in 90 % H20 / 10 % D20, at 25 °C. Three 
NH signals are observed, showing that both rings must be in the same configuration. 
For labelling scheme, see Figure 4.23. 
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Bridging Methylene Proton Resonances 
Again, there is a shift from two sets of linker protons in the chloride complex 
to only one set showing that there is only one configuration present and the cyclam 
ring is in the same configuration in both rings. 
Aromatic Resonances 
There is only one resonance for the aromatic protons in the complex, 
indicating it is a symmetrical complex. 
Proton Resonances from the Cyclam Rings 
One set of NH peaks and one set of linking CH2 groups shows that there is 
only one type of cyclam ring present in solution for the product of the reaction of 
{CO2(xylyl-bicyclam)Cl4]Cl2 with 6 molar equivalents of sodium acetate. The ['H, 
13c] HSQC supports this, as there are 10 observable carbon signals in the region for 
the resonances from the cyclam rings, shown in Figure 4.23, along with the labelling 
scheme used. There are also three signals present from acetate, which could arise 
from two bound acetates, and one free acetate. One of the NH signals, proton 10, 
shows a NOESY cross peak in the 2D ['H, 'H] NOESY NMR spectrum to the signal 
for proton 12a, showing that these protons are both on the same side of the ring. The 
NH labelled proton 7 shows NOESY peaks to both proton 5a and proton 8a, showing 
that these are all on the same face of the cyclam ring. The linker proton 14a shows a 
NOESY peak to the proton 12a, which is one of the central methylene protons in one 
of the 3 carbon bridges, showing that proton 12a is axial and on the same face of the 
149 
ring as the linker group and the linker is on the same face as the NH labelled 10. The 
other linker proton, 14b, shows a NOESY cross peak to the signal from proton 2a. 
Since the linker protons only show interactions with one NH proton, and the UV-vis 
spectroscopy results show this to be trans configuration, it is likely that both the 
cyclam rings are in the trans-Ill configuration. A trans- I configuration would give 
NOESY signals between the linker and all three NH signals, but this does not happen 
in this case. The full assignment is listed in Table 4.8. 
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Figure 4.23 2D ['H, ' 3 C] HSQC NMR spectrum of CO2(xylyl-bicyclam)C1 4}Cl2 + 6 
molar equiv of NaOAc, recorded in 90 % H 20 / 10 % D20 at 25 °C. Protons on the 
same carbon atom are differentiated by a and b. The labelling scheme is also shown. 
150 
Table 4.8' H, 13C and ' 5N Chemical shifts of Co 2(xylyl-bicyclam)C141C12, 13, 
reacted with 6 molar equiv of NaOAc, recorded in 90 % H20 / 10 % D20 at 25 
°C. 
Peak 'H / 13C / ' 5N I Peak 'H / ' 3C / 15N / 
ppm ppm ppm ppm ppm ppm 
la 2.78 8b 2.56 
58.7 




3.55 9b 2.61 
52.6 
2b 3.09 10 10.19 -5.2 
3 7.58 1.1 ha 2.68 
50.2 __ 
4a 2,94 llb 2.60 
48.9 
4b 2.58 12a 2.74 
27.4 
5a 2.33 12b 2.12 
j 	
29.3 
5b 2.18 13a 2.52 
54.1 
6a 2.33 13b 2.28 
50.9 




8.08 -5.99 14b 3.82 
8a 2.82 56.2 15 7.44 135.4 
4.4 Discussion 
4.4.1 Reactions of Xylyl-bicyclam With Zinc Complexes 
Zinc is found in the blood, especially on the surface of proteins. It is most 
commonly found bound to histidine and cysteine. 9 The reactions in this work using 
zinc acetate and zinc histidine under physiological conditions were carried out to see 
if xylyl-bicyclam could bind zinc under such conditions. The results showed that 
xylyl-bicyclam could complex zinc from zinc acetate under these conditions, 45 % of 
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the xylyl-bicyclam remained uncomplexed. Three configurations were found, trans-
I, trans-Ill and cis-V, with trans-I being the most abundant. When the reaction was 
repeated with zinc histidine, only the trans-I and trans-ITT configurations were 
observed. The bulky histidine ligand is likely to cause steric hindrance, preventing 
the formation of the cis-V configuration, found in the reaction of Zn(OAc)2 with 
xylyl-bicyclam. 
4.4.2 Configurations of Metal-Xy!yl-Bicyclam Complexes in Solution 
The palladium complex, 12, was found to be in only one configuration, trans-
III. Pd is a d8  metal, and favours square-planar complexes, meaning that all its 
electrons are paired. All the published crystal structures for Pd-cyclam complexes 
are in the trans-Ill configuration, and NMR studies on various Pd(cyclam) 2 
complexes in Chapter 3 showed the only configuration present to be trans-Ill. The 
addition of excess acetate to this complex (12) did not result in any change in 
configuration. This is in contrast to the Zn 2(xylyl-bicyclam)(C104)4 complex, which 
has been shown to change configuration in the presence of excess acetate, favouring 
the cis-V configuration.' 5  The lack of axial ligands in the case of [Pd 2(xylyl-
bicyclam)](OAc)4, and palladium's strong preference for square-planar coordination 
seem to prevent any change in configuration. This could be a main factor in its lack 
of anti-HIV activity. 
Configurations of the nickel xylyl-bicyclam complex, 10, could not be 
identified, due to the very complicated NMR spectrum. This is due to the presence 
of both paramagnetic and diamagnetic species in solution. This was also found in the 
NMR spectra of the [Ni(cyclam)] 2 complexes, 4-6, in Chapter 3, and in 
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[Ni(cyc1am)](C104)2. 16  However, the UV-vis spectroscopy showed the presence of 
one peak, at 456 rim, a d-d transition. Tetrahedral Ni(II) complexes have a strong 
absorption band of the order € = 102 M- I cm-1 , at approximately 670 nm, absent in 
these complexes. 17 Furthermore, octahedral Ni(II) complexes show three absorptions 
bands, corresponding to the three spin-allowed transitions 3  A2 + 3T2g , 3 A2 + 
3T ig(F) and 3A2g * 3 T ig(P).' 7 A trans- {Ni(cyclam)(H20)21C124H20 complex has 
been shown to have three absorption bands in the UV-vis spectra, at 333 rim, 507 rim 
and 667 rim, showing the Ni2 to be octahedrally coordinated. 18 Ni2 is a d8 metal, 
and generally shows a strong preference for square-planar coordination, as this 
results in all the electrons being paired. The UV-vis spectroscopy of 10 suggests that 
the majority of the complex is in the square planar configuration, however, the peaks 
for this are obviously masked in the NMR spectrum by the presence of other 
paramagnetic species. There are two weak shoulder peaks observable in the visible 
spectrum, at approximately 350 nm and 560 nm, which could be from a minor 
octahedral configuration. 
It is possible for Ni-cyclam complexes to interconvert between cis and trans 
configurations, this has been followed by UV-vis spectroscopy, as reported by 
Billo. 19  He reported the cis-[Ni(cyclam)(H20)J 2 could convert to the trans form by 
changing the pH. He also noted that the trans isomer was in rapid equilibrium with 
the planar [Ni(cyc1am)] 2 , which had a UV-vis absorption peak at 450 nm. This 
agrees with the value found here for the UV-vis absorption of Ni 2(xylyl-
bicyclam)(OAc)4, 10, which has a strong absorption band at 456 rim, showing it is a 
planar configuration. The cis-trans isomerism of Ni-cyclam complexes has been 
shown to be highly pH dependent. At pH = 3, the isomerism is very slow (half-life = 
153 
250 days), whereas at pH = 10, the isomerism is very rapid (half-life = 7 s). ° Future 
work could involve investigating the 'H NMR spectra of Ni 2(xylyl-bicyclam)(OAc)4, 
10, at different pH values to see if isomerisation between the paramagnetic or the 
diamagnetic species can occur and under what conditions this is favoured. 
Again, configurations of the copper xylyl-bicyclam complex, 11, could not be 
identified due to the presence of a paramagnetic species broadening the NMR 
spectra. Cu2 is a d9  metal, which means it always produces paramagnetic 
complexes, as there is always an unpaired electron. The acetate peak in the NMR 
spectrum was not broadened, which could mean the acetate is not be bound to the 
paramagnetic Cu 2+  centre, and water is in the axial positions, as in the copper-cyclam 
complex in Chapter 3. The absorption peak in the UV-vis spectrum is at 513 nm and 
gives an extinction coeffient of 84 M', which is similar to the values found for 
[Cu(cyclam)(H20)2](OAc)2, 8, in Chapter 3, and to Cu(cyclam)(C104)2. 2 ' Both of 
these Cu-cyclam complexes were shown to be trans-Ill in the solid state, showing 
that this Cu2-xylyl-bicyclam is also likely to be in this configuration. 
Co 3+  is a d6  metal, and in this case, a low spin complex was synthesised. A 
high spin complex would have produced broad peaks in the NMR spectrum, due to 
paramagnetic broadening effects. Co 3+  is generally found to be low-spin, due to the 
extra stability for the filled t2g  orbital, but high-spin Co 
3+  complexes are known, for 
example in CoF6 3 . The chloride complex, 13, was found to have two cyclam 
configurations present in solution. Both of these are trans configurations, as the UV-
vis spectroscopy showed the presence of three absorption bands, which is 
characteristic of trans Co(III) complexes.'7' 
22  It is likely that these configurations 
are trans-Ill and trans-I, as these are the most stable configurations. The solid-state 
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structure of the analogous cyclam complex, [Co(cyclarn)C12]Cl, is found to be in the 
trans-Ill configuration. 23 However, it could be that both chloride and water occupy 
the axial positions in solution, which would give the appearance of two species in 
solution. However, the ES-MS data showed no evidence of water being part of the 
coordination sphere. 
4.4.3 Addition of Acetate to [CO 2(Xy1y1-bicycIamC14JC12 
There are many possible reactions that could occur upon the addition of 
acetate to [CO2(xylyl-bicyclam)C14]C12. It is possible that the chloride could 
dissolute first and be replaced with water. This could occur up to four times, then the 
water could be replaced by acetate ions, again up to four times. Or the reaction could 
involve direct substitution of chloride with acetate, up to four times. Furthermore, 
the order in which the acetate replaces the chloride could vary, the second acetate to 
go on could be on the same Co 
3+ as the first acetate, or the other Co 3+  ion. 
Additionally, the configurations of the cyclam rings could be influenced by these 
changes, and could themselves be changing at the same time. Also, one or both of 
the cyclam rings could adopt a cis configuration instead of trans, resulting in only 
one acetate being bound to each Co 
3+  centre. The reaction reached completion after 
46 hours. UV-vis spectroscopy on the final product indicates the configuration to be 
trans, as there are 3 absorption bands present in the UV-vis spectrum. Also, there 
are three NH signals observed in the 2D [ 1 H, ' 5N] HSQC NMR spectrum, and only 
one set of linker protons in the 2D [ 1 H, ' 3 C] HSQC NMR spectrum, which further 
supports that the complex is all in the same configuration. The results here indicate a 
trans complex, which is in contrast to the zinc-xylyl-bicyclam complex, which upon 
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addition of excess acetate, drives the formation of the cis-V configuration, which is 
not apparent in this case. 15 
4.5 Conclusions 
Xylyl-bicyclam was successfully synthesised. This was reacted with zinc 
acetate, with the reaction followed by 'H NMR spectroscopy. The reaction occurred 
within 5 minutes and reached equilibrium in this time. Three configurations of 
cyclam were identified from this reaction; trans-I, trans-Ill and cis-V, with trans-I 
being the most abundant. 
Xylyl-bicyclam was also reacted with zinc histidine. This reaction produced 
two configurations, trans-I and trans-Ill. The bulky histidine appears to prevent the 
folding of the cyclam ring into the cis-V configuration. 
2+ 	2+ 	3+ 	2-1- Pd , Cu , Co and Ni were reacted successfully with xylyl-bicyclam and 
the products were identified with mass spectrometry, NMR spectroscopy and UV-vis 
spectroscopy. 
Pd2(xylyl-bicyclam)(OAc)4 was found to exist in only one configuration, and 
this was identified as trans-Ill. This was reacted with sodium acetate, but no change 
in the 'H NMR spectrum occurred, showing that [Pd 2(xylyl-bicyclam)] 4 does not 
readily undergo a configurational change. 
[CO2(xylyl-bicyclarn)C14]Cl2 was found to exist in two trans cyclam 
configurations in aqueous solution. This complex was reacted with sodium acetate, 
and it was found that there was a significant change in the NMR spectra. The 
spectrum changed immediately upon addition, with the final product was obtained 
after 46 hours. Intermediate species formed and disappeared within this time. These 
were not identified due to their rapid appearance and disappearance. The final 
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product consisted of only one isomer, shown by only 3 NH peaks in the [ 1 H, 15N] 
HSQC. One of the NH peaks is shifted towards a high frequency (10.19 ppm), 
indicative of it being involved in hydrogen bonding with an acetate ion. The final 
configuration was identified as trans-Ill using UV-vis and NMR spectroscopy. 
Ni2(xylyl-bicyclam)(OAc)4 was found to have a mixture of paramagnetic and 
diamagnetic peaks present in the 1D 'H NMR spectra. The presence of the two 
cyclam rings allows a mixture of paramagnetic-paramagnetic, paramagnetic-
diamagnetic and diamagnetic-diamagnetic species to be present, as well as different 
configurations of these combinations to be present. 
Cu2(xylyl-bicyclarn)(OAc)4 was paramagnetic, due to Cu 2 being d9 , 
therefore always having an unpaired electron. In the ID 'H NMR spectrum, there 
was one unbroadened peak, from the acetate, at 1.93 ppm (23.5 ppm in the 13C 
dimension). There were five broad peaks observed in the Ill  NMR spectrum. It is 
possible that acetate is not bound to the Cu 2 , and that water is bound in the axial 
positions, as in the Cu2tcyclam  structure shown in Chapter 3. This would explain 
why the acetate peak appears to be unbroadened. 
None of the metal-xylyl-bicyclam complexes made here were found to be in 
the cis-V configuration in solution, which has been shown to be important in the 
binding of metal-xylyl-bicyclams to the CXCR4 coreceptor. 15 The inability to form 
this configuration could explain the reduced activity level of nickel-, copper-, cobalt-
and palladium-xylyl-bicyclams against HIV. 
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Chapter 5 Synthesis and Solution Studies of Pyridyl 
Isocyclam and its Metal Complexes 
5.1 Introduction 
5.1.1 Anti-HIV Macrocycles 
In 1999, Bridger et al. reported the results of a study that involved varying 
the size and substituents of bis-tetraazamacrocycles, such as xylyl-bicyclam 
(AMD3 100) with the aim of improving the anti-HIV activity of these bis 
macrocycles. 1  Many analogues were tested, with neutral heteroatoms, such as 
oxygen and sulphur, and heteroaromatic groups being introduced into the macrocycle 
as a replacement for the amino groups in AMD 3100. It was found that the 
introduction of one or more heteroatoms into the macrocyclic ring resulted in 
substantially reduced activity. 
However, it was found that introducing a pyridine ring to the macrocycle 
gave activity comparable with that of the saturated macrocycle. The ring size of the 
macrocycle with the newly incorporated pyridine ring was also varied between 12-16 
members per ring. The optimum structure with a pyridine ring incorporated was a 
new ligand, called AMD3329, which had better activity than AMD3 100. The 
cyclam ring has been replaced with the pyridyl isocyclam, 14, shown in Figure 5.1. 
The active form is the bis-macrocycle, 15. The anti-HIV activity levels of AMD 
3100 (xylyl-bicyclam) and AMD 3329 are shown in Table 5.1. AMD3329 inhibited 
HIV-1 and HIV-2 replication at a 3-5 fold lower concentration than that of 
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Figure 5.1 Structure of 14, referred to as pyridyl isocyclam, and the structure of 
AMD 3329, referred to as 15. 
The macrocycle is still a 14-membered ring, with 4 nitrogen groups 
incorporated into the ring as for a cyclam. However, in the case of AMD 3329, the 
order of the carbon bridges between the nitrogen groups is not the same as it is in 
cyclam. In AMD 3329, the sequence is 2, 3, 3, 2 whereas in cyclam it is 2, 3, 2, 3. 
The pyridine ring in AMD 3329 adds rigidity compared to the more flexible cyclam. 
In this thesis, studies were carried out on one of the constituent macrocycles 
of AMD 3329, 4,7,10, 17-tetraaza-bicyclo[ 11.3.1 ]heptadeca-1 (16),13(17),14-triene, 
14, and the bis-macrocycle 15, including the binding of metal ions and its properties 
once complexed with metals, the configurations of metal adducts using 'H, ' 3C, and 
' 5N NMR spectroscopy. 111 C NMR studies aided the characterisation of the novel 
metal lomacrocycles. 
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Table 5.1 Comparison of the Anti-HIV Activities of AMID 3100 and AMD 3329' 
Compound Structure EC50 (jiM) CC5 0 
HIV-1 	HIV-2 (jiM) 
(III) 	(ROD) 
AMD3329 - 0.0008 0.0016 194 
(15) H 






NH HN H HN 
L) L) 
highest concentrations tested. 
5.1.2 Cadmium Chemistry 
Cadmium, along with zinc and mercury, makes up group 12 of the periodic 
table. Its usual oxidation state is +2. Cadmium chemistry closes resembles that of 
zinc, and it can be used as an isomorphous replacement for zinc. 2 67 Z has a nuclear 
spin of 5/2, and as such produces very broad NMR lines, making it hard to study 
using NMR. Zn(II) is readily available in the body and it may play a key role in the 
activity of antiviral macrocycles. It is possible that the xylyl-bicyclam picks up zinc 
from the blood. The biological activity of metal lomacrocycl e complexes appears to 
depend on recognition of the membrane receptor protein CXCR4 via interactions 
with amino acid side chains. Cadmium NMR spectroscopy has been used in many 
cases to study interesting structural and dynamic problems in inorganic and 
bioinorganic chemistry. 2  Cadmium has many favourable chemical and magnetic 
properties which make it ideal for use as a replacement for several metal ions such as 
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the coordination of Cd 2 is similar to that of Zn2 and Ca2 . Also, Cd2 and Ca 
2+ 
 
have very similar ionic radii, therefore Cd 2 can also be used as a replacement for 
Ca2 . 3  Cadmium is often used as a starting point to elucidate the structure of 
biomolecules that contain zinc, although there have been significant differences 
reported between the analogous Zn and Cd complexes. Furthermore, Cd 2 chemical 
shifts are extremely sensitive to the nature, number and geometric arrangement of the 
ligands within the coordination sphere. Both naturally occurring isotopes of 
cadmium (11  'Cd and 113Cd) have spin = ½ isotopes, which are present in 12.7 % and 
12.3 % natural abundance, respectively. The absolute sensitivity of "Cd is 7.6 
times that of 13C. 'Cd with 96 % enrichment is commercially available, and the 
enrichment results in an 8 fold enhancement in sensitivity. Cadmium NMR can 
therefore be used to study complexes and examine their binding sites in proteins. 
Work has previously been carried out in our laboratory on 111 C cyclam complexes, 
proving that this is an effective and useful technique. 4 
5.2 Experimental 
5.2.1 Synthesis of 14 
Macrocycle 14 was synthesised using a method based on a previously 
published synthetic route to AMD 3329, as shown in Scheme 5.1, using the 
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Scheme 5.1 Synthetic route to 14 
Synthesis of 2,6-Bis(bromornethyl)pyridine Hydrobromide, I 
2,6-B is(brornomethyl)pyridine hydrobromide was made using a published 
method, as shown in Scheme 5.1. 
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2,6-Pyridinedimethanol (2.3g. 16.5 mmol) was dissolved in hydrobromic acid 
(48 %, 30 mL) and acetic anhydride (150 mL) was added and the reaction was heated 
at 100 °C overnight. Upon cooling, a powder formed, which was separated and 
washed with ethyl acetate to give 2,6-bis(bromomethyl)pyridine hydrobromide (f) as 
a colourless solid (4.9 g, 14.1 mmol, 87 % yield). 
'H NMR (250 MHz, DMSO-d6) 7.87 (1H, t, J = 7.7 Hz), 7.51 (2 H, d, J = 7.7 Hz), 
4.70(4H, s). 
Synthesis of (6-cyanomethyl-pyridin-2-yl)-aCetonitrile, II 
2,6-Bis(bromomethyl)pyridine hydrobromide (I, 12.0 g, 34 mmol) was 
dissolved in a mixture of benzene (100 mL) and water (50 mL) whilst under N7. 
Cetyltrimethylammonium bromide (1.2 g, 3.4 mmol) was added, and sodium cyanide 
(10.2 g, 208 rnmol) was then added with stirring. The reaction was heated under 
reflux (90 °C) for 4 hours and then allowed to cool to room temperature. The 
aqueous layer was then separated and washed with benzene (2 x 100 rnL) and 
dichloromethane (2 x 75 mL). The combined organic layers were then dried using 
sodium sulfate. This was removed by filtration and the solvent removed under high 
vacuum. This produced a brown crystalline solid. A solution of this in CH 2C12 was 
passed through a short plug of basic alumina gave a white solid (II, 4.6 g, 29.3 
mmol, 86 % yield). 
'H NMR (CDC13, 500 MHz) : 7.79 (t, 11-1, J = 7.78 Hz), 7.40 (d, 2H, J = 7.78 Hz), 
3.94 (s, 4H). 
ES-MS m/z = 157.8 [M+H]. 
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Synthesis of 2,6-Bis(2-aminoethyl)pyridine, III 
The dinitrile II (2.0 g, 12.7 mmol) was dissolved in methanol saturated with 
ammonia (50 mL). Raney nickel (5 g) was added and the mixture was hydrogenated 
at 45 psi and room temperature for 48 hours. The catalyst was removed by filtration 
through Celite and the solvent was removed under high vacuum. This resulted in a 
brown oil (Ill, 1.5 g, 9.09 mmol, 71 % yield). 
'H NMR (CDC13, 250 MHz) : 7.53 (t, 1H, J = 7.6 Hz), 7.01 (d, 2H, J = 7.6 Hz),3.08 
(t, 4H, J = 6.4 Hz), 2.95-2.83 (m, 4H). 
ES-MS : rn/z = 165.8 [M+H]. 
Synthesis of 2,6Bis(N,N'ptoIuenesuIfony1-2-amiflOethY1)pyridifle, IV 
A solution of p-toluene-sulfonyl chloride (2.34 g, 13.33 mmol, 2.2 molar 
equiv) in DCM (50 mL) was added dropwise over one hour to a solution of the 
diamine III (1.0 g, 6.06 mmol) in DCM (100 mL) and triethylamine (2 mL). The 
mixture was then allowed to stir at room temperature under N 2 overnight. The 
solution was washed with saturated aqueous sodium bicarbonate and brine, and the 
organic layer was dried with Na 2 SO4. This was removed by filtration and the solvent 
removed under high vacuum to give a brown oil. This was then purified using 
column chromatography on silica gel (CH2C12/MeOH 98:2) to give a white solid (IV, 
1.48 g, 3.13 mrnol, 51 % yield.) 
'H NMR (CDC13, 250 MHz): 7.71 (d, 4H, 8.3 Hz), 7.43 (t, 1H, J = 7.7 Hz), 7.25 (d, 
4H, 8.3 Hz), 6.90 (d, 2H, J = 7.7 Hz), 5.81 (t, 3H), 3.35-3.25 (m, 4H), 2.86 (t, 4H, 6.3 
Hz), 2.39 (s, 6H). 
ES-MS : mlz = 474.0 [M+H]. 
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Synthesis of N-(diethoxyphosphoryl)diethanolamine, V 
N-(Diethoxyphosphoryl)-O ,O' -bis(2-methylsulfonyl)diethanolamine 	was 
made using a published method, shown in Scheme 5.2.6 
HO
,,^N,".












Scheme 5.2 Synthetic route to N-(diethoxyphosphoryl)-O,O' -bis(2- 
methylsulfonyl)diethanolamine, V, for use in Scheme 5.1 
A solution of diethyl chlorophosphate (16.4 g, 96 mmol) in DCM (50 ml-) 
was added dropwise to a solution of diethanolamine (10.0 g, 96 mmol) in DCM and 
triethylamine (16 ml-) dropwise over one hour. The mixture was then left to stir at 
room temperature overnight. The solution was then washed with brine (100 mL) and 
the organic layer dried over Na 2 SO4. This was removed by filtration and the solvent 
evaporated off to give a colourless oil. (12.2 g, 50.6 mmol, 52 %) 
'H NMR (250 MHz, CDC11) : 3.81-4.02 (m, 8H), 3.31-3.43 (m, 4H), 1.32 (td, 61-I, J 
= 7.2 Hz, J P-H = 0.9 Hz). 
A solution of N-(diethoxyphosphoryl)diethanolamine (12 g, 49.7 mmol) in 
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DCM (200 rnL) and triethylamine (20.4 mL) was cooled to 0 °C. A solution of 
methanesulfonyl chloride (12.0 g, 104 mmol, 2.1 molar equiv) in DCM (100 mL) 
was added dropwise to the chilled solution over a period of two hours. The reaction 
mixture was then left to stir overnight under N2. The solution was then washed with 
saturated aqueous ammonium chloride (200 mL) and brine (200 mL). The organic 
layer was then dried using Na2SO4 for one hour and then this was removed by 
filtration. The solution was then dried under high vacuum to give an orange oil (V, 
15.1 g, 38 mmol, 76% yield). 
'H NMR (250 MHz, CDC11) : 4.29 (t, 4H, J = 5.6 Hz), 3.81-4.02 (m, 4H), 3.41 (dt, 
4H, J = 5.6 Hz, 2JPH = 11.9 Hz), 3.02 (s, 6H), 1.32 (td, 6H, J = 7.1 Hz, J P-H = 0.9 
Hz). 
ES-MS: rn/z = 397.9 [M-i-H]t 
Macrocyclization, VI 
A solution of the ditosylate (IV, 346 mg, 0.63 rnrnol) was prepared in 
anhydrous DMF (100 mL) with stirring under nitrogen. Cesium carbonate (619 mg, 
1.9 mmol) was added and the yellow solution was heated to 65 T. A solution of N-
(diethoxyphosphoryl)-O,O' -bis(2-methylsulfonyl)diethanolamine (V. 167 mg, 0.63 
rnrnol) was prepared in anhydrous DMF (100 mL) and added dropwise to the first 
solution over a period of 8 hours. The reaction was then stirred at 65 °C for 24 
hours. The resulting yellow solution was concentrated to dryness to give an orange 
product. This was partitioned between CH 2 C12 (150 mL) and brine (90 mL). The 
aqueous layer was then further extracted with CH202 (2 x 50 rnL) and the combined 
organic layers were dried over anhydrous magnesium sulfate. Once filtered, the 
clear yellow solution was concentrated to dryness to give an orange oil. This was 
purified using column chromatography on silica gel (hexane : ethyl acetate, 9:1) to 
give a white powder (VI, 209 mg, 46 % yield). 
'H NMR (CDC13, 250 MHz) : 7.66 (d, 4H, 8.4 Hz), 7.49 (t, 1H, J = 7.8 Hz), 7.25 (d, 
4H, J = 8.4 Hz), 6.99 (d, 2H, 7.8 Hz), 3.93-3.83 (rn, 4H), 3.63-3.56 (m, 4H), 3.02-
2.95 (m, 4H), 2.80-2.73 (m, 4H), 2.50-2.39 (m, 4H), 2.24 (s, 6H), 1.22 (td, 6H, J = 
7.0 Hz). 
ES-MS : mlz = 679.1 [M+H]t 
Removal of Dep Protecting Group, VII 
A solution of the protected macrocycle (VI, 180 mg, 0.25 mmol) was 
dissolved in glacial acetic acid (4 mL) and 30 % HBr/acetic acid (2 mL) was added. 
The reaction mixture was then stirred at room temperature for 2 hours. Ether (250 
mL) was added to precipitate a white solid. This was allowed to settle, and the ether 
was removed by decantation. The solid was washed with ether (3 x 100 rnL), and the 
solid was dried under high vacuum. The solid was partitioned between sodium 
hydroxide (1 M, 5 ml) and dichloromethane (50 mL). The organic layer was 
separated and dried over sodium sulfate. This was removed by filtration and the 
solvent was removed under high vacuum to give a white solid (VII, 83 mg, 0.151 
mmol, 61 % yield). 
'H NMR (360 MHz, CDC11) : 7.65 (d, 4H, J = 8.2 Hz), 7.45 (t, 1H, J = 7.7 Hz), 7.28 
(d, 4H, J = 8.2 Hz), 7.01 (d, 2H, J = 7.7 Hz), 3.64-3.59 (m, 4H), 3.08-3.02 (m, 4H), 
2.98 (t, 41-1, J = 6.3 Hz), 2.51 (t, 4H, J = 6.3 Hz), 2.40 (s, 6H). 
' 3C NMR (360 MHz, CDC13): 157.8, 143.2, 136.8, 135.6, 129.5, 127.1, 121.2, 49.7, 
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49.4, 47.9, 37.9, 21.3. 
ES-MS mlz = 543.2 [M+H]t 
Removal of Tosyl Protecting Groups, 14 
A solution of the di-protected macrocycle (VII, 25 mg, 0.046 mrnol) was 
dissolved in concentrated H2SO4 (1 rnL) and stirred at 110 °C for two hours. The 
dark brown solution was allowed to cool to room temperature and the pH was 
adjusted to pH 14 with 10 M NaOH. The aqueous solution was extracted with 
CHC13 (3 x 20 mL) and the combined organic extracts were dried using MgSO 4 . 
This was concentrated to give a pale yellow oil, 14 (8 mg, 0.034 mmol, 74 % yield). 
'H NMR (360 MHz, CDC13) : 7.55 (t, 1H, J = 7.6 Hz), 7.04 (d, 2H, J = 7.6 Hz), 3.24-
3.17 (m, 4H), 3.14-3.07 (m, 4H), 2.92-2.87 (m, 41-1), 2.86-2.82 (m, 4H) 
"C NMR (69 MHz, CDC1 3): 137.4, 121.8, 47.7, 46.4, 46.0, 35.7. 
ES-MS : mlz = 234.2 [M+H]' 
5.2.2 Synthesis of 15 
Ligand 15 was synthesised using the synthetic route shown in Scheme 5.1, 
using compounds 1-VIII. 
Dimerisation, VII 
To a solution of the di-protected tetraazamacrocycle (VII, 40 mg, 0.073 
mmol) in anhydrous CH 3CN (5 mL) was added a,a'-dibromo-p-xylene (9.8 mg, 
0.037 mmol, 0.5 molar equiv) and potassium carbonate (31 mg, 0.22 mrnol, 3.0 
molar equiv), and the mixture was heated to reflux for 18 h with stirring whilst under 
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N2. The reaction mixture was allowed to cool to room temperature and concentrated 
under high vacuum and the residue was partitioned between CH 2C12 (30 mL) and 
1-120 (15 mL). The aqueous layer was separated and extracted with CH2C12 (2 x 15 
mL). The combined organic phases were dried (MgSO 4) and concentrated, and the 
residue was purified by column chromatography on silica gel using ethyl acetate 
hexane (1:1), giving the fully protected bis-tetraazamacrocycle (VIII, 38 mg, 0.032 
mmol, 86 % yield). 
'H NMR (360 MHz, CDC13) 7.58 (d, 8H, J = 8.17 Hz), 7.49 (t, 211, J = 7.5 Hz), 
7.24 (d, 8H, J = 8.17 Hz), 7.08 (s, 4H), 6.97 (d, 4H, J = 7.5 Hz), 3.75-3.67 (m, 8H), 
3.44 (s, 4H), 3.04-2.97 (m, 8H), 2.82-2.74 (m, 8H), 2.41 (s, 12H), 2.17-2.09 (m, 8H). 
3c NMR (360 MHz, CDCI3) 160.3, 144.3, 138.5, 138.2, 137.8, 130.7, 129.7, 
128.1, 123.5, 60.8, 54.1, 49.8, 49.1, 40.2, 22.5. 
ES-MS : m/z = 1188.1 [M-i-H]t 
Removal of Ts Group, 15 
A solution of protected bis-tetraazamacrocycle (VIII, 30 mg, 0.025 mmol) 
was dissolved in concentrated H2SO4 and stirred at 110 °C for two hours. The dark 
brown solution was allowed to cool to room temperature and the pH was adjusted to 
pH 14 with IOM NaOH. The aqueous solution was extracted with CHC13 (3 x 20 
mL) and the combined organic extracts were dried using MgSO 4. This was 
concentrated to give a pale yellow oil, 15 (13 mg, 0.022 mmol, 88 % yield). 
'H NMR (500 MHz, CDC13) : 7.59 (t, 2H, J = 7.53 Hz), 7.03 (d, 4H, J = 7.53 Hz), 
6.48 (s, 411), 3.34 (s, 4H), 3.07-3.02 (m, 411), 3.02-2.96 (m, 4H), 2.66-2.59 (in, 4H), 
2.57-2.49 (in, 4H). 
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' 3C NMR (125 MHz, CDC13): 139.6, 124.0, 131.3, 61.8, 50.7, 39.8, 50.0, 56.4. 
ES-MS : m/z = 571.5 [Mi-H]t 
5.2.3 Preparation of"Cd Acetate Complex, 16 
The "Cd(H) complex of macrocycle 14 was prepared using method based on 
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Scheme 5.3 Synthetic route to 16 
'''Cd02 (1.64 mg, 0.0128 mM) was dissolved in acetic acid (2 molar equiv, 1 
M, 25.4 pL) using a sonic bath until all the red 11 Cd02 had been converted to white 
IUCd(OA02. The excess water was then removed using high vacuum to give 
"Cd(OAc)2. (2.46 mg, 83 % yield). 
The macrocycle 14 (2 mg, 0.0085 mmol) was dissolved in methanol (1 rnL) 
and "Cd(OAc)2 (2.0 mg, 1 molar equiv, 0.0085 mmol) was added. The solution 
was refluxed for two hours under N 2 with stirring. The clear solution was then 
filtered and concentrated under vacuum until a white precipitate had formed. The 
precipitate was filtered off and washed with ether and dried under high vacuum to 
give 16 (3.2 mg, 0.0069 mmol, 81 % yield). It was dissolved in 90 % H 20 / 10 % 
D20 (600 iL, 12 mmol, pH = 6.8) and 2D ['H, 'H] COSY, NOESY and TOCSY, 
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['H, ' 3C] HSQC, [ 1 H, ' 5N] HSQC and ['H, "Cd] HSQC NMR spectra were 
recorded. 
ES-MS mlz = 403.9 [M-OAc]. 
Selected IR (KBr, cm'): 3441 s (NH), 2925 m (CH), 2359 s (CH), 1573 m (CO), 
1417 in (CO), 670 w (pyridine), 474 w (pyridine). 
5.2.4 Preparation of Zn Acetate Complex, 17 
Complex 17 was prepared in the same way as the 111 C complex, as shown in 
Scheme 5.4. 
	
H 	 H 
rN 	 Zn(OAc)2 
H—N 	N 	
2(OAc) t_i -*IP- MeOH 	 .  
H 	 H 
Scheme 5.4 Synthetic route to 17 
Zn(OAc)2 (0.0017 mmol, 3 mg) was dissolved in methanol (2 nil-) and 
macrocycle 14 (1 molar equiv, 0.0017 rnmol, 4 mg) was added. The reaction was 
then heated under reflux for 2 hours. The clear solution was then filtered and 
concentrated under vacuum until a white precipitate had formed. The precipitate was 
filtered off and washed with ether and dried under high vacuum to give 17 (5.3 mg, 
0.0013 rnmol, 76 % yield). It was dissolved in 90 % H 20 / 10 % D20 (600 pL, 12 
mmol, pH = 6.9) and 2D ['H, 'H] COSY, NOESY and TOCSY, ['H, 13C] HSQC and 
['H, ' 5 N] HSQC NMR spectra were recorded. 
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ES-MS : mlz = 357.2 [M-OAc1. 
Selected JR (KBr, cm'): 3466 s (NH), 2359 s (CH), 1637 in (NH), 1572 in (CO), 
1410 in (CO), 1384 (CO), 643 w (pyridine). 
5.2.5 Preparation of 111 Gd Acetate Complex, 18 
The synthesis of 18 was based on the synthesis of similar zinc-xylyl-bicyclam 








Scheme 5.5 Synthetic route to 18 
Ligand 15 (5 mg, 0.0087 mmol) was dissolved in methanol (1 mL) and 
"Cd(OAc)2 (4.0 mg, 2 molar equiv, 0.0175 mmol) was added. The solution was 
refluxed for two hours under N2 with stilTing. The clear solution was then filtered 
and concentrated under vacuum until a white precipitate had formed. The precipitate 
was filtered off and washed with ether and dried under high vacuum to give 18 (7.5 
mg, 0.0073 mmol, 84 % yield). It was dissolved in 90 % 1 -120 / 10 % D20 (600 iL, 
12 mmol, pH = 6.8) and ['H, 'H] COSY, NOESY and TOCSY, ['H, ' 3C] HSQC, 
['H, ' 5N] HSQC and ['H, "Cd] HSQC spectra were recorded. 
ES-MS rn]z = 455.3 [M-20Ac] 2 , 426.3 [M-30Ac + H] 2 . 
Selected IR (KBr, cm'): 3420 s (NH), 2918 in (CH), 2870 s (CH), 1573 in (CO), 
1412 in (CO), 620 w (pyridine). 
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5.2.6 Addition ofAcetate to Zn Complex, 17 
Complex 17 (1 mg, 0.0024 rnmol) was dissolved in 90 % H 20 I 10 % D20 
(600 tL, pH = 6.6) and a 1D 'H NMR spectrum was recorded. Then 1 molar 
equivalent of NaOAc (1 M, 2.4 tL) was added, and the pH was adjusted to pH = 6.8 
with acetic acid and sodium hydroxide. Another 1D 'H NMR spectrum was 
recorded. 1D spectra were recorded over 2 hours. This was repeated until 10 molar 
equivalents of acetate had been added, with the pH being adjusted to pH = 6.8 each 
time. 
5.2.7 pH Titration of 14 
Macrocycle 14 (2.3 mg, 0.0098 mmol) was dissolved in 90 % H 20 I 10 % D20 (600 
pL) to give a clear, colourless solution. Sodium perchlorate (7 mg, 0.1 M) was 
added. The pH of the solution was measured and a 1D NMR spectrum was recorded. 
The pH was adjusted using NaOH and HC1, and the pH was recorded over the range 
0.5-13, with 1D NMR spectra being recorded at various intervals. 
5.3 Results 
5.3.1 Synthesis of 14 
The macrocycle 14 was successfully synthesised using the synthetic route 
shown in Scheme 5.1. 1D and 2D NMR spectra (['H, 'H] COSY, NOESY and 
TOCSY and ['H, ' 3C] HSQC spectra (Figure 5.3)) were used to characterise the 
compound fully. The results are summarised in Table 5.2. 
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A NOESY cross-peak was observed between peak at 3.10 ppm and the peak 
at 7.04 ppm, and therefore it was concluded that the peak at 3.10 ppm must be due to 
the protons labelled 3 (for numbering scheme, see Figure 5.2). There was a further 
COSY cross-peak between 3 and the peak at 3.20 ppm, which was then assigned as 
4. The peaks for 5 and 6 overlap in the 'H NMR spectrum, but in the 13 C spectrum, 
there are two peaks at 46.0 ppm and 47.7 ppm. However, assignment of these two 
peaks proved impossible. 
5H4 3 
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 8 ( 1 H) 
Figure 5.2 'H NMR spectrum of 14, recorded in CDC1 3 at 25 °C, with the 
numbering scheme. 
Table 5.2 1  H and 13C NMR shifts for 14, recorded in CDC13 at 25 T. For 
labelling scheme, see Figure 5.2. 
Peak 1 H / ppm 13C / ppm 
1 7.55 137.6 
2 7.04 121.8 
3 3.14-3.07 35.7 
4 3.24-3.17 46.4 
5/6 2.92-2.87 46.0 
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Figure 5.3 2D ['H, ' 3C] HSQC NMR spectrum of 14 recorded in CDC13, at 25 °C. 
7.0 
ö( 1 H) 
7.5 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 6 (IH) 
Figure 5.4 2D ['H, 'H] NOESY NMR spectrum of 14 recorded in CDC1 3 , at 25 °C, 
showing the key NOESY interaction between CH (2) in the pyridine ring to the 
neighbouring CH2 group (3). For labelling scheme see Figure 5.2. 
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5.3.2 Synthesis of 15 
The bis-pyridyl isocyclam with a p-xylene linker 15 was successfully 
synthesised using the synthetic route shown in Scheme 5.1, and 1 D and 2D NMR 
spectra (['H, 'H] COSY, NOESY and ['H, ' 3C] HSQC) were used to fully 
characterise it (Figure 5.5 (a) - (c)). The data are summarised in Table 5.3. 
The singlet from the methylene linker protons (labelled 7 in Figure 5.5) 
shows a NOESY peak to the singlet from the aromatic peaks from the phenyl linker 
(labelled 8), and a further NOESY peak to the signals from the NCH2CH2N region 
(labelled 5 and 6). The para position in the pyridine ring (1) gives a triplet at 7.59 
ppm. The meta protons in the pyridine ring (2) give a doublet at 7.03 ppm, which 
shows a NOESY peak to the CH 2 group next to the pyridine ring (labelled 3, shown 
in Fig. 6.2). These protons (3) have a large shift of their associated carbon signal 
(39.8 ppm, shown in Figure 5.5 (c)), due to the close proximity to the pyridine ring. 
Table 5.3 'H and 13C NMR shifts of 15, recorded in CDC13 at 25 T. 
Label 'H shift I ppm 13C shift / ppm 
1 7.59 139.6 
2 7.03 124.0 
3 3.02-2.96 39.8 
4 3.07-3.02 50.7 
5/6 2.66-2.59 50.0 
5/6 2.57-2.49 56.4 
7 3.34 61.8 
8 6.48 131.3 
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Figure 5.5 (a) Structure of 15 and its 'H NMR spectrum, recorded in CDC13, with 
corresponding labelling scheme. (b) ['H, 'H] 2D NOESY NMR spectrum, showing 
the key interactions (c) ['H, ' 3 C] 2D HSQC NMR spectrum, showing the correlation 
between the proton and carbon peaks. * = CHCI3. 
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5.3.3 Synthesis and NMR Spectroscopy of"C'd(II) complex, 16 
The "Cd(II) complex 16 was synthesised successfully and characterised 
using mass spectrometry and NMR spectroscopy. The 'H NMR spectrum of 16, 
acquired immediately after dissolving the sample in 10% D 2 0 / 90% H20, is shown 
in Figure 5.6. No changes were observed over a period of 4 weeks at ambient 
temperature. There are three regions that can be studied for this complex, the 
aromatic region, the Gil 2 groups from the macrocyclic framework, and the NH 
region. Few signals in the spectrum were cleanly resolved. In order to overcome this 
problem, and to assign fully the 'H NMR spectrum, 2D NMR studies were used to 
identify and characterise the configurations present. The 2D ['H, "Cd] HSQC 
NMR spectrum (Figure 5.7) showed that there were two "Cd peaks, at 212.7 ppm 
and 219.5 ppm. This spectrum was used in conjunction with the other 2D NMR 









8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 6 ( 1 H) 
Figure 5.6 1D 'H NMR spectrum of 16, recorded in 90 % H 20 / 10 % D20 at 25 °C. 
(* = residual solvent, MeOH). The labelling scheme is also shown. 
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( 1 H) 
Figure 5.72D ["Cd, 'H] HSQC NMR spectrum of 16, recorded in 90 % H20, 10 % 
D20 at 25 °C, showing that two cadmium species are present. 
Aromatic Region 
There are two triplets from the para protons in the pyridine ring (Figure 5.8). 
This indicates that there are two configurations of the macrocycle present. One of 
these shows two cross-peaks to the meta protons in the pyridine ring in the 2 D ['H, 
'H] COSY NMR spectrum. This indicates that this configuration (species A) is 
unsymmetrical, as in a symmetrical configuration these meta protons would be 
equivalent, and produce only one signal. This is the case in the second configuration 
(species B), where the triplet from the para proton only shows a COSY cross-peak to 
one doublet from the meta protons. Two possible structures for this complex are 
shown in Figure 5.9, with the chirality of the NH groups indicated. Only two of the 
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Figure 5.8 2D ['Fl, 
I HI COSY NMR spectrum of 16, recorded in 90 % H20 / 10 % 
D20 at 25 °C, showing corinectiVities between the 
para and meta protons of species 
A (solid lines) and species B (dashed lines). The labelling scheme is included. 
Figure 5.9 Possible structures for metal complexes of pyridyl isocyclam. Structures 
were drawn and optimised using HyperChem. Hydrogen atoms have been removed 
from all positions except the nitrogens for clarity. Possible hydrogen bond 
interactions between the acetate groups and the NH groups are indicated by dashed 
lines. (a) The NH groups are all on the same face of the macrocycle, (b) the two 
equivalent NH groups point in the same direction, while the third one points in the 
opposite direction. 
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CH2 Groups From Ring 
There were 12 pairs of signals in the 2D ['H, ' 3C] HQSC NMR spectrum. A 
symmetrical configuration would have 4 pairs of signals from the CH2 groups in the 
ring, while an unsymmetrical configuration would have 8 pairs. The peaks split into 
two distinct regions, one ranging from 38-42 ppm and one from 45 to 52 ppm, shown 
in Figure 5.10-5.11. The peaks that are shifted towards higher field are those next to 
the pyridine ring, while the lower field peaks arise from CH2 groups that are all next 
to NH groups. There are three pairs of peaks in the higher field region, two are from 
species A and one pair from species B. The peaks were integrated, and it was found 
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Figure 5.10 2D ['H, ' 3C] NMR spectrum of the Cd(II) complex 16, recorded in 90 
% H20, 10 % D20 at 25 T. Peaks from species A are labelled. For labelling 
scheme, see Figure 5.8. Protons that are on the same carbon atom are referred to as a 
and b. Peaks for species B are labelled in Figure 5.11 
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Figure 5.11 2D [ 1 11, ' 3C] NMR spectrum of the Cd(II) complex 16, recorded in 90 
% HO, 10 % D20 at 25 T. Peaks from species B are labelled. For labelling 
scheme, see Figure 5.8. Protons that are on the same carbon atom are referred to as a 
and b. As it is a symmetrical configuration, only 4 pairs of protons are observed. 
NH Region 
Five signals are observed in the 2D ['H, 15  N] HSQC NMR spectrum. These 
signals are all split into doublets, due to coupling to "Cd. Two coupling constants 
can be determined : 1 1 ( 15N-"Cd) and 2J ('H-"Cd). The values for these are listed 
in Table 5.4. The symmetrical configuration, species B, produces two NH signals, as 
N5 and N  1 are equivalent, while species A shows three signals in the 2D ['H, 15N] 
HSQC NMR spectrum. 
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Figure 5.12 2D [Ill 15N] HSQC NMR spectrum of the Cd(II) complex 16, 
recorded in 90 % H20, 10 % D20, at 25 °C, showing peaks for the NH peaks of the 
two major species A and B. The splittings arise from "Cd coupling. 
Table 5.4 Coupling constants involving 1H, ' 5N and '"Cd for 16. For labelling 
scheme, see Figure 5.12 
Peak label 'H / ppm 15N / ppm 1J (' 5N-"Cd) 
/Hz 
2J ('H-"Cd) I 
Hz 
AS 2.92 6.5 107 26 
A8 3.21 -4.0 102 14 
All 3.48 10.6 111 24 
B5 3.78 11.2 131 24 
B8 1.11 2.8 179 15 
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The structure of species A was determined as follows. Protons on the same 
carbon atom are distinguished using a and b. From the 2D ['H, 'H] NOESY NMR 
spectrum, it can be seen that there are NOESY cross-peaks between the meta proton 
(2) on the pyridine ring, and a peak in the aliphatic region, labelled 3b. Then, in the 
2D ['H, ' 3C] HSQC NMR spectrum, proton 3b is one the most upfield shifted peaks, 
further supporting that this proton is next to the pyridine ring. Proton 3b is likely to 
be equatorial, as this would be closest to the meta proton. From the 2D ['H, 13 C] 
HSQC NMR spectrum, the pair can be found (3a). Then, in the 2D ['H, 'HI COSY 
NMR spectrum, a cross-peak is present between protons 3a and 4a, showing that 
proton 4a is an axial proton, as COSY interactions are strongest between axial-axial 
protons. There is also a cross-peak from proton 4a to proton 5, which is an NH 
proton, indicating that proton 5 is an axial proton. Proton 5 also has a COSY cross-
peak to proton 6a, again suggesting that this is an axial proton on the same side of the 
ring as the NH. Proton 6a has a COSY cross-peak to proton 6b, confirmed by the 2D 
['H, ' 3C] HSQC NMR spectrum, and also cross-peak to proton 7a. From the 2D ['H, 
' 3C] HSQC NMR spectrum, proton 7b was found. Proton 7a was found to have 
COSY cross-peaks to protons 7b and 8. Proton 8 (an NH proton) then shows a 
COSY cross-peak to proton 9b. There is a COSY cross-peak from proton 9b to 
proton lOa, and proton lOb was found from the 2D ['H, 13C] HSQC NMR spectrum. 
Proton 1 O has a COSY cross-peak to proton 11, which is an NH proton. Proton 11 
shows a COSY cross-peak to proton 12b. From proton 12a, there is a COSY peak to 
proton 13a. Also proton 12b has a COSY peak to proton 13b. Proton 13a also shows 
a NOESY peak to proton 14, the proton in the meta position on the pyridine ring, 
suggesting that proton 13a is assignable to an equatorial proton. The data are 
S. 
summarised in Table 5.5. 
Table 5.5 Assignment of the major configuration of the Cd(II) macrocycle 16 in 





10 H 12 13 
Assignment 'H / 13C / 15N / Assignment 'H / 13C I ' 5N / 
ppm ppm ppm ppm ppm ppm 
1 7.87 143.6 8 3.21 -4.1 
2 7.39 126.2 9a 2.55 
48.4 3a 2.94 9b 2.96 
41.1 
31i 3.12 lOa 2.80 
48.5 
 4a 3.33 lOb 2.97
48. 8 
4b 2.88 11 3.48 10.6 
5 2.92 6.5 12a 3.53 
52.0 
 6a 2.56 12b 2.57
51. 2 
6J 2.97 13a 3.06 
39.3 7a 2.29 13b 2.82 
47.7 
7b 3.12 14 7.30 125.8 
For species B, again there is a NOESY cross-peak between the signal from 
the meta proton from the pyridine ring and proton 3b, which is the most upfield 
shifted peak in the 2D ['H, ' 3C] HSQC NMR spectrum. The proton that gives rise to 
this signal, labelled 3b, should be an equatorial proton. The pair to this prton was 
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found from the 2D ['H, °C] HSQC NMR spectrum. The proton 3b was found to 
show a COSY cross-peak to proton 4b, which in turn showed a COSY cross-peak to 
the proton 4a. Proton 4a was also found to have a COSY cross-peak to proton 5, 
which is an NH proton. The signal from proton 5 also showed a COSY cross-peak to 
the signal from proton 6a. The 2D ['H, ' 3C] HSQC NMR spectrum was used to find 
proton 6b. From proton 6a, there is a COSY peak to proton 7a. The 2D ['H, 13 CJ 
HSQC NMR spectrum was used to locate the resonance for proton 7b. Proton 7a 
shows a COSY cross-peak to proton 8, an NH proton. This is the only COSY cross-
peak observable from proton 8. 
Table 5.6 Assignment of the minor configuration of the Cd(II) macrocycle 16 in 
90 % H20 / 10 % D20 at 25 °C, species B. 
8 
Assignment 'H / 13C / 15N / Assignment 'HI 13C / 15N / 
ppm ppm ppm ppm ppm ppm 
1 7.81 143.0 5 3.78 11.2 
2 126.5 7.27 6a 2.89 
50.5 
3a 2.88 6b 2.80 
39.2 
3b 3.19 7a 2.64 
47.8 
4a 2.91 7b 3.03 
50.2 
4b 3.28 8 2.76 1.1 
IM 
5.3.4 Synthesis and NMR Spectroscopy of Zn (II) Complex, 17 
This complex was synthesised and its solution structure was investigated 
using 1D and 2D NMR studies. ['H, 'Fl] COSY, NOESY and TOCSY, ['H, 13C] 
HSQC and ['H, 15N] HSQC NMR spectra were recorded. The structure was solved 
in a similar manner to the "Cd complex, and two major configurations of the 
macrocycle were identified. The ID 'H NMR spectrum is shown in Figure 5.13. 
The full assignments of the two configurations are given in Table 5.7 and Table 5.8. 
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Figure 5.13 1D 'H NMR spectrum of 17 in 90 % H20 / 10% D20 at 25 °C. (* = 
residual solvent peaks, methanol and DMF). 
NH Region 
Five signals were observed in the 2D ['H, ' 5N] HSQC NMR spectrum, as 
shown in Figure 5.14, which shows two configurations are present, an unsymmetrical 
one, species A, and a symmetrical one, species B. Integrating the NH peaks for 
no 
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Figure 5.14 2D ['H, 15N] HSQC NMR spectrum of 17, recorded in 90%H20/  10 
% D20 at 25 T. The peaks from species A are shown with a solid line, the peaks 
from species B are shown in a dotted line. Three peaks are present from species A 
because it is not symmetrical, whereas species B is symmetrical, and as such two of 
its NH protons are equivalent. 
Aromatic Region 
There are two triplets present from the para protons in the pyridine ring. This 
indicates that there are two configurations of the macrocycle present. A similar 
splitting pattern is observed to the "Cd complex, showing that there is one 
symmetrical and one unsymmetrical configuration present. 
CH2 Groups From Ring 
There are 12 pairs of signals in the 2D ['H, ' 3C] HQSC NMR spectrum 
(shown in Figure 5.15). Species B has 4 pairs of signals from the CU 2 groups in the 
ring, while species A has 8 pairs. The signals closest to the pyridine ring (labelled 3 
190 
and 13) have the greatest upfield shift in the 13C dimension of the 21) ['H, ' 3C] 
HSQC NMR spectrum. There are three pairs of signals in this region, two are from 
species A, with one pair from species B. These signals were integrated in the ratio 
34:34:32, showing that the solution is made up of 68 % species A, 32 % species B. 
611 4 3 
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Figure 5.15 2D[ 1 H, ' 3C] HSQCNMR spectrum ofl7in9O%H20/ 10%D20at 
25 °C. The peaks from species A are shown with solid boxes, the peaks from species 
B with dotted circles. Protons on the same carbon atom are referred to as a and b. 
191 
Table 5.7 Assignment of the NMR peaks for the major configuration of Zn(II) 
complex 17 in 90 % H20 / 10 % D20 at 25 °C, Species A. For labelling scheme 
see Figure 5.15. 
Peak 'HI ' 3C1 ' 5N/ Peak "Cl 
ppm ppm ppm ppm ppm ppm 
1 7.90 143.9 8 3.47 -2.3 
2 7.38 127.0 9a 2.99 
47.7 
 3a 3.03 9b 2.89
36.5 
3b 3.05 lOa 2.74 
48.4 4a 3.34 lOb 2.98 
49. 9 
4b 2.91 11 4.15 11.0__  
5 4.09 2.6 12a 3.44 
50.5  6a 2.68 12b 2.88
52. 0 
6b 3.12 13a 3.18 
37.6 7a 2.37 13b 3.00 
47. 6 
7b 3.19 14 7.34 126.4 
Table 5.8 Assignment of the NMR peaks for the minor configuration of Zn(II) 
complex 17 in 90 % 1120 /10 % DO at 25 °C, Species B. For labelling scheme 
see Figure 5.15. 
Peak 'H/ ' 3C/ ' 5N/ Peak 'H/ ' 3C/ ' 5N/ 	I 
ppm ppm ppm ppm ppm ppm 
1 7.92 144.0 5 3.83 8.5 
2 7.39 126.5 6a 3.21 
49.7 
 3a 3.10 6b 2.56
38.2 
3b 3.01 7a 3.27 
49.2 4a 3.34 7b 2.57 
4 9.4 
4b 3.04 8 3.51 1.7 
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5.3.5 Synthesis and NMR Spectroscopy of 18 
This Cd(II')2-bis(pyridyl isocyclam) complex was characterised using 1D and 
2D NMR studies. There are 4 regions of these spectra that can be studied, the 
aromatic region, the methylene linker proton region, the NH peaks and the peaks 
from the CH2 groups in the ring (Figure 5.16). The ['H, "Cd] HSQC spectrum 
showed that there were four "Cd peaks present (Figure 5.17). The major 
configuration has a "Cd peak at 215.8 ppm (species A), and there is another 
relatively intense peak at 201.8 ppm (species B). There are also very small signals 
for two other species present, at 208.5 ppm and 221.8 ppm, but these were not 
observed in any other spectra recorded (['H, 'H] COSY, NOESY and TOCSY, ['H, 
' 3C] HSQC and ['H, ' 5N] HSQC 2D NMR spectra, under the same conditions), and 
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Figure 5.16 'H NMR spectrum of 18, recorded in 90 % H20 / 10 % D20 at 25 °C, 
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Figure 5.17 ['H, 111 Cd] HSQC spectra of 18, showing 4 "'Cd peaks. Only the 
major two peaks were found to correlate to peaks in the other 2D NMR spectra 
recorded. 
Aromatic Region 
In the 1D proton NMR spectrum, there are two triplets in the aromatic region 
(Figure 5.18). These arise from the proton in the para position in the pyridine ring. 
This can be used to identify the number of species present, as there should be one 
triplet for each species. There is one major one (82 %, species A) and one much 
smaller one (18 %, species B, calculated from the relative integrals). 
The splitting pattern of the peaks for the protons in the mew position in the 
pyridine ring can be used to help identify the configuration of the macrocycle. In 
this case, this proved difficult, as the signal from the aromatic protons in the phenyl 
linker overlaps with peaks from the pyridine ring. However, this is resolved in the 
2D NMR spectra. From the ['H, 'H] COSY spectrum (Figure 5.19), there appear to 
vjI 
be two doublets present, as the triplet from species A shows two COSY peaks to the 
doublet region, which means that the ring is not in a symmetrical environment, and 
the NH groups have different orientations. The para proton (triplet at 7.89 ppm) 
should only show COSY cross-peaks to the meta protons in the pyridine ring, in this 
case the para proton shows two COSY peaks, which means that the molecule must 
be unsymmetrical to produce such splitting. This can also be observed in the [ 1 11, 
13q HSQC, where three peaks are found in this region (Figure 5.20). These 
integrate to 41:41:18, indicating that two are from species A, and one is from species 
B. 
7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 	6 ( 1 H) 
Figure 5.18 1D 'H spectrum of 18 recorded in 90 % H20/ 10% D20, showing the 
aromatic region. A triplet is present from the para proton in the pyridine ring for 
each configuration of the macrocycle. 
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Figure 5.19 ['H, 'H] 2D COSY NMR spectrum of 18 recorded in 90 % H20 / 10 
% DO, showing the aromatic region. This shows that for species A (solid lines), 
there are two signals from the meta protons in the pyridine ring, implying that the 
molecule is not symmetrical. Furthermore, there is only one cross-peak from the 
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8.0 	7.8 	7.6 	7.4 8 ( 1 H) 
Figure 5.20 2D ['H, °C] HSQC NMR spectrum showing the signals from the 
meta and para positions in the pyridine ring in 18, shows there are three signals from 
the meta protons (shown by m). Only one peak is observed for the mew protons of 
species B, whereas two are observed for species A. The minor doublet shows a 
cross-peak in the ['H, 111 Cd]-HSQC NMR spectrum to the " 1 Cd peak at 201.8 ppm. 
There is one peak for each triplet (shown by p). 
Methylene Linker Region 
The signals from the phenyl linker protons overlap with one of the doublet 
peaks in the I  and the 2D [ 1 H, 1H] COSY NMR spectra. However, these can be 
distinguished from these peaks in the 2D ['H, "Cl HSQC NMR spectrum. The 
presence of a singlet for each species in this region indicates that both of the 
macrocycles for each species are in the same configuration, as if the macrocycles 
were in different configurations, AB quartets would be observed in this region. The 
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['H, 13C] 2D HSQC NMR spectrum showed that there is one major set of linker 
protons, shown in Figure 5.21, labelled 14a and 14b, at 4.12 and 3.92 ppm. There is 
a small peak at 3.93 ppm, which is from species B, shown in Figure 5.23, labelled 
14. 
The NOESY spectrum shows cross-peaks from the para protons to peaks at 
3.11 ppm and 3.18 ppm, which are assigned as the equatorial protons on the CH2 
groups closest to the pyridine ring (peaks 3a and 14a in Figure 5.21). These protons 
were found to correlate with the most low frequency shifted 13C peaks in the 2D 
' 3C] HSQC NMR spectrum (40.4 ppm and 39.2 ppm respectively). There is only one 
acetate signal present, (1.97 ppm, 25.15 ppm) indicating that all the acetate is in the 
same environment. There are three possibilities for this; either all the acetate is 
bound to the cadmium, all of the acetate is unbound, or finally, there could be free 
and bound acetate in fast exchange. If acetate was bound, this would allow hydrogen 
bonding to occur between the acetate and an NH group on each face of the 
macrocycle, stabilising the configuration. 
NH Region 
The 2D ['H, ' 5N] HSQC NMR spectrum showed that there are three NH 
signals (Figure 5.22). Both of these are split into two peaks due to coupling to "Cd. 
For the peak at 3.78 ppm, 'J(1 5N, "Cd) = 124 Hz; 2.J ('HN, "Cd) = 24 Hz. For the 
peak at 3.29 ppm, 'J(' 5N, "Cd) = 122 Hz; 2J( 'HN, "Cd) = 25 Hz. The two peaks 
were both attributed to species A. There is one weak peak observed for species B,. at 
3.92 ppm, with '.J(' 5N, "Cd) = 144 Hz; 2J( 1 HN, "Cd) = 22 Hz. 
The assignments of 'H, ' 3C and ' 5N NMR peaks for the complex are given in 
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Table 6.2. The numbering scheme is shown in Figure 5.22, and a fully assigned ['H, 
13C] HSQC spectrum is shown in Figure 5.21. 
6 ( 3C) 	 13 	6 ("C) 
40 
2 
130 	 C221 I 	45 
1351 	
° 
15 	I 	50 
55 
I—c 








8.0 	7.8 	7.6 	7.4 6 ('H) 	4.0 	3.5 	3.0 	6 ('H) 
Figure 5.21 The assigned 2D [ 1 H, ' 3C] HSQC NMR spectrum of the major 
configuration (species A) of 18 recorded in 90 % H20 I 10 % D20.For the numbering 
scheme, see Figure 5.22. Protons on the same carbon atom are referred to as a and b. 












4.0 	3.8 	3.6 	3.4 a ('H) 
Figure 5.22 2D ['El, ' 5N] HSQC NMR spectrum of 18, recorded in 90 % H20 / 10 
% D20. Three 15NH peaks are observed, which are both split by coupling to "Cd, 
two from species A and one of weak intensity from species B. 
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Table 5.9 Assignment of the major configuration of 18 in 90 % H20 / 10 % D20 
at 25 °C, corresponding to the 111 Cd peak at 215.8 ppm. 








1 7.89 143.7 










4b 2.57 lib 2.95 










7b 2.54 14b 3.92 
8a 2.76 
50.7 
15 7.32 125.9 
8b 2.38 
Species B 
From the integrals, it can be calculated that species B makes up 18 % of the 
total 18 in solution. It appears to be a totally symmetrical form, as there are only 4 
sets of 13C peaks present in the region from the ring CH2 groups in the 2D ['H, 13C] 
HSQC NMR spectrum (labelled 3-6 in Figure 5.23). These all show cross peaks in 
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the 2D ['H, "Cd] HSQC NMR spectrum to the "Cd peak at 201.8 ppm. Only one 
peak was observed for the linker protons at 3.93 ppm ( 13C shift = 57.8 ppm, labelled 
7 in Figure 5.23). Based on the assignment of the major configurations, the peaks 
nearest the pyridine ring can be assigned (peaks 3 and 4). There is only one doublet 
present from the meta protons in the pyridine ring, supporting that the configuration 
is symmetrical. One peak was observed in the 2D ['H, ' 5N] HSQC NMR spectrum 
for this species. There is also only one signal for the aromatic protons in the phenyl 
linker. The assignment is given in Table 5.10, with the fully assigned 2D ['H, 13C] 
HSQC spectrum in Figure 5.23. 
8("C) 8 ("C) 3a 	3b 
.' __ 40- a 
2 
130- 
is 45- 6a 
0 
135- - 50 C 0 
/ 
140- 55- 1 14 	 a 	a 
145- 60- 
8.0 
I 	 I 	 I 
7.8 7.6 741 3 
( 1 H) 4.0 	3.5 	3.0 	6 (1 H) 
Figure 5.23 The assigned 2D ['El, ' 3C] HSQC NMR spectrum of the minor 
configuration (species B) of 18. The numbering scheme used is shown in Table 5.10. 
Protons on the same carbon atom are referred to as a and b. 
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Table 5.10 'Hand ' 3C assignment for species B of 18 
I 
11 
Peak 'H / ppm ' 3C I ppm 15N I ppm Peak 1 H I ppm 13C / ppm 
1 7.79 142.9 6 a 3.32 
2 7.26 126.2 6 b 2.83 




3 b 2.94 7 b 2.77 
4 a 2.98 
51.3 
14 3.92 57.8 
4b 334 15 7.39 133.6 
5 3.92 13.2 
13.6 Addition ofAcetate to Zn(II) Complex, 17 
Acetate was added to the Zn(II) complex, 17, from ito 10 molar equivalents, 
to investigate the effect of excess acetate on the configuration. The 'H NMR spectra 
recorded showed that the peaks shifted slightly, but no configurational change 
occurred. The pH was kept constant throughout the reaction to ensure that any 
changes were not as a result of pH. The small change in peak positions could arise 
from non-specific interactions with the added acetate. The acetate peak increased in 
intensity, but no shift in the acetate peak was observed. 
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5.3.7 pH Titration of Ligand 14 
The pH of a solution of ligand 14 was adjusted from pH = 0.5 to pH = 13.5, 
and 'H NMR spectra were recorded with each adjustment. The peaks shifted greatly, 
and the change in each peak observed was plotted. The shift of peak 4 is shown in 
Figure 5.24. From this, pKa values can be determined using Henderson-Hasselbalch 
equation, giving the pKa values of 1.48 and 9.81. Similar values were obtained from 
plotting other peaks. There also appears to be at least one more pKa value, below 1, 









0 2 	4 	.6 	8 	10 	12 	14 
pH 
Figure 5.24 Chemical shift of peak 4 of ligand 14, plotted against pH in order to 
determine piCa values of 14. Two pKa  values are determined, at 1.48 and 9.81. A 
further pKa is likely below pH = 1, shown by the steep slope below 1. 
203 
5.4 Discussion 
5.4.1 Fyridyl Isocyclams 
No work has been published on any metal complex of pyridyl isocyclam, 14. 
Suggested structures for the metal complexes are shown in Figure 5.9. It is notable 
that once complexed to a metal, pyridyl isocyclam only has two chiral N centres, as 
opposed to cyclam, which has 4. Both the structures shown in Figure 5.9 have two 
NH groups on the same face of the macrocycle, and as such, could form the same 
double hydrogen bonds to aspartate and glutamate residues as seen in the model of 
Zn2-xylyl-bicyclam bound to the CXCR4 receptor. 7 
There are reported crystal structures of the analogous 12 membered pyridyl 
complex, and of a 14-membered isomer of pyridyl isocyclam. 8' They are shown in 
Figure 5.25. In the 12-membered complex, copper is five-coordinate, and the ligand 
is quite folded, whereas in the 14-membered complex, cobalt is six-coordinate, and 
the ligand is more planar. There are 4 crystal structures in the CSD of the 14-
membered complex, two with octahedral Co(III), 9 one with 5-coordinate Cu(II),' ° 
and one with 4-coordinate Cu(II)." In all the complexes, the NH groups are all on 
the same face of the macrocycle, as shown in Figure 5.25. There is only one reported 
crystal structure of the 12-membered complex in the CSD. 8 In this, the asymmetric 
unit contains 2 cations of the complex, with one containing copper in a distorted 
square pyramidal environment, and one copper in a distorted trigonal bipyramidal 
environment. It is notable that the NH groups are all on the same side of the 
macrocycle in each of the crystal structures shown. This leads to the conclusion that 
pyridyl isocyclam, 14, would also adopt this configuration, and in solution, this 




configuration could then be the structure shown in Figure 5.9(b). 
Figure 5.25 Line drawings and crystal structures of (a) a 12-membered pyridyl 
macrocycle8  and (b) a 14-membered isomer of pyridyl isocyclam. 9 
The pKa values for these two macrocycles have also been published, 12, 13 and 
are shown in Table 5.11. One of these is a 12-membered macrocycle, and one is a 
14-membered one, an isomer of pyridyl-isocyclam, 14. It was shown for these two 
macrocycles that they have lower pKai and pK.2 values than cyclam, which is to be 
expected, as the pyridine ring should impart lower basicity to the ring. Only 2 pIta 
values for pyridyl isocyclam, 14, could be determined: of 9.81 and 1.48. It appeared 
that there could also be another one of <1. - 
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Table 5.11 pA'3 values for pyridyl macrocycles12' 13 
N 	HN Cn V C3 
pK3 i 10.33 9.92 
pKI2 7.83 8.56 
pKj 1.27 4.66 
pKa4 <1 <1 
5.4.2 "CdNMR Studies 
"Cd (or " 3Cd) is as sensitive to NMR detection as 13C. Solid state 1111113  Cd 
NMR studies have been used to study both Cd coordinated compounds and Cd-
substituted metalloproteins.'4' 15  Solution state 111/113 Cd NMR spectroscopy has been 
used in many studies, for instance in the identification of Cd binding sites in bovine 
serum albumin, 16  and in the study of pH dependence of metal-thiolate clusters in 
rabbit liver metallothionein.' 7 Generally, cadmium-substituted metalloproteins retain 
at least some of their biological activity. 3, 18 Work has recently been done on the 
membrane-permeable metal chelator N,N,N',N'-tetrakis(2-
pyridylmethyl)ethylenediamine (TPEN), using NMR studies to show there was a 
dynamic conformational flexibility in both the [Zn(TPEN)] 2  and the [Cd(TPEN)] 2 
complexes in solution. 19  A graph of chemical shifts of cadmium bound ligands is 
shown in Figure 5.26. 
RITi 
lIIlIIIIIIIIIIIIII! 
I 	I 	I 	I 
800 600 400 200 0 
8(1111113 Cd) 
Figure 5.26 Typical "Cd NMR shifts. Cd-C refers to complexes such as 
Cd(CH3)2, Cd(CH3)(0C611 5 ) and Cd(C6H5)2. 2 
It has been shown that there is a consistent correlation between "Cd (or 
113Cd) NMR chemical shift and the identity of the ligands bound to cadmium .2 
Cadmium has a large span of chemical shift, at over 900 ppm, which allows the 
characterisation of coordination number and type of ligands bound. Oxygen ligands 
have been shown to provide the greatest shielding, with shifts of -100 ppm to 0 ppm, 
nitrogen and halide ligands are relatively deshielding, with sulphur being the most 
deshielding. The shift of Cd-S compounds can be as high as 800 ppm. It has been 
shown that tetrahedral coordination appears to be deshielded relative to octahedral 
complexes by approximately 50-100 ppm. A similar relationship has been shown 
between octahedral and heptacoordinated complexes. 
I'l3 	spectroscopy has been used in many studies, mainly of proteins to 
identify binding sites, in both solution and solid state NMR studies. Cd(JJ) is of 
similar size to both Zn(II) and Ca(II). The nuclear spin quantum number of '/ and 
reasonably high detection frequency (similar to that of 13C) makes "Cd easy to 
detect, although problems can arise from its negative gyromagnetic ratio and line-
broadening due to relaxation via chemical shift isotropy mechanisms at high fields 
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and for large complexes (macromolecules). Unlike other probes, such as Co, Cd 2 
has a filled d-shell and the coordination geometries are not influenced by ligand field 
effects. 
The "Cd macrocycle 16 was found to be in two configurations, in 60:40 
ratio, with the unsymmetrical configuration being the more abundant. The bis- 
macrocyclic "Cd complex 18 was again found to be in the same two configurations, 
with the ratio of unsymmetrical : symmetrical being 82:18. The "Cd chemical 
shifts are within the expected range for cadmium bound to nitrogen. Values for lj 
("Cd-' 5N) coupling constants, when pyridines and substituted pyridines are used as 
ligands, have been shown to be in the range 135 - 150 Hz. 20 Here, values were 
found to range from 100 - 180 Hz. Similarly, the 15N shifts are within the expected 
range for nitrogen bound to "Cd. There is only one acetate signal present, 
indicating that all the acetate is in the same environment, and if bound then is in fast 
exchange between bound and free. If the acetate binds to the Cd(II) in the 
macrocycle, this would allow hydrogen bonding to occur between the acetate and an 
NH group on the macrocycle, stabilising the configuration. 
5.4.3 NMR Studies of Zn(II)-Pyridyl Isocyclam 
Zn(II) has a ff111 d shell, 3d 10, and its coordination number can vary between 
4, 5 and 6. There are 11 zinc-cyclam structures in the CSD. All of these are in the 
trans-Ill configuration. However, it has been shown that on dissolving the 
crystalline Zn-cyclam can equilibrate to a mixture of trans-Ill, trans-I and cis-V. 2 ' 
In the present case, complex 17 was found to be in two configurations. There was 
only one acetate signal present, indicating that all the acetate is either bound or 
unbound, or free and bound acetate could be in fast exchange. The two 
configurations were present in the ratio 68 % : 32 %, with the unsymmetrical 
configuration being more abundant. The isomer ratio is shifted slightly towards the 
unsymmetrical configuration compared to the equivalent cadmium complex (60:40). 
However, this difference could.just arise from errors in calculating the integrals. 
It was found that no significant changes occurred upon the addition of up to 
ten equivalents of acetate to the Zn(II) complex 17. This could show that all the 
acetate is in fast exchange, or it could be that no acetate is bound to the metal, and 
water could be part of the inner coordination sphere. This is the case in 
[Zn(cyclam)(H20)2](OAc)2. 2 ' It has been shown previously that acetate can induce 
conformational changes in Zn-cyclam and Zn 2 xylylbicyclam  complexes, however, 
no significant changes occurred in this case. 7, 21 There is no evidence for 
interconversion between configurations in this pyridyl isocyclam under the 
investigated conditions. 
5.5 Conclusions 
The macrocycle 14 was successfully synthesised and two Pic a values were 
determined. The macrocycle was also successfully complexed with Cd(II) and 
Zn(II), complexes 16 and 17 respectively. Th e novel metallomacrocycles were 
identified using mass spectrometry and NMR spectroscopy. 2D NMR studies were 
used to identify the configurations of the metallomacrocycles in aqueous solution. 
There were two major configurations for both the cadmium and the zinc complexes, 
a symmetrical one and an unsymmetrical one. For both metal ions, the 
unsymmetrical configuration was the most abundant. It is possible that acetate 
bound to the metal forms hydrogen bonds to the NH groups on the ring. Addition of 
excess acetate to the zinc complex 17 was found to have no effect on the 
configuration of the complex. These are the first reported metal complexes of this 
macrocycle. 
The bis-macrocycle 15 was successfully synthesised and fully characterised 
by NMR. The 111 C complex was also synthesised as the acetate salt (complex 18). 
The solution structure of this "Cd complex in aqueous solution was studied using 
2D NMR. It was found to exist in two configurations, a symmetrical and an 
unsymmetrical one. The unsymmetrical one was found to be the most abundant, 
with the solution containing of 82 % of this configuration. There is a shift towards 
this unsymmetrical configuration compared to the monomer (complex 16, in which 
the unsymmetrical configuration was 60 % of the solution). Detailed NMR studies 
showed both macrocycles to be the same configuration in the two species present. 
This is the first reported metal complex of this potent anti-HIV agent, and this 
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Chapter 6 Interaction of Metal Cyclams with Lysozyme 
6.1 Introduction 
Lysozyme is a secretory enzyme, made up of 129 amino acid residues, with a 
molecular weight of 14. kD It catalyses the hydrolysis of polysaccharides in cell 
walls, resulting in the breakdown of bacterial walls.' It is a widespread enzyme, 
found in both animals and plants. In humans, it is found in saliva, tears, leucocytes 
and the kidneys. It has been well studied, and its structure has been characterised in 
both the solid and solution states. The amino acid sequence was first determined in 
1963.2. 3 Hen Egg White Lysozyme (HEWL) was the first enzyme to have its three-
dimensional structure determined by X-ray diffraction techniques, in 1965, and has 
since been extensively studied. During this study, 4 disulfide bridges were clearly 
identified, along with a site where competitive inhibitor molecules can bind. It was 
found that the a-helical content was quite low, with only 6 lengths of helix identified, 
which included 55 of the 129 amino acid residues, resulting in only 42 % of the 
molecule being composed of a-helices. It was shown that the lysozyme molecule has 
a hydrophobic spine, containing several tryptophan residues. 
In view of the targeting of anti-HIV cyclam derivatives to CXCR4, it is 
important to understand the nature of the interactions which determine their binding 
sites on proteins and in particular whether proteins can recognize different 
configurations of metal cyclams selectively. However, there appear to be no reported 
structures of protein adducts of metal cyclams. In particular it has been suggested  
that carboxylate groups in a protein positioned above the faces of a 
metallomacrocycle might stabilize the unusual cis-V configuration. Lysozyme was 
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chosen as a model protein to study protein-cyclam adducts, because it is readily 
crystallized  and the active site contains carboxylates from G1u35 and Asp52 in close 
proximity which are known to bind to metal ions such as 
6.2 Experimental 
Complexes 4, 8 and 13 were prepared and characterised as described in Chapter 3 (4 
and 8) and Chapter 4(13). 
6.2.1 Crystallization of Lysome with [Cu2(xylyl-bieyc1am)J(0A04 
A .0.1 M sodium phosphate buffer solution at pH = 8.4 was prepared by 
mixing NaH2PO4 (5 mL, 0.5 M) and Na21{PO4 (95 mL, 0.5 M). .A solution of 
Cu2(xylyl-bicyclam)(OAc)4 (13, 0.1 mM, 1 mL in .buffer) was prepared to give a 
dark blue solution. A clear solution of HEWL (50 mg/ mL in buffer) and a saturated 
solution of NaCl in water were prepared. All solutions, and distilled water (20 mL), 
were filtered using a syringe filter to remove any particles. The reservoir solution for 
the crystallisation plate was prepared using buffer (100 jsL), NaCl (200 j.xL) and 
water (700 j.tL) in each well (24 wells). On the cover slip, HEWL (2.5 ' 
Cu2(xylyl-bicyclam)(OAc)4 (2.5 jiL) and reservoir solution (5 jiL) were added to 
form a drop. Six identical wells and coverslips were prepared and the cover slips 
were sealed to the wells using, vacuum grease. Three further sets of six conditions 
were prepared using the following conditions: buffer (100 j.iL), NaCl (300 Rd-) and 
water (600 L), buffer (100 jsL), NaCl (500 1iL) and water (400 Rd-) and finally 
buffer (100 p.L), NaCl (400 RL) and water (500 RL). The hanging drop was prepared 
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in the same way each time. The crystallisation tray was stored in the refrigerator at 4 
°C for 2 weeks. 
6.2.2 Crystallization of Lysozyme atpH=4.5 
Acetate buffer (0.05 M) was prepared from glacial acetic acid (0.003 moles) 
and NaOAc (0.0019 moles) made up to 100 niL with water. The pH was adjusted 
with NaOAc to obtain the desired pH. A solution of ITIEWL (50 mg/mL in buffer 
solution) and a saturated solution of NaCl were prepared. All solutions and water 
(20 mL) were filtered through a syringe filter. Six crystallisation wells were set up 
with the reservoir, containing buffer (100 jiL), NaCl (200 j.tL) and water (700 jiL). A 
further six were set up with buffer (100 uxL), NaCl (300 sL) and water (600 RL). 
Hanging drops were prepared on the cover slips using HEWL:reservoir solution in 
the following ratios : 2:3, 3:2, 4:1. Two of each were set up for each set of the 
reservoir solutions. The coverslips were sealed using vacuum grease and the 
crystallisation tray was stored in the fridge at 4 °C for 4 days. During this time 
hexagonal crystals had grown in all cells. 
6.2.3 Soaking of Lysozyme Crystals With [Cu(cyclam)(H20)2](OAc)2,  8 
The lysozyrne crystals were soaked in a saturated solution of 8 in reservoir 
solution for 5 days at 288 K. The resulting purple crystal was then removed in a 
cryoloop and frozen in liquid nitrogen by using type , B immersion oil as a 
cryoprotectant. 
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6.2.4 Soaking of Lysozyme Crystals With Cu 2(xylyl-bicyclain)(0Ac) 4, 13 
The lysozyme crystals were soaked in a saturated solution of 13 in reservoir 
solution for 27 hours: The resulting purple crystal was then removed in a ciyolOop 
and frozen as above. 
The handling of lysozyme crystals, collection of x-ray diffraction data and 
solution of the structure were carried out by Dr Lain McNae and Professor Malcolm 
Walkinshaw (School of Biological Sciences, University of Edinburgh) 
6.2.5 NMR Studies of Lysozyme with fCu(cyclam)(H20)2](0Ac)2, 8 
All NMR experiments were performed in 90 % H20 I 10 % D20. The water 
resonance was suppressed by presaturation. Standard pulse sequences were used for 
2D TOCSY and COSY (mixing times of 60 and 80 ms, respectively). The pH of 5 
mM solutions of HEWL in 90 % H20/10 % D20 used for NMR titrations was 
adjusted to 4.6 using 0.1 M HC1. Titrations were carried out by adding microlitre 
aliquots of aqueous Cu-cyclam (8) (125 mM, pH 4.60), from 1 to 10 molar 
equivalents. The assignments for 1fl  NMR resonances of HEWL are based on those 
given by Noda et al..8 
6.2.6 NMR Studies of Lysozyme with Cu 2(xylyl-bicyclam)(0Ac)4, 13 
All NMR experiments were performed in 90 % 1120 / 10 % D20. The water 
resonance was suppressed by ptesaturation. Standard pulse sequences were used for 
2D TOCSY and COSY (mixing times of 60 and 80 ms, respectively). The pH of 5 
mM solutions of HEWL in 90 % H20/10 % D20 used for NMR titrations was 
adjusted to 4.6 using 0.1 M HCl. Titrations were carried out by adding microlitre 
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aliquots of aqueous Cu2(xylyl-bicyclam)(OAc)4 (13) (125 mM, pH 4.57), from 1 to 
10 molar equivalents. 
6.2.7 NMR Studies of Lysozyme with [Ni(cyclam)(OA c)2] 1120, 4 
All NMR experiments were performed in 90 % H20 / 10 % D20. The water 
resonance was suppressed by presaturation. Standard pulse sequences were used for 
2D TOCSY and COSY (mixing times of 60 and 80 ms, respectively). The pH of 5 
mM solutions of HIEWL in 90 % H20/10 % D20 used for NMR titrations was 
adjusted to 4.6 using 0.1 M HC1. Titrations were carried out by adding microlitre 
aliquots of aqueous Ni-cyclam (4) (125 mlvi, pH 4.55), adding 1, 5 and 10 molar 
equivalents. 
6.3 Results 
6.3.1 NMR Studies with Lysozyme and Metal Cyclarns 
The main features of the 1D Ill  NMR spectrum of lysozynie were unchanged 
after the addition of up to 10 equivalents of complexes 8, 13 and 4 (Figure 6.1-6.3). 
However, specific Trp resonances broadened, as seen in the 1D (Figure 6.4) and 2D 
(Figure 6.5-6.6) NMR spectra. 
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Figure 6.1 	1D 1 H NMR spectra of lysozyme, lysozyme + 5 molar equiv 
Cu(cyclam), S and lysozyme + 10 molar equiv Cu(cyclam), 8, recorded in 90 % H20 
/ 10% D20 at 25 °C, pH = 4.60. 
water 11dioxan acetate 
+ 10 eq Curbicyciarn 
+ 5 eq Cu2-bicyclarn 
Lysozyme 
11 10 9 	8.7 	6 	5 	4 	3 	2 	1 	05(H) 
Figure 6.2 	1D 'H NMR spectra of lysozyme, lysozyme + 5 molar equiv Cu2- 
(xylyl-bicyclam), 13 and lysozyme + 10 molar equiv Cu2-(xylyl-bicyclam), 13, 




Figure 6.3 	1D 'H NMR spectra of lysozyme, lysozyme + 5 molar equiv Ni- 
(cyclam), 4 and lysozyme + 10 molar equiv Ni-(cyclam), 4, recorded in 90 % H20 / 
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Figure 6.4 	Effect of Cu(cyclam), Cu2(xylyl-bicyclam) and Ni(cyclam) on 
tryptophan indole NH resonances of lysozyme. As is evident from the plot of 
linewidth versus Cu(cyclam) concentration, there are specific paramagnetic 
broadening effects on Trp-62, Trp-63, and slight broadening of Trp-123, implying 
that these residues are close to the bound Cu 2t The linewidth of the backbone NH 
resonance of Cys-76 is also shown for comparison. However in the case of the 
Cu2(xylyl-bicyclam), the broadening of Trp-62, Trp-63 and Trp-108 are the most 
significant, with Trp-123 only broadening slightly. Trp-1 11 broadens slightly in both 
cases. In the case of the Ni(cyclam), Tip 63 broadens to the point of not being 
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Figure 6.5 2D ['H, 'H] COSY NMR spedra of lysozyme in 90 % H20 / 10 % 
D20, before (left), after (middle) addition of 10 molar equivalents of 
[Cu(cyclam)(H20)2](OA02, and (right) addition of 10 molar equivalents of 
[Cu2(xylyl-bicyclam)](OA04 . Assignments: a, Trp-63 He VHS ';b, Trp-62 He VHS 
c, Trp-108 He 'IHS ', d, His-15 He 'IHS 2  e, Trp-123 Hi 2/H. The labelling 
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Figure 6.6 2D ['H, 'H] COSY NMR spectra of lysozyme in 90 % H20 / 10 % 
D20, before (left), after (middle) addition of 1 molar equivalent of 
[Ni(cyclam)(OAc)2}, and (right) addition of 5 molar equivalents of 
[Ni(cyclam)(OA02]. There was little change in the 2D NMR spectrum after the 
addition of 10 molar equivalents of [Ni(cyclam)(OAc)2]. 
6.3.2 Crystallization of Lysogyme 
The attempt to co-crystallize Cu2-xylyl-bicyclam, 13, with lysozyme at pH= 
8.4 resulted in only precipitate forming in each of the wells. The attempts to grow 
crystals of lysozyme alone at pH = 4.5 resulted in hexagonal crystals, which were 
then used in the soaking experiments with the copper complexes 8 and 13, (Figure 
6.7). The x-ray structures of these adducts were solved to a resolution of 1.75 and 
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1.6 A, respectively, by Dr. lain McNae. The overall structure of lysozyme is not 
changed by formation of adducts with either complex 8 or 13. The positions of the 
copper atoms in both the monocyclam and bicyclam structures were unequivocally 
detected as strong peaks in an jF,,j-jF cj map. In each case, this revealed two binding 
sites per asymmetric unit. Site 1 is close to the side chain of Asp 101, whilst site 2 is 
closest to the side-chain of Trp 123 and the backbone carbonyl of Gly 117 (Figure 
6.8). 
, 
Figure 6.7 	Hexagonal crystals of lysozyme in immersion oil before and after 
soaking in the presence of Cu2-xylyl-bicyclam. The colourless lysozyme crystals 















Figure 6.8 	The two Cu-cyclam (8) and Cu2-xylyl-bicyclam (13) binding sites in 
crystals of HEWL. (A) Cu-bicyclam-HEWL. 21F01 - FCI density is shown around the 
cyclams at 0.9-. No electron density is seen for the p-phenylenebis(methylene) 
linker. (B) Cu-cyclam-HEWL. 21F01 - IFI density is shown around the cyclams at 
0.9.. (C) Stereoview of an overlay of the cyclam positions in lysozyme. Colour code: 
orange, Cu2-bicyclam; green, Cu-cyclam. Molecule I (only just seen in bottom left of 
picture) is green and contains Asp-101, Trp-62, and Trp-63; molecule 2 is purple and 
contains Trp-123; and molecule 3 (only just seen at top of picture) is yellow and 
contains Gly-1 17. Amino acid code: D = Asp, W = Trp, G = Gly. 
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6.4 Discussion 
6.4.1 Copper-Macrocycle-Lysoz,yme Interactions in Solution 
Resonances from protons in the protein which are within a few Angstroms of 
Cu2  in a bound Cu-cyclam would be expected to broaden significantly on account of 
the paramagnetism of Cu 2 (3d9 ; dipolar broadening cc r 6, where r = Cu - H 
distance). 9  The main effect of adding metal-cyclams to lysozyme was the 
broadening of specific Trp resonances, as seen in 1D (Figure 6.1-6.3) and 2D (Figure 
6.5) NMR spectra. For Cu-cyclam, 8, line-broadening of tryptophan indole NH 
resonances decreased in the order (Figure 6.4): 
Trp62,Trp63 > Trp123 >> Trp108, Trplll, 
with Trp 108 and Tip 111 being little affected by Cu-cyclam. Cu-cyclam also had 
little effect on the H6 and HE resonances of the only His residue in lysozyme, His 15. 
However, in the case of complex 13, the Cu(II)-xylyl-bicyclam, (Figure 6.4-6.5) the 
effect is much more pronounced, with the most significant change being the effect on 
TrplO8. The line broadening increases dramatically for Trp62 and Trp63 also. The 
order of line-broadening in this case is: 
Trp63 > Trp108 > Trp62 >>Trp123, Trpl 11 
The increased line broadening can be attributed to there being double the amount of 
paramagnetic copper present. Trp-108 is found in a region in the sequence in which 
a highly persistent hydrophobic cluster has been identified in lysozyme.'°' ' This 
could form key hydrophobic interactions with the cyclam ring. It is possible that the 
linker from xylyl-bicyclam brings the second cyclam ring into an orientation that 
allows it to interact with Trp-108 (Figure 6.9). 
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Figure 6.9 	The location of Trp 108 (purple) in relation to one the cyclam rings 
from Cu2(xylyl-bicyclam) (blue). Trp62 is also highlighted in green. In solution, the 
resonance for Trpl08 broadens significantly, indicating that there is a copper atom 
close to it. It is possible that the orientation of the second cyclam ring (not found in 
the crystal structure) is such that the macrocycle is located close enough to bind to 
TrpIO8. 
Several other residues change significantly upon reaction of complex 13 with 
lysozyme. The peak for Asn59H shifts from 5.64 ppm to 5.69 ppm. In the crystal 
structure, this can be seen to sit next to Trp62 and Trp63, which are both involved 
with bonding to the Cu-cyclam ring, and as such influence the chemical shift of 
amino acids in close proximity to themselves. Also, Asn59 sits on the surface of the 
Offld  
protein, close to the binding site for one of the cyclam rings, hence it could be 
directly involved with binding a second cyclam ring from Cu2-bicyclam. 
It can be seen clearly in the 1D NMR spectrum that the peak arising from 
Ala90 FIB (1.34 ppm) is altered by the interaction with complex 13. This residue is 
located on the surface of the protein, and it is not located near either of the two main 
binding sites found in the crystal structure. This could be a further binding site,, and 
as a hydrophobic 'residue, could be involved in hydrophobic interactions with a 
cyclam ring.  
6.4.2 Nickel-Macrocycle-Lysozyme Interactions in Solution 
Again, the main features of the 1D 1 11 NMR spectrum of HEWL were 
unchanged after addition of up to 10 molar equivalents of the Ni" complex 3 (Figure 
6.3) which indicated that the interaction had little effect on the overall protein fold. 
In this case, the solution contains a mixture of paramagnetic and diamagnetic Ni-
cyclam, as shown by the presence of narrow and broadened peaks in the 1D spectrum 
(Figure 6.3). Upon binding to lysozyme, broadened peaks from paramagnetic Ni-
cyclam can still be observed in the 1D spectrum, at 40.3, 19.0, -8.4 and -18.1 ppm. 
However, the fact that resonances from the lysozyme broadened, indicates that there 
is a paramagnetic species interacting with the lysozyme, as little broadening would 
be expected if the diamagnetic species was the only one to bind. In the case of this 
nickel complex, the residues from lysozyme that are broadened are Tip 62 and'Trp 
63 (Figure 6.4). Trp63 is the most affected peak in the spectrum, its NH signal is too 
broad to observe in the 1D NMR spectrum after the addition of 5 and 10 molar 
equivalents of the nickel complex. In the 2D NMR spectrum, the cross peak from 
228 
Trp63 disappears upon the addition of 1 molar equivalent (Figure 6.6). This is the 
only significant change to the 2D NMR spectra after the addition of 1 molar 
equivalent of Ni-cyclam. However, following the addition of 5 molar equivalents, 
the signal from Tip 62 also disappears. There is little change in the 2D spectra 
between the addition of,5 and 10 molar equivalents. This shows that initially, Trp63 
is the favoured binding site, but with the addition of more complex Trp62.becomes 
important in binding Ni-cyclam. 
6.4.3 Copper-Macrocycle Binding Sites in Crystalline Lysozjme 
Colourless lysozyme crystals turned purple on soaking in solutions containing 
either Cu-cyclam 8 or Cu2-bicyclam 13 (Figure 6.7). The metal binding positions are 
similar in both the monocyclam and the bicyclam structures. Site 1 is close to the 
side chain of Asp101, whilst site 2 is closest to the side-chain of Trp123 and the 
backbone carbonyl of Glyl 17, Figure 6.8. These residues are on different regions on 
the protein surface. The packing of the protein molecules in the crystal brings the 
binding sites close to each other, Figure 6.10. The crystal packing and the interaction 
between the cyclam rings therefore appear to play a crucial role in the formation of 
the binding site. 
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Figure 6.10 The location of Cu-cyclam (A) and Cu-bicyclam (B) sites at the 
interfaces between lysozyme molecules in crystals. No density is resolved for the 
linker or the second cyclam ring for the xylyl-bicyclam complex. Cu-cyclam rings 
and tryptophan residues in the binding sites are space-filling, and the former are 
coloured according to the lysozyme molecule to which they belong. (W = Trp). 
In the structure of Cu2-bicyclam-I-{EWL, two cyclam rings were readily 
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identified. Both adopt the trans configuration (Figure 6.8). No electron density was 
present for the p-phenylenebis(methylene) group which links the two cyclam rings. 
Although the rings in the two sites are close (Cu - Cu distance 8.45 A), it was not 
possible to model the two cyclam rings as part of a single bicyclam unit (therefore 
only monocyclam rings were built and refined). The next closest cyclam ring in the 
crystal is too distant (Cu - Cu distance 14.87 A) to be modelled as part of a single 
bicyclam. Hence it appears that the cyclam rings in sites 1 and 2 belong to two 
different C112-xylyl-bicyclam molecules. 
In Cu-cyclam-HEWL, the Cu in site 1 is in a slightly different position to that 
in the bicyclam structure and the cyclam ring in this structure has strong density 
consistent with a cis configuration. Copper in site 2 is in a similar position to that 
found in the bicyclam structure and the planarity of the cyclam ring is indicative of 
the presence of a trans configuration (Figure 6.8). 
6.4.4 Metal Coordination, H-bonding and Hydrophobic Interactions 
In site 2, the cyclams in both the monocyclam and bicyclam structures adopt 
trans configurations. The trans-Ill configuration is common for octahedral metal 
cyclam complexes and trans-I for square-planar metal cyclam complexes 12.  The 
cyclam ring stacks on Trp123 and a (cyclam)CH ... OC(Gly1 17) hydrogen bond is 
formed (Figure 6.8). Cu 2 In the monocyclam structure is also very weakly co-. 
ordinated to a water molecule (Cu-0 3.05 A). Comparison of the positions of the 
cyclam in the monocyclam and xylyl-bicyclam structures reveals that although there 
is very little movement in the Cu position (0.8 A) there is a distinct change in the 
orientation of the cyclam plane (Figure 6.8C). This appears to be a consequence of 
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the difference in binding mode for the cyclam in site 1. 
In site 1, the cyclam ring of Cu2-xylyl-bicyclam has a trans configuration. 
The Cu2 in this cyclam coordinates directly to oxygen OD1 of the side-chain of 
Asp101 (Cu-OD1 2.7 A) and also very weakly to a water molecule (Cu-0 3.07 A) on 
the opposite side of the ring (Figure 6.11). In the monocylam structure, the cyclam 
ring adopts a cis configuration. The Cu in this ring does not coordinate directly to 
Asp101 and is in a significantly different position to that found in the bicyclarn 
structure (Cu movement 1.61 A; Figure 6.8C). In this folded conformation, two 
NH ... O hydrogen bonds are formed between the carboxylate oxygens of Asp101 and 
two NH groups on opposite sides of the cyclam ring (0D2.- Ni 2.70 A, OD1 - N10 
2.93 A, Figure 6. 11). . 
The Cu in this ring coordinates weakly to two 2 water molecules (Cu - 0 = 
2.76, 2.88 A). In both the cyclam and xylyl-bicyclam structures, the cyclam in site 1 
- is sandwiched between the indole rings of Trp62 and Trp63 and stacks directly with 
Tip 62. This hydrophobic interaction with tryptophan would therefore appear to be 
important for the binding of these cyclams in both cis and trans configurations. 
Girard el al. , in their search for heavy atom derivatives useful in anomalous 
dispersion methods of solving protein structures, have studied adducts of HEWL 
with Gd-HPD03A, the Gd3 complex of a derivative of the smaller [12JaneN4 
macrocycle cyclen (1,4,7,10-tetraazacyclododecane). They were unable to produce 
Gd-HPD03A-lysozyme by soaking, only by co-crystallization. Intriguingly Gd-
HPD03A binds in same sites 1 and 2 as Cu-(bi)cyclam (Figure 6.12); the main 
protein interaction is between Trp62 and the cyclen with no direct metal coordination 












Figure 6.11 Close contacts in the binding sites. (A) Site 1 for Cu-cyclam. (B) Site 
2 for Cu-cyclam. (C) Site 1 for Cu2-bicyclam. (D) Site 2 for Cu2-bicyclam. The 
shortest intersite contacts are indicated, but the relative orientations of the sites are 















Figure 6.12 Tryptophan interactions with macrocycles and proline. (A) 
Lysozyme–Cu(cyclam). (B) Lysozyme–Cu2(xylyl-bicyclam). (C) Lysozyme-
Gd(HPD03A) (PDB ID code 1H87). (D) Human IgE-Fc bound to high-affinity 
receptor FcERIa (PDB ID code 1F6A). Amino acid code: D = Asp, W = Trp. 
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The difference in the orientation of the cyclam plane in site 2 of the 
monocyclam and xylyl-bicyclam structures is likely to be a consequence of the 
difference in conformation of the cyclam in site 1. In both structures, the cyclams 
interact weakly with each other (closest ring-ring distance 3.21 A for xylyl-bicyclam, 
3.34 A for monocyclam, Figure 6.11-6.12). The overlay of the monocyclam and 
xylyl-bicyclam structures (Figure 6.8C) reveals that the different orientations of the 
plane conserve the tightness of the cyclam-cyclam interaction (which would 
otherwise increase to 3.62 A). It is unclear why the cyclam in site 1 is in the trans 
configuration in the xylyl-bicyclam structure compared to the cis configuration for 
monocyclam. The lack of difference between the protein structures does not provide 
any clues. It would therefore seem likely that this difference is related to the presence 
of a linker between the cyclam rings for xylyl-bicyclam, although the linker is 
disordered. 
The cis cyclam configuration in the solid state structure of the zinc complex 
of the drug xylyl-bicyclam, [Zn2(xylyl-bicyclam)(OAc2)2](OAc)2 -2MeOH, is 
stabilised by one bidentate acetate, the other acetate forms double H-bonds to the 
NH groups on the opposite face of the cyclam ring which adopts the folded cis-V 
configuration . In the Cu-cyclam-HEWL structure, there is no direct coordination of 
Cu2  to a carboxylate, only NH H-bonding, and the carboxylate oxygen coordination 
sites appear to be occupied by weakly-bound watermolecules. Cis metallocyclams 
with two bound aqua ligands are unusual, although Barefield et al. 14  prepared cis-
[Ni(cyclam)(H20)2]C12-2H20 via displacement of a chelated ethylenediamine by 
water under acidic conditions. In solution, the interaction of carboxylate groups with 
Zn2  cyclams readily leads to the formation of the folded cis-V configuration, 
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equilibria being reached within an hour at millimolar concentrations, at 298 K 5 1 15 . 
 
6.4.5 CXCR4 binding sites 
Previously  a model was built of human CXCR4 coreceptor based on the 
ray structure of rhodopsin' 6 and docked Zn2-xylyl-bicyclam such that there is direct 
coordination of Zn2 in one cyclam ring to the carboxylate of Asp l7l, and of Zn 2 in 
the other to Asp262. In the latter site, G1u288 on the opposite side of the ring can 
form double H-bonds to two ring NH groups, and the macrocycle folds into the cis-V 
configuration. In the first site a trans-1 or trans-Ill configuration is more likely for 
the cyclam ring. Inspection of the same CXCR4 model reveals that there are Trp 
indole rings close to each of the docked cyclams, Figure 6.13. 






Figure 6.13 A model showing [Zn2(xylyl-bicyclam)] 4 bound to the human 
coreceptor CXCR4. One of the cyclam rings in a trans configuration is stacked on 
Trp- 195 and its Zn is bound to Asp-171. The other cyclam ring has a folded 
configuration (cis) and is close to Trp-283; its Zn is bound to Asp-262, and two ring 
NH groups are H bonded to the oxygens of Glu-288. 
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Notable is the stacking of Trp195 on the trans-cyclarn ring which contains 
Zn bound to Asp 171. These are all features seen in the lysozyme-Cu-(bi)cyclam 
structures. The hydrophobic interaction of the N(CH2)2N and N(CH 2)2N backbone of 
cyclam with tryptophan indole rings has a parallel in the hydrophobic contact of the 
N(CH2)3CH cyclic side-chain of proline with tryptophan at some protein-protein 
interfaces, often as a Trp-Pro-Trp sandwich, e.g. the IgE receptor' 7, Fig. 6.12D. Such 
hydrophobic interactions may therefore play a key role in the binding of cyclain anti-
HIV complexes to the CXCR4 co-receptor. 
6.5 Conclusions 
Antiviral bicyclams target the membrane co-receptor protein CXCR4' 8 , and 
co-receptor binding is enhanced by the presence of Ni 2t Cu2 or Zn2 in the cyclam 
ring 19. Currently there are only structural models of CXCR4-cyclam adducts.5' 19, 20 
These models have emphasized the importance of aspartate carboxylate side-chains 
of CXCR4 in forming the H-bonds to cyclam NH groups and in coordination to 
cyclam-bound metal ions. Cyclam rings in metallocyclam complexes have 
configurational flexibility and in one model a folded cis configuration is stabilized by 
interactions with carboxylate side-chains 5 . 
The work reported in this chapter represents the first experimental 
characterisation of protein-metallocyclam interactions. The solution structures and 
x-ray crystal structures of Cu-cyclam and Cu2-xylyl-bicyclam complexes of 
lysozyme establish that protein recognition can involve a range of both polar and 
non-polar interactions. These include H-bonding between the cyclam ring and 
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protein carboxylate groups, which, for the Cu-cyclam structure, anchors the cyclam 
ring in the unusual folded cis configuration without direct coordination of Cu 2 to the 
protein. The key interactions in the solid state are with Trp123, Trp62, Trp63 and 
Asp 101. However in solution the key residues that interact with Cu(cyclam) are 
Trp62, Trp63 and Trp123, and for Cu2(xylyl-bicyclam), they are Trp62, Trp63 and 
Trp108. The solution studies of the interaction of the Ni-cyclam complex with 
lysozyme showed the major interactions to be only with Trp 63 and Trp 62. The 
presence of an additional cyclam ring, as in a xylyl-bicyclam, can influence the 
configuration adopted by the bound macrocycle. Intriguingly hydrophobic 
interactions between the cyclam ring and the indole ring of tryptophan, reminiscent 
of tryptophan-proline sandwiches often found at protein-protein interfaces, occur not 
only in the crystals of HEWL but also in aqueous solution. Such tryptophan stacking 
interactions are possible in models of CXCR4 adducts of metallocyclams which 
contain at the same time other features important for metallocyclam docking, 
including metal coordination to Aspl7l and Asp262. Tryptophan, an amphipathic 
amino acid, is often located towards the surface (interfacial regions) of membrane 
proteins21 , and may play a crucial role in the recognition of antiviral metallocyclams 
by the protein co-receptor. 
PM 
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Chapter 7 Conclusions and Future Work 
7.1 Conformations of Metallocyclams 
Xylyl-bicyclam has been found to be a potent anti-HIV drug," 2  and is also 
currently in clinical trials as a stem cell mobilization drug. 3 The zinc complex of 
xylyl-bicyclam has been shown to be more active that the ligand alone, whereas all 
other metals cause a decrease or a loss of activity."" Little is understood as to why 
this happens. Work in this thesis investigated the properties of metal cyclams, metal 
xylyl-bicyclams, and metal complexes of pyridyl isocyclam. 
Antiviral bicyclams target the membrane co-receptor protein CXCR4, 5 and 
co-receptor binding is enhanced by the presence of Ni 2t Cu2 or Zn2 in the cyclam 
ring. 6  Currently there are only structural models of CXCR4-cyclam adducts. 
6-8 
These models have emphasized the importance of aspartate carboxylate side-chains 
of CXCR4 in forming the fl-bonds to cyclam Nil groups and in coordination to 
cyclam-bound metal ions. Cyclam rings in metallocyclam complexes have 
configurational flexibility and in one model a folded cis configuration is stabilized by 
interactions with carboxylate side-chains. 8 
There are five possible trans configurations for metal-cyclam complexes in 
solution (Figure 1.12).' 10  The configurations that are symmetrical about the 
diagonal can fold to form cis isomers, e.g., the trans-V isomer can fold to give the 
cis-V structure. Work done here on Pd(II)-cyclam and Pd(II)2-xylyl-bicyclam 
showed the cyclam ring to be in the trans-Ill configuration in the solid and solution 
state. Varying the counterion had no effect on the configuration of the cyclam ring. 
Addition of acetate to the Pd(II)2-xylyl-bicyclam did not induceS any configurational 
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change in the cyclam framework. This is in contrast to Zn(ll)-cyclam and Zn(II)2-
xylyl-bicyclam, which forms a higher proportion of the cis-V configuration in 
solution when excess acetate is added. 
In the solid state, Ni(II)-cyclam was found to adopt the trans-Ill 
configuration, with axial counterions, whereas in solution, Ni(II) cyclam can also be 
found in the diamagnetic square-planar trans-I configuration. A paramagnetic 
configuration is also present in solution, as revealed by the NMR, likely to be the 
trans-Ill isomer, but this could not be fully characterised. Ni2(xylyl-
bicyclam)(OAc)4 was found to have a mixture of paramagnetic and diamagnetic 
peaks present in the 1D 'H NMR spectra. The presence of the two cyclam rings 
allows a mixture of paramagnetic-paramagnetic, paramagnetic-diamagnetic and 
diamagnetic-diamagnetic species to be present, as well as different configurations of 
these combinations. 
Cu(II)-cyclam was found to be trans-Ill in the solid state, with water bound 
in the axial positions, and acetate as a coünterion. The solution NMR supported this, 
with the acetate peak being the only non-broadened peak in the spectrum, showing 
that there is no configurational change between the solid and the solution state. The 
1D 'H NMR spectrum of Cu2(xylyl-bicyclam)(OAc)4 was significantly broadened 
because of paramagnetic broadening effects, due to Cu 2' being d9, therefore always 
having an unpaired electron. In the 1D 'H NMR spectrum, there was one 
unbroadened peak, from the acetate, at 1.93 ppm, suggesting that the structure is the 
same as that for Cu-cyclam one, in that acetate is not bound to the copper, just a 
counterion. 
Co(III)-cyclam adopts a trans-Ill configuration in the solid state, with acetate 
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in the axial positions. Three configurations were observed in solution, trans-Ill, 
trans-I and a further unidentified trans configuration. All the acetate was bound 
directly to the cobalt in solution, as no peaks were observed for free acetate. 
[CO2(xylyl-bicyclam)C14]Cl2 was found to have two trans cyclam configurations 
present. This complex was reacted with sodium acetate, and it was found that there 
was a significant change in the NMR spectra. The spectrum changed immediately 
upon addition, with the final product was obtained after 46 hours. Intermediate 
species formed and disappeared within this time. These were not identified due to 
their rapid appearance and disappearance. The final product consisted of only one 
trans-Ill isomer, shown by only 3 NH peaks in the ['H, 15N] HSQC. One of the NH 
peaks is shifted towards a high frequency (10.19 ppm), indicative of it being 
involved in hydrogen bonding with an acetate ion. 
All the solution structures for the metal-xylyl-bicyclams made here were 
found to be in trans configurations, which could explain the loss of activity 
compared to the zinc complex. The zinc complex has been shown to exist in three 
configurations in solution, trans-I, trans-II and cis-V. 8 In addition to this, addition of 
excess acetate has been shown to drive the formation of the cis-V configuration. 8 
However, in this case, no cis isomers were observed, either with or without the 
addition of excess acetate. 
It is possible that xylyl-bicyclam forms complexes with zinc in the blood, and 
that this is actually the active form in the body. As such, it could be considered a 
pro-drug. In order to see if xylyl-bicyclam could complex zinc under physiological 
conditions, it was reacted with zinc acetate and zinc histidine, with the. reaction 
followed by 1 H NMR. Both reactions occurred within 5 minutes and reached 
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equilibrium in this time. In the reaction with zinc acetate, trans-I, trans-Ill and cis-V 
were identified, with trans-I being the most abundant. However, the reaction with 
zinc histidine only produced two configurations, trans-I and trans-Ill. The bulky 
histidine appears to prevent the folding of the cyclam ring into the cis-V 
configuration. 
The macrocycle pyridyl isocyclam was successfully synthesised and two pKa  
values were determined, of 9.81 and 1.48. The macrocycle was also successfully 
complexed with Cd(II) and Zn(II). The novel metallomacrocycles were 
characterised using mass spectrometry and .NMR spectroscopy. Both the zinc and 
the cadmium complexes were found to be in two configurations, an unsymmetrical 
one and a symmetrical one. The unsymmetrical configuration was the most abundant 
in both cases. Addition of excess acetate to the zinc complex was found to have no 
effect on the configuration of the complex. These are the first reported metal 
complexes of this macrocycle. 
The bis-macrocycle of pyridyl isocyclam with a phenyl linker (AMD 3329) 
was synthesised and complexed with Cd(II), and the structure fully characterised 
using 2D NMR studies, including ['H, "Cd] HSQC NMR spectra. It was again 
found to exist in two configurations; however the unsymmetrical configuration was 
more abundant in this bis-macrocycle compared to the monomer complexes. This 
bis-macrocycle (AMD 3329) is the most potent anti-HIV.bis-macrocycle reported to 
date." 
The first experimental characterisation of protein-metallocyclam interactions 
was carried out in this work. The solution structures and x-ray crystal structures of 
Cu-cyclam and Cu2-xylyl-bicyclam complexes of lysozyme were studied, and the 
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key interactions in the solid state are with Trp123, Trp62, Trp63 and Asp101. Both 
polar and non-polar interactions between the protein and the metallomacrocycles 
were found. These include H-bonding between the cyclam ring and protein 
carboxylate groups, which, for the Cu-cyclam structure, anchors the cyclam ring in 
the unusual folded cis configuration without direct coordination of Cu 2 to the 
protein. In solution, the Cu-cyclam was found to interact with Trp62, Trp63 and 
Trp123, and for Cu2-xylyl-bicyclam, Trp62, Trp63 and TrplO8. The solution studies 
of the interaction of the Ni-cyclam complex with lysozyme showed the major 
interactions to be only with Trp 63 and Trp 62. Tryptophan is often located towards 
the surface (interfacial regions) of membrane proteins 12,  and may play a crucial role 
in the recognition of antiviral metallocyclams by the protein co-receptor. 
7.2 Future Work 
Future work that could be carried out on this project includes the following. 
Studying the binding of metal complexes of AMD 3329 and its component 
monomer with lysozyme; the 	complexes made here could be used for this. 
Analysis of the coordination number of the  metal in the Cd (and other) complexes 
using EXAFS. This could be significant in identifying how many amino acids the 
metal complexes of AMD 3329 would interact with. 
EPR studies on the paramagnetic copper and nickel cyclam and xylyl-bicyclam 
complexes. 
pH studies on Ni(II)2-xylyl-bicyclam to investigate if either the paramagnetic or 
diamagnetic form is favoured at various pH values. This would identify which 
configuration is significant in the body at physiological pH. 
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Temperature-dependence studies on the metal-xylyl-bicyclam complexes, using 
NMR spectroscopy, to study any configurational changes that might occur at higher 
temperatures. 
Synthesis of other metal complexes of AMD 3329, such as zinc and nickel, to 
investigate the configurations of the macrocycle when complexed to different metals 
and testing of these metal complexes for their anti-HIV activity. 
Study the interaction in solution of metallomacrocycles and bovine rhodopsin 
using NMR spectroscopy and x-ray crystallography. 
Preparation of xylyl-bicyclam with different metals in each cyclam ring, and 
investigating the solution and solid state structures of these heterometal bicyclarns. 
This type of study could also be carried out on AMD 3329. This would be useful in 
trying to control the configuration of each component macrocycle, as it seems to be 
the cis-V configuration that is important in the anti-HIV activity of xylyl-bicyclam. 
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